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Errata 
Insert the following paragraph after the second paragraph on page 19: 
Experimentally determined topologies for proteins with the above "6 + 6" TM structure 
usually have both their - and C-termini located in the cytoplasm (28, 78, 198). However, 
while membrane proteins with N -termini located in the perip lasm are less common, they 
are not unusual. For example, bacteriorhodopsin has 7 TM helices and a periplasmic N -
terminus (201 , and references therein). 
Insert the following paragraph after the second paragraph on page 69: 
The inhibition of cell growth by the addition of IPTG to AN3521 (pAN910 in MC15) cell 
cultures suggested that over-expression of the pitA::6xHis at the levels induced by IPTG 
from the TS promoter may be toxic to the cells. This was further tested by transferring 
pitA: :6xHis into vector pBR322, so the characteristics of P itA with a 6xHis tag could be 
compared with wild type PitA in a similar environment. While a protein was produced by 
zn vitro transcription/translation from this plasmid , it did not allow growth of strain 
A 3066 on 500µM Pi minimal media, unlike the PitA control plasmid. Thus the C-
terminal 6xHis tag has a detrimental effect on the activity of PitA. However, pitA :: 6xHis 
placed in the pGex vector system under the control of the tac promoter could grow in strain 
A 3066 upon the addition of IPTG. This strain showed negligible growth without IPTG 
induction. Thus under certain conditions PitA6xHis protein can allow Pi transport. The 
var ing results in different vector systems suggest that PitA6xHis protein can be toxic to 
cells. but this depends on the level of expression and other undefined conditions within the 
cells and cellular environment. , 
Replace the first paragraph on page 74 with the following paragraph: 
Measurement of 33Pi uptake by cells was carried out under conditions in which Pi uptake 
was linear over time. Examples of the experiments used to determine Krnapp and V rna~/PP are 
given in Figure 3 .17. Two families of curves exist for PitB activity, with significantly 
different V maxapp values. The experiments providing the two higher V maxapp values were 
carried out within a week of each other. Subsequent experiments could not replicate the 
high maximum velocities obtained here. All possible variables were checked, including 
buffers, substrates, equipment and cultures. Statistical analysis was used to combine the 
Km app and V max app parameters from individual experiments to produce the values listed in 
Table 3.3. 
Insert the following as the second paragraph on page 75: 
It is possible that the different V maxapp values obtained for PitB activity in Figure 3.17 
could be caused by a complex balance of regulatory systems that have a large effect on PitB 
expression ( discussed in more detail in Chapter 7.) 
Insert the following sentence after the second paragraph on page 108. 
Pi uptake for the PitA amino acid substitutions listed in Table 6.3 which have positive 
growth on 500µM Pi could be measured to ascertain whether these mutations also affect 
PitA activity. 
Statement 
The work described in this Thesis was performed by the author, except where 
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Abstract 
Escherichia coli contains two major systems for active uptake of inorganic phosphate 
(Pi). The high-affinity Pst system (pstSCAB) is induced by low external Pi 
concentrations as part of the pho regulon and is an ABC transporter, requiring ATP for 
active transport. The low-affinity Pit system had previously been shown to be a 
secondary active transporter, dependent on the proton-motive force, expressed 
constitutively and with all know,n mutations mapping to one locus. However, the 
discovery of a second E. coli Pit transporter by the Cox laboratory suggested these 
conclusions may need to be re-examined. These two Pit genes, subsequently named 
pitA and pitB, have a putative amino acid sequence identity of 81 % and preliminary 
experiments indicated that the proteins have significantly different Km app values for Pi. 
Thus, PitA and PitB have been characterised and compared to investigate the 
relationship between the structure and function of these Pi transporters. pitA and pitB 
were defined as separate E. coli gene products and the putative open reading frames 
were confirmed. Plasmid-borne PitA was found to have an apparent Km (Km app) of 
approximately 2µM, which was 14-fold lower than the Kmapp of 28µM obtained for 
PitB. 
Strain K-10 lacks Pit activity when the Pst system is mutated and this Pit mutation was 
identified. The K-10 strain contains a nonfunctional pitA, which has a single base change 
( G to A at nucleotide 65 8 in the open reading frame), causing an aspartic acid to replace 
glycine 220. This mutation greatly decreased the amount of PitA protein present in cell 
membranes, indicating that the aspartic acid substitution disrupts membrane protein 
assembly. Genomic pitB had wild type sequence, even though this strain was not active 
as a Pi transporter. 
Subsequent investigation of pitB regulation suggested that pitB encodes a functional Pi 
transporter whose repression at low Pi levels is mediated through the pho regulon. 
While wild type plasmid-borne pitB expressed in a pitA l1pstC345 mutant allowed 
growth on media containing 500µM Pi as the sole source of phosphate, E. coli with a 
wild type genomic pitB (pitA 11pstC345 double mutant) was unable to grow under these 
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conditions, making it indistinguishable from a pitA pitB L1pstC345 triple mutant. The 
mutation L1pstC345 constitutively activates the pho regulon, which is normally induced 
by phosphate starvation. Removal of pho regulon activation, by deleting the phoB-
phoR operon, allowed the pitB+ pitA L1pstC345 strain to utilise Pi and to transport Pi at 
rates significantly higher than background levels . In addition, post-transcriptional or 
post-translational regulation of PitB protein may also occur. This was suggested by an 
unexpected decrease in the Kmapp of plasmid-borne PitB in the pANl 116 plasmid 
construct that was accompanied by greatly increased levels of protein expression. 
The three charged residues His-225, Asp-229 and Lys-232 were shown to be important 
for PitA structure or function, as mutation of each residue to a polar amino acid greatly 
reduced the initial rate of Pi uptake, while still allowing assembly of the mutant protein 
in the membrane. These residues are analogous to charged amino acids important in the 
function of lactose permease and are identical to residues in PitB, with His-225 and 
Asp-229 being highly conserved throughout the PiT family of Pi transporters. A 
possible model for the secondary structure of PitA within the cytoplasmic membrane 
was revised to move this triad from a 'periplasmic loop 6' into a 'transmembrane 
ex-helix 6' position. (The alternative perisplasmic location of this loop still remains 
plausible.) This area of PitA is obviously important for the mechanism. As well as 
containing the above triad of amino acids, this putative transmembrane helix plus the 
putative 'loop 5' region contains sequence determining the difference in Km app between 
PitA and PitB, as shown by chimera analysis. Nearby single mutations G220D and 
A2 l 3 D cause complete loss of Pi uptake and minimal insertion of protein in the 
membrane. Mutation of amino acids associated with one of the 'highly conserved 
regions' of the PiT family of transporters completely abolished Pi uptake activity, while 
allowing normal levels of membrane protein assembly, indicating the importance of this 
sequence in Pit structure or function. More detailed studies are required before this 
information can be integrated into a mechanistic model for PitA function. 
Vl 
Abbreviations 
A adenosine 
A angstrom 
AMP adenosine monophosphate 
ANU Australian National University 
Amp ampicillin 
APS ammonium persulfate 
ATP adenosine triphosphate 
bp base pairs 
C cytosine 
oc degrees Celsius 
Cat chloramphenicol 
cpm counts per minute 
DNA deoxyribonucleic acid 
ds double strand 
DTT D L-dithiothreito 1 
EDTA ethylenediamine tetra-acetic acid 
G guanos1ne 
IPTG isopropyl ~-d-thiogalactoside 
JCSMR John Curtin School of Medical Research 
kb kilobase(s) 
kDa kilodalton( s) 
Km kanamycin 
K app 
m apparent maximum Km 
LB Luria Bertani 
mA milliamps 
mRNA messenger ribonucleic acid 
MDR multiple drug resistance 
ORF open reading frame 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
.. 
Vll 
Pi 
Pi media 
PMSF 
PVDF 
RF 
RNA 
rpm 
SEM 
SDS 
ss 
T 
TE 
TEMED 
TM 
Tris 
w/v 
UV 
V 
V app 
max 
v/v 
inorganic phosphate 
minimal media containing 500µM Pi as the sole source of phosphate 
phenyl-methansulfonylfluoride 
polyvinylidene difluoride 
replicative form 
ribonucleic acid 
revolutions per minute 
standard error of the mean 
sodium dodecyl sulfate 
single strand 
thymidine 
Tris-EDTA 
N.N.N'N' -tetramethyl-ethylenediamine 
transmembrane 
Tris {hydroxymethol amino-methane} 
weight per volume 
ultraviolet 
voltage 
apparent maximum velocity 
volume per volume 
Vlll 
Table of contents 
CHAPTER ONE 
GENERAL INTRODUCTION 
1.1 Phosphorus transport in Escherichia coli 
1.2.1 The outer membrane 
1.2.2 The periplasm 
1.2.3 The cytoplasmic membrane 
1.3 The phosphate transporters of Escherichia coli K-12 
1.3.1 PhoE 
1.3.2 Pit 
1.3.3 Pst system 
1.3.4 GlpT 
1.3.5 UhpT 
1.3.6 U gp system 
1.4 Regulation of inorganic phosphate transport in Escherichia coli 
1.5 Mechanisms of membrane transporters 
1.5 .1 Classification of membrane proteins by their mechanism of transport 
1.5.2 Secondary active transporters 
1.6 The PiT family 
1. 7 The structure of membrane proteins 
1. 7 .1 The basic structural motifs of membrane proteins 
1.7.2 The general structure of outer membrane ~barrel proteins 
1.7.3 The general structure of cytoplasmic membrane proteins 
1.8 Methods to determine membrane protein structure 
1.8.1 Direct methods for the determination of membrane protein structure 
1.8.2 Indirect methods for the determination of membrane protein structure 
1.9 The functional analysis of membrane proteins 
1.9. l Methods for the functional analysis of membrane proteins 
1.9.2 Structural and functional analysis of lactose permease 
1.9.3 The success of indirect techniques in structure and function predictions 
1.10 Aims of the project 
CHAPTER TWO 
EXPERIMENTAL PROCEDURES 
1 
1 
1 
2 
3 
4 
4 
5 
7 
8 
9 
10 
10 
13 
13 
14 
15 
16 
16 
17 
18 
21 
21 
25 
27 
27 
28 
33 
37 
38 
2.1 Bacterial strains and plasmids 38 
2.2 Oligonucleotide sequences 38 
2.3 Growth media 38 
2.4 General molecular biology techniques 40 
2.4.1 Small scale purification of plasmid DNA or replicative form M13 DNA 40 
2.4.2 Large scale purification of plasmid DNA by caesium chloride (CsCl) density gradient 41 
2.4.3 Purification of chromosomal DNA from E. coli 42 
IX 
2.4.4 Preparation of single-stranded Ml3 DNA 42 
2.4.5 Spectrophotometric analysis of DNA 43 
2.4.6 Agarose gel electrophoresis 43 
2.4. 7 "Rapid cracking" of phage or colonies 43 
2.4.8 Synthesis and preparation of oligonucleotides 44 
2.4.9 Polymerase chain reaction (PCR) 44 
2.4.10 Purification of PCR products 45 
2.4.11 Site-directed mutagenesis 45 
2.4.12 Manual sequencing of DNA 46 
2.4.13 Automated sequencing of DNA 48 
2.5 Recombinant DNA techniques 48 
2.5 .1 Restriction endonuclease digestion of DNA 48 
2.5 .2 Elimination of 5' and 3' protruding ends 49 
2.5.3 Removal of terminal phosphates from linearised DNA 49 
2.5 .4 Phosphorylation of oligonucleotides 49 
2.5.5 Purification of DNA fragments from agarose gels 50 
2.5 .6 Ligation of DNA 50 
2.5. 7 Preparation of competent E. coli 50 
2.5.8 Transformation of competent E. coli with plasmid DNA 52 
2.6 Genomic recombinant DNA techniques 53 
2.6.1 Genetic recombination on the E. coli genome 53 
2.6.2 Bacteriophage Plkc transduction 53 
2. 7 Protein biochemistry techniques 55 
2. 7 .1 Gel electrophoresis of proteins 55 
2. 7 .2 Coomassie staining of polyacrylamide gels 55 
2. 7 .3 Measurement of protein concentration 56 
2. 7 .4 Detection of protein by Western blot 56 
2. 7 .5 Preparation of cytoplasmic membranes from E. coli by centrifugation 57 
2. 7 .6 Preparation of cytoplasmic membranes from E. coli by ammonium sulfate precipitation 5 8 
2.7.7 Solubilisation of cytoplasmic membranes 58 
2.8 Over-expression and purification of protein using the 6xHistidine affinity tag 58 
2.9 In vitro transcription/translation of plasmid DNA 60 
2.10 Identification of E. coli cells able to transport inorganic phosphate (Pi) 60 
2.11 Inorganic phosphate (Pi) transport assay 61 
2.12 phoA alkaline phosphatase assay 62 
2.13 Production of antipeptide polyclonal antibodies 62 
2.13.l Peptides used for raising antibodies 62 
2.13.2 Immunisation of rabbits with Multi-Antigenic Peptides 63 
2.13.3 Detection of antipeptide polyclonal antibodies in rabbit serum 63 
2.13.4 Purification of polyclonal antipeptide antibodies from serum by immunoaffinity 
chromatography 64 
2.14 Analysis of DNA sequences using MacTargsearch 2.0 64 
CHAPTER THREE 66 
ESCHERICHIA COLI HAS TWO P/TGENES WITH DISTINCT 
CHARACTERISTICS 
3.1 Introduction 66 
X 
3.2 Comparison of the nucleotide sequences of pitA and pitB 67 
3.3 Are pitA and pitB genes or alleles? 67 
3.4 Over-expression and purification of PitA 68 
3.5 Identification of the translation starts of the pitA and pitB open reading frames using site-
directed mutagenesis 71 
3.6 Comparison of the deduced amino acid sequences of PitA and PitB 72 
3. 7 Kinetic parameters of PitA and PitB 73 
3.8 Discussion 7 4 
CHAPTER FOUR 76 
IDENTIFICATION OF THEE. COLI K-10 PIT MUTATION 
4.1 Introduction 
4.2 Identification of the E. coli K-10 pit mutation/s 
4.3 Functional analysis of pitAl from K-10 strain AN3066 
4.3. l pitAJ Pi transport 
4.3.2 Preparation of pitA(G220D) by site-directed mutagenesis 
4.3 .3 Analysis of PitA expression using polyclonal PitA antipeptide antisera 
4.3.4 Comparison of PitA assembly in strains containing either wild type pitA or pitAJ 
4.4 Discussion 
CHAPTER FIVE 
EXPRESSION AND REGULATION OF PITA AND PITB 
76 
77 
78 
78 
78 
79 
80 
81 
84 
5.1 Introduction 84 
5.2 Preparation of a Pi transport triple mutant 86 
5.3 Expression of wild type pitA 87 
5.3 .1 Expression of wild type pitA from the K-12 genome 87 
5.3.2 Expression of plasmid-borne pitA or pitB in a Pi transport triple mutant strain 88 
5.4 Expression and activity of wild type pitB 88 
5.4.1 Variability of pitB kinetic parameters Kmapp and Ymaxapp 88 
5.4.2 PitB antipeptide antibody production 89 
5.4.3 Investigation of PitB protein expression 90 
5.5 Regulation of pitB 91 
5.5. l Deletion of the phoB-phoR operon from pitA J fJ.pstC345 strains with/without genomic pitB 91 
5.5 .2 Effect of the pho regulon on pitB activity 92 
5.6 Discussion 93 
Xl 
CHAPTER SIX 
INVESTIGATIONS INTO THE STRUCTURE AND FUNCTION OF PITA 
6.1 Introduction 
6.2 Putative topological models for PitA and PitB 
102 
102 
104 
6.3 Identification of important amino acids in PitA 106 
6.3.1 Investigation of charged or polar amino acids located within the putative transmembrane helices 
of PitA 106 
6.3.2 Investigation of the role of other PitA amino acids 107 
6.4 Investigation of substrate binding by PitA and PitB through the construction and analysis of 
chimeras 108 
6.4.1 Preparation of pitA and pitB with silent restriction endonuclease sites 108 
6.4.2 Production and analysis of chimeras I 09 
6.5 Sequence comparison and domain analysis of PitA and PitB with other members of the PiT 
family 110 
6.6 Discussion 
CHAPTER SEVEN 
OVERVIEW AND FUTURE DIRECTIONS 
7 .1 Introduction 
7 .2 Regulation of the Pit system 
7 .3 Structure and function studies on PitA and PitB 
BIBLIOGRAPHY 
112 
118 
118 
118 
124 
131 
.. 
Xll 
Publications 
Harris, R. M., Webb, D. C., Howitt, S. M. and Cox, G. B. 2001. Characterisation of 
PitA and PitB from Escherichia coli J. Bacteriol. 183 :5008-5014. 
Xlll 
Chapter one 
General Introduction 
General Introauction 
1.1 Phosphorus transport in Escherichia coli 
Phosphorus plays a key role in the metabolism of all cells. It is intrinsic for DNA and 
RNA synthesis, is a key to the lipid component of membranes, is essential for cell 
energy and membrane transport and is involved in many cell signaling and regulatory 
functions through phosphorylation and dephosphorylation. Therefore it is not 
surprising that many bacteria have evolved multiple systems for transporting 
phosphorus. Escherichia coli can utilise inorganic phosphate (Pi), organophosphates or 
phosphonate as phosphorus sources for growth, although Pi is the preferred source. 
Many phosphorylated compounds which cannot be metabolised are hydrolysed to 
release Pi into the periplasm. When Pi is plentiful transport is carried out by general 
porins and the inner membrane Pit transporter. The level of external Pi regulates 
expression of genes in 0.5-1 % of the E. coli chromosome (204). When Pi 
concentrations become limiting, many proteins involved in Pi transport and metabolism 
are induced. These include an outer membrane porin, periplasmic enzymes which 
break down a variety of phosphorylated compounds and inner membrane transporters 
which have a high affinity for Pi or transport additional sources of phosphate, such as 
organophosphates or phosphonate (Figure 1.1 ). 
1.2.1 The outer membrane 
Gram negative bacteria have two membrane structures that nutrients have to cross 
before reaching the cytoplasm. The major function of the outer membrane is to act as a 
coarse sieve to exclude noxious molecules present in the external environment (184). It 
consists of an asymmetric lipid bilayer, with a lipopolysaccharide outer leaflet and a 
phospholipid inner leaflet. The hydrophobic core of this membrane prevents the entry 
of amphiphilic and hydrophilic compounds, while the outer leaflet of 
lipopolysaccharide is thought to reduce spontaneous diffusion by uncharged 
hydrophobic molecules by creating a membrane interior with low fluidity. Thus the 
outer membrane is 50-100 times less permeable to steroids than the symmetrical 
phospholipid bilayer of a typical inner (cytoplasmic) membrane ( 184 ). 
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Figure 1.1 
Proteins involved in phosphate transport under high and low 
external concentrations of inorganic phosphate (Pi). 
The transport systems and proteins involved are: 
Outer membrane 
OmpF/other general porins 
Transport small molecules (less than 600 Daltons ). 
PhoE (phosphoporin) 
Transports small molecules (less than 600 Daltons ), with a slight preference for 
negatively charged substrates. Induced by Pi limitation. 
Periplasm 
AP ( alkaline phosphatase) 
Breaks down a variety of phosphate compounds, releasing Pi. Induced by Pi 
limitation. 
Binding proteins from various binding protein dependent ABC transporters. 
Inner membrane 
Pit (low-affinity inorganic phosphate transporter) 
Transports inorganic phosphate. PitA seems to be constitutive. Single protein. 
Pst (high-affinity inorganic phosphate transporter) 
Transports inorganic phosphate. Induced by Pi limitation. A binding protein 
dependent ABC transporter consisting of PstS (binding protein), PstA and PstC 
(membrane components) and PstB ( contains the nucleotide binding domain). 
GlpT (sn-glycerol 3-phosphate transporter) 
Transports sn-glycerol 3-phosphate (G3P) .as a Pi-linked antiporter, and can 
provide a net uptake of Pi by importing 2 monovalent G3P in exchange for one 
divalent G3P. Induced by G3P or glycerol. Undergoes catabolite repression. 
UhpT (hexose phosphate transporter) 
Transports various hexose phosphates, such as glucose 6-phosphate (G6P) as a 
Pi-linked anti porter. May provide a net uptake of Pi by a similar mechanism to 
GlpT, but the available evidence is conflicting. Activated by external G6P. 
Undergoes catabolite repression. 
Ugp (G3P/glycerophosphoryl diester transporter) 
Transports G3P and glycerophosphoryl diesters. Induced by Pi limitation. G3P 
can provide the sole source of Pi through this transporter. Undergoes catabolite 
repression. This is a binding protein dependent ABC transporter. 
Phn (phosphonate transporter) 
Transports phosphonates (Pn) which have a direct phosphate/carbon bond. This 
binding protein dependent ABC transporter is induced by Pi limitation, but is 
cryptic in K-12 and K-10 strains. 
Figure 1.lA 
Phosphate transport at high inorganic phosphate (PJ concentrations 
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Figure 1.lB 
Phosphate transport at low inorganic phosphate (PJ concentrations 
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Proteins inserted in the membrane assist in the passage of nutrients, wastes and 
information and those exposed at the cell surface have also become receptors for 
pathogenic agents such as bacteriophages and bacteriocins (130). 
About 5 0% of the outer membrane consists of protein, either as lipoproteins anchored 
to the membrane by N-terminally attached lipids, or in the form of integral membrane 
proteins. In particular, this membrane contains a large number of pore forming proteins 
called porins, which allow the diffusion of ions and small hydrophilic molecules. 
Several porins have little solute specificity and behave as general diffusion channels 
(184), while other substrate specific porins have binding sites for nutrients such as 
maltose and carry out facilitated diffusion (14). TonB-dependent receptors concentrate 
large nutrient molecules present at low concentrations in the external environment, such 
as vitamin B 12, by using energy from the electrochemical potential of the cytoplasmic 
membrane. 
Inorganic phosphate (Pi) can diffuse through many of the general porins in the outer 
membrane. Under conditions of limiting Pi the general porin PhoE is induced. PhoE 
has a slight preference for negative ions but transports only molecules with a molecular 
mass below 600 daltons. Therefore larger polyphosphates and phosphorylated 
compounds diffuse through the outer membrane through proteins that have yet to be 
determined (204, 205). 
1.Z.Z The periplasm 
The outer membrane is attached by proteins to an underlying peptidoglycan layer which 
provides rigidity to the cell while being permeable to all nutrients and wastes (129, 
248). This polymer of amino sugars acts as a cell wall, preventing the rupture of the 
cytoplasmic membrane in environments of low osmolarity. 
The space between the outer and inner membranes, called the periplasm, contains the 
peptidoglycan layer and a gel composed of proteins and polysaccharides (97). The 
polysaccharides help to buffer the cell against the variable ionic and osmotic 
environments it may be exposed to. Periplasmic proteins are involved in the growth 
and maintenance of the outer membrane, the inactivation of toxins, chemotaxis and the 
processing of nutrients. The inner cytoplasmic membrane is impermeable to many 
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nutrients that can cross the outer membrane. Therefore many compounds, such as 
polyphosphates and organophosphates ( other than the sn-glycerol phosphates and 
hexose phosphates), must be broken down by periplasmic enzymes into transportable 
nutrients. The periplasm contains a number of phosphatases that release Pi from 
phosphorylated compounds. Some, such as acid phosphatase (appA) and 2'-3' cyclic 
phosphodiesterase ( cdpB) are present in the periplasm under all conditions, while others 
like alkaline phosphatase (phoA) are induced under conditions of Pi limitation. PhoA is 
important in Pi metabolism as it has a wide substrate specificity. The periplasm also 
contains specific binding proteins that efficiently deliver substrates present at low 
concentrations to their relevant transporters present in the inner membrane. Low 
concentrations of Pi induce the expression of substrate binding proteins for several high 
affinity transporters such as Pst (Pi transporter) and U gp (G3P transporter) 
(Figure 1.1 B) (204). 
1.2.3 The cytoplasmic membrane 
The inner cytoplasmic membrane consists of a double layer of phospholipid, rather than 
the asymmetric lipopolysaccharide/phospholipid bilayer of the outer membrane. It is 
much less permeable than the outer membrane. This allows nutrients to be 
concentrated across the inner lipid bilayer ( 184 ). The membrane is permeable only to 
water, oxygen, carbon dioxide and small hydrophobic molecules. This impermeability 
is maintained by specific integral membrane proteins which are required to transport 
ions and nutrients into the cytoplasm ( 46). Approximately 70% of the mass of the 
cytoplasmic membrane is protein, and these proteins have roles in nutrient and waste 
transport, energy generation, transmembrane signaling, chemotaxis and the 
translocation of envelope macromolecules (182). The impermeability of this membrane 
to protons and other ions allows the development of an electrochemical potential across 
this barrier which can be used directly by proteins to energise the concentration of 
nutrients in the cell, or it may be used to store chemical energy via the synthesis of 
ATP. Membrane proteins do form ion channels, but these are gated to preserve the 
integrity of the membrane potential (203). The cytoplasmic membrane is much more 
fluid than the outer membrane, due to the high phospholipid content of the lipid bilayer, 
allowing proteins to freely diffuse sideways within the plane of the membrane (243). 
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E. coli has four major systems which can transport Pi through its cytoplasmic 
membrane, with two of these being highly specific for Pi (211 ). The high affinity 
phosphate-specific transporter (Pst) is induced when Pi is scarce (170, 289), while the 
lower affinity inorganic phosphate transporter (Pit) is the general phosphate transporter 
(211). The sn-glycerol 3-phosphate transporter (GlpT) and the hexose phosphate 
transporter (UhpT) accept Pi as a low-affinity analog of G3P (91) and glucose-6P (199, 
295) respectively. In the absence of Pst and Pit neither of these transporters can 
support cell growth when supplied with Pi. Under physiological conditions these two 
systems are induced by the presence of their respective organophosphates in the extra-
cellular environment, and can use these to fill the cell's carbon requiren1ents. While 
GlpT can reportedly use G3P as the sole source of Pi (23 7, 249), there are conflicting 
reports on the ability of Uhp T to do the same when supplied with glucose-6P Pi ( 101, 
249). A second sn-glycerol-3-phosphate transporter (U gp) induced by the pho regulon 
under conditions of Pi limitation, is probably the preferred mechanism for supplying Pi 
from G3P (Figure 1. lB) (302). 
Many bacteria can also use phosphonates (Pn) as the sole source of phosphate under 
conditions of Pi limitation. Phosphonates have a direct carbon-phosphorus bond in 
place of the carbon-oxygen-phosphorus ester linkage found in organophosphates. E. 
coli contains a binding protein dependent Pn transporter that is under pho regulon 
control ((280) and references therein). However Pn utilisation is cryptic inE. coli K12, 
due to a frameshift mutation in the phnE (EcoK) gene, so Pn cannot serve as a source of 
phosphate in this strain ( 160, 282). 
1.3 The phosphate transporters of Escherichia 
coli K-12 
1.3.1 Pho£ 
Phosphoporin (PhoE) is an outer membrane porin which allows the diffusion of small 
hydrophilic molecules, (less than 600 daltons ), through a water filled channel. The 
X-ray crystal structure of PhoE has been solved, showing it to form stable trimers, each 
consisting of a 16-stranded anti-parallel ~-barrel with one strand looping into the 
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internal channel to form a constricting eyelet ( 42). This porin is weakly anion selective 
(13), and this charge specificity is provided by positively charged residues on the 
eyelet, within the channel and near the channel mouth (11, 15, 267). PhoE expression 
is induced by the pho regulon under conditions of phosphate limitation (See Section 1.4 
for details), increasing the diffusion rate of anions, such as small polyphosphates, 
through the outer membrane. However these molecules, plus various 
organophosphates, also enter the periplasm via other proteins which have yet to be 
determined (205). While voltage gated closing of this porin can be induced (235), it is 
not certain that this occurs under physiological conditions ( 130, 183, 23 9). 
1.3.2 Pit 
Studies on Pit in wild type cells (170, 290), Pst deficient mutants (212), spheroplasts 
(211) and membrane vesicles ( 131) suggest that Pit is a constitutive system which 
catalyses an electrogenic symport of Pi and protons. Transport of these substrates is 
coupled exclusively to the proton motive force and is completely abolished by the 
uncoupler CCCP (211 ). Divalent cations, such as Mg2+ or Ca2+, were shown to be 
essential for Pit activity (218) and experiments by van Veen et al (268) with membrane 
vesicles indicate that Pi is transported as a neutral metal phosphate (MeHPO4) chelate 
formed by complexation of divalent metal ions, such as Mg2+, Ca2+, Mn2+, or Co2+ 
with HPO4 2-. The complex is symported with a proton stoichiometry close to one 
(268). This cotransport of divalent metal ions is supported by the recent identification 
of a pitA mutant that accumulates reduced amounts of zinc(II), conferring resistance to 
toxic external concentrations of zinc (12). 
Efflux and homologous exchange of metal phosphate can occur under particular 
conditions, but there is no mixed exchange of metal phosphate for Pi, glycerol-3-
phosphate or glucose-6-phosphate. As expected, efflux was inhibited by the proton 
motive force, with the deprotonation of the carrier on its outer surface the limiting step 
(268). Interestingly, Beard et al (12) suggest that PitA may also play a role in Zn2+ 
efflux when the ion reaches toxic external concentrations (>2mM). The strictly aerobic 
bacteria, Acinetobacter johnsonii, which accumulates polyphosphate, becomes enriched 
in wastewater treatment plants with alternating aerobic and anaerobic conditions by 
generating a proton-motive force through the coupled efflux of MeHPO4 and protons 
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(269). During exchange the Pit carrier is recycled in a protonated form. Exchange was 
inhibited by the membrane potential only, presumably by preventing the outward 
movement of this positively charged ternary complex (268). 
Pi transport in E. coli has also been shown to be increased by K+ (170). Russell and 
Rosenberg (217, 218) showed that K+ transport indirectly stimulated Pit. Electrogenic 
K+ uptake coupled to H+ expulsion helps cells to maintain an alkaline pH in the cytosol, 
preventing the internal deprotonation of Pit being inhibited by high H+ concentrations. 
Pit is the low affinity transporter of Pi in E. coli, having an apparent Km (Kmapp) for Pi 
which is between 40- to 200-fold higher than the Pst system (Kmapp ,_,0.2 µM (211, 
290)). The kinetic constants for Pit have been measured under a variety of conditions 
producing a Kmapp of between 12 and 38µM. Originally the Kmapps of Pit and Pst were 
measured simultaneously in wild type cells, giving Pit a Kmapp of 9.2µM (pH 7.0, 
400µM MgSO4) (170). When Pit was genetically isolated from Pst a Kmapp of 25_µM 
(pH 6.9, lmM MgSO4), or 38.2µM (pH 7.5, 8mM MgSO4) was observed in whole cell 
assays (211, 290). The Kmapp obtained for Pit in membrane vesicles was l 1.9µM (pH 
7.0, 1 0mM MgSO4). However at pH 7.0 only 36% of Mg2+ is complexed with HPO42-
giving MgHPO4 a Kmapp of 8.8µM (268). 
Elvin et al (59) isolated a Pit gene that confers Pi uptake on a Pi auxotrophic pit pst 
mutant in a dosage dependent manner. The single copy plasmid pCE26 expressing Pit 
could restore wild type activity, showing pit+ to be dominant over pit, while the 
multicopy plasmid pCE27 could increase uptake 8- to 10-fold. While there is no direct 
proof that the Pit system has a single membrane component, Elvin et al (59) suggest 
that this amplification would not be expected if Pit was not the sole component of this 
system (60). 
There are now over 50 members of the PiT transporter family, which is defined by 
homology to domain PD 1131 (ProDom database - (3 7)). All characterised PiT 
members transport Pi, with the exception of cysP, an inorganic sulfate transporter 
(167). This family is described in more detail in Section 1.6. 
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1.3.3 Pst system 
If the external Pi concentration falls below around O. lmM, the high-affinity phosphate-
specific transport (Pst) system is induced by the pho regulon (291 ). This has a Km app 
for Pi of around 0.2 µM (211, 290). The Pst system is a periplasmic binding protein-
dependent transport system composed of four proteins. PstS is the periplasmic binding 
protein, while PstA and PstC are integral membrane proteins that are proposed to have 
6 transmembrane (TM) a-helices each. PstB is a hydrophilic protein associated with 
PstA and PstC on the cytoplasmic side of the membrane that contains an ATP binding 
fold and is thought to be important in energy generation for the system (31, 7 4, 284 ). 
The pst operon contains genes for these four proteins plus pho U, which encodes a 
protein required for repression of the pho regulon but which is apparently not required 
for Pi transport through the Pst system (2, 254, 259). An intact Pst system is also 
thought to be required for repression of the pho regulon, and may play a role in 
detecting the external Pi concentration. Many Pst mutants derepress the pho regulon as 
well as prevent Pi uptake. However, there are single amino acid substitutions within 
PstA and PstC membrane proteins which separate these functions, inactivating Pi 
transport without affecting pho regulon control ( 43, 44). This is discussed further in 
Section 1.4. 
Site-directed mutagenesis studies indicate R-220 in PstA and R-237 and E-241 in PstC 
are required for Pi transport and that these residues interact with each other, possibly by 
forming a Pi relay system. Paired proline residues may also play an important role in 
the configuration of the protein. A double proline to alanine PstC mutant caused a 
permanently 'open' conformation in Pst and the equivalent double proline PstA mutant 
represented a permanently 'closed' configuration (284). 
The X-ray crystal structure of the PstS binding protein shows that Pi is tightly held in 
place by 12 hydrogen bonds and is totally devoid of water of hydration. Eleven of 
these hydrogen bonds are donor groups (mainly from peptide backbone NH and side 
chain OH groups, plus one arginine side chain ) and one aspartic carboxylate side chain 
is an acceptor group, recognising a proton on either the monobasic or dibasic Pi. 
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Therefore there are no strong charge interactions ( 155). Whether other Pi transporters 
bind Pi in a similar manner is not known. 
1.3.4 GlpT 
sn-glycerol 3-phosphate is a precursor for membrane phospholipid biosynthesis, and 
can also be used by the cell as the sole source of carbon or phosphate. When used as a 
carbon source G3P is taken up exclusively by the GlpT transport system, whose genes 
are induced by the presence of glycerol or G3P as part of the glp regulon. Repression 
occurs via the glp repressor GlpR in the absence of glycerol or G3P, and through 
catabolite repression mediated by CAP-cAMP (56). 
GlpT is a Pi-linked antiporter which catalyses the uptake of G3P by electroneutral 
exchange of G3P and Pi, although it is also able to exchange Pi:Pi or G3P:G3P. Other 
substrates identified include glycerol-2-phosphate, arsenate and phosphonomycin ( 61 ). 
It is a chemiosmotic transporter, concentrating substrate by use of the electrochemical 
potential of the cell. GlpT may be able use G3P as the sole source of phosphate, as 
well as carbon (237). Maloney et al (164) proposed a mechanism whereby GlpT can 
have a net import of Pi. Antiporters recognise both the monovalent and divalent forms 
of their substrates. As the cytoplasm is usually more alkaline than the periplasm, two 
monovalent G3P can be imported, while one divalent G3P is exported, giving a net 
import of a divalent G3P and two protons (164). However, under conditions of Pi 
limitation Ugp, a G3P transporter induced by the pho regulon, would be expected to be 
the normal route ofG3P import (Figure 1.1B) (302). 
GlpT is a member of the Major Facilitator Superfamily (227) and has a typical topology 
of 12 TM a-helices, which has been supported by PhoA and Lacz protein fusion 
experiments (78). The protein has been over-expressed, purified and actively 
reconstituted into liposomes ( 6). While this protein has been found to operate as a 
monomer, the native protein has been identified as a homo-oligomer ( 141 ). 
Several E. coli strains that were originally selected for wild type Pit activity by their 
sensitivity to arsenate, such as strain C600, underwent rapid Pi exchange when supplied 
with carbon sources other than glucose. These were found to have a glpR mutation that 
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causes arsenate sensitivity as well as rapid Pi exchange through constitutive expression 
of GlpT (61). This occurs because GlpT can substitute arsenate for Pi in its catalysis of 
G3P:Pi antiport or Pi:Pi exchange. Glucose inhibits this response by causing catabolite 
repression of the glpT gene. Although wild type Pit is sensitive to arsenate, constitutive 
GlpT confers arsenate sensitivity on pit mutant strains that would otherwise be 
resistant, such as strain HR159 (pit zhg::TNl0 glpR). Thus, isolation of Pit mutants 
using the auxotrophic requirement for G3P has proven to be a less ambiguous selection 
criteria than arsenate resistance ( 60, 249). 
1.3.5 UhpT 
The hexose phosphate transporter has a high degree of sequence similarity to GlpT, and 
is also an obligate anion antiporter whose main function is assumed to be the import of 
sugar phosphates for use as a carbon source (164). UhpT catalyses the uptake of a 
number of organophosphate compounds including the phosphate esters of hexoses, 
pentoses, heptoses, amino sugars and sugar alcohols by electroneutral exchange with Pi 
(119). Pi:Pi exchange also occurs, as in the similar GlpT system (247). Thus active 
transport is directly coupled to the downhill movement of Pi (119). There are four 
genes in the uhp operon, which are all essential for uhp expression. Induction through 
the uhp regulatory system (UhpA, UhpB) is activated by external glucose 6-P. A third 
protein, UhpC, is also involved in signaling the presence of glucose 6-phosphate (104). 
The promoter contains multiple sites for UhpA and also contains a single binding site 
for the cAMP-dependent transcriptional activator CAP ( 172). UhpT is a member of the 
Major Facilitator Superfamily (227) and contains 12 TM segments, based on 
hydropathy profiles and a number of phoA gene fusions (149). 
It has previously been reported that UhpT supplied with organophosphate can provide 
the cell's sole source of phosphate (249). This would be possible through a mechanism 
similar to that described for GlpT, using glucose 6-P instead of G3P (164). However 
Hoffer et al (101) have been unable to grow pit pst strains with glucose 6-P as the 
phosphate source and either glucose or glycerol as the carbon source. (This strain does 
grow with G3P as the phosphate source, which could be transported through either 
GlpT or Ugp.) 
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1.3.6 Ugp system 
The Ugp transporter catalyses the uptake of G3P and glycerophosphoryl diesters (the 
diacylation products of phospholipids) and is induced by the pho regulon under 
conditions of Pi limitation (4,237). When G3P is taken up exclusively by Ugp it can be 
used as the sole source of Pi but not as the sole source of carbon (26). However 
Kasahara et al ( 120) found that the ugp operon contains a second promoter with a 
cAMP-CRP binding site that is induced by carbon starvation, suggesting U gp plays a 
role in carbon metabolism. U gp activity increases the internal Pi concentration upon 
degradation of transported G 3 P, and is inhibited by high intracellular Pi concentrations 
(302). 
U gp is a periplasmic binding protein-dependent transport system. It consists of four 
proteins, which are a substrate binding protein (U gpB) two integral membrane 
components (U gpA and U gpE), and an ATP-binding subunit (U gpC) ( 4, 302). 
• • 1nor9an1c 1.JJ. Regulation of phosphate 
transport in Escherichia coli 
When inorganic phosphate (Pi), the preferred phosphorus source for E. coli, is in excess 
the low affinity Pit transport system imports the phosphorus requirements of the cell. 
Genes involved in the high affinity transport of Pi and the transport and assimilation of 
other phosphate sources are only activated when the Pi concentration in the culture 
medium becomes low, falling below 0.1-lmM (291). The induction of many of these 
genes is mediated through the pho regulon (280). Recent 2D protein experiments, 
which examined only proteins with pls less than seven, have shown that the pho 
regulon induces about 118 proteins and represses around 19 proteins under conditions 
of Pi limitation (2 71 ). Over 3 8 of these genes have been identified, with most being 
involved in phosphate transport and/or assimilation (86, 281 ). 
The pho regulon is controlled by the phoB-phoR operon which has identity to a number 
of two-component regulatory systems that sense and respond to changing 
environmental stimuli in bacteria (210). Pi-dependent activation requires the histidine 
kinase PhoR to autophosphorylate and then phosphorylate the transcriptional regulator 
PhoB. A phosphorylated PhoB dimer then activates genes in the pho regulon by 
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binding to a pho box consensus sequence found within the regulatory regions of these 
genes, which is also present in the phoBR operon, allowing auto-amplification of the 
system ((161) plus references therein, 83, 191,242, 280). When the Pi concentration is 
restored to normal, interactions between the Pst system, Pho U and PhoR catalyse 
dephosphorylation of PhoB, and transcription is suppressed (Figure 1.2) ( 181, 282). 
While the mechanism of this inhibition has yet to be determined, it has been shown that 
the majority of mutations in either PhoU or any of the four Pst proteins result in high 
constitutive pho regulon gene expression. It is believed that the Pst system plays a role 
in the detection of the external Pi concentration to initiate inhibition of the pho regulon, 
and that this repression is independent of Pi transport, as specific mutations in PstA or 
PstC abolished Pi transport without affecting repression ( 43, 44). PhoU is a product of 
the pstSCAB-pho U operon, and is loosely associated with the inner membrane but has 
no role in Pi transport (250). An extremely deleterious growth defect caused by a phoU 
deletion was found to be a consequence of high-level Pst synthesis (84). External Pi 
was proposed to provide the signal for pho regulon activation and inhibition because 
derepression of the pho regulon by low external Pi concentrations is not accompanied 
by a lowering of the cell's internal Pi concentration (280). Recently, this idea has been 
challenged by evidence that overproduction of either PitA or PitB in the absence of the 
PstS phosphate binding protein can restore regulation of the pho regulon. Hoffer et al 
(100) propose that PhoU associated with the Pst system may detect Pi concentration 
internally by direct access to Pi that enters the cell via this system. PitA or PitB 
transport Pi as a neutral complex associated with divalent cations (268), which 
normally may not be available to PhoU. However upon overproduction of Pit in the 
PstS mutant, this Pi may become accessible to PhoU (Figure 1.3). 
PhoB consists of an N-terminal phosphorylation domain and a C-terminal DNA-
binding/transactivation domain, which interacts with the RNA polymerase cr70 subunit 
and the DNA binding sequence TGTCA (159). There is evidence that these domains 
interact in the inactive, unphosphorylated PhoB (58). PhoB is activated by 
phosphorylation, which disrupts this interaction and allows the dimerisation of PhoB 
through the N-terminal domains (65). The crystal structure of the N-terminal domain 
has recently been determined, showing it is similar to other response regulators from 
the two component regulator family (246). The three dimensional nuclear magnetic 
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Figure 1.2 
Postulated mechanism for the involvement of the Pst system 
in the repression of the pho regulon. 
This diagram is modified from Wanner, B. L. (280). 
Under low Pi conditions Pi-dependent activation requires the histidine kinase PhoR to 
autophosphorylate and then phosphorylate the transcriptional regulator PhoB. A 
phosphorylated PhoB dimer then activates genes in the pho regulon by binding to a pho 
box consensus sequence found within the regulatory regions of these genes. When the 
Pi concentration is restored tQ normal, interactions between the Pst system, Pho U and 
PhoR catalyse dephosphorylation of PhoB, and transcription is suppressed. 
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Proposed control of the pho regulon by internal inorganic 
phosphate (P) concentrations. 
Overproduction of either PitA or PitB in the absence of the PstS phosphate 
binding protein can restore regulation of the pho regulon. Hoff er et al (100) 
propose that PhoU associated with the Pst syste1n may normally detect Pi 
concentration intemall y by direct access to Pi that enters the cell via this 
sys te1n. PitA or PitB transport Pi as a neutral complex associated with 
divalent cations, which usually may not be available to PhoU. However upon 
overproduction of Pit in the PstS mutant, Pi transported through either Pit 
protein 1nay beco1ne accessible to PhoU. 
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resonance (NMR) structure of the C-terminal domain has also recently been solved, 
allowing interactions of this domain with the pho box to be proposed and modeled 
( 191 ). 
Genes activated by the pho regulon contain an 18 base consensus pho box normally 
located 10 bases upstream from the -10 region of the promoter which effectively 
replaces the -35 promoter region ((191) and references therein). The generally accepted 
sequence is 5'-CTGTCATA(A/T)A(T/A)CTGTCA(C/T)-3', which consists of two 
binding sites for PhoB separated by an AT-rich region. NMR studies using the PhoB 
binding/transactivation domain and a variety of DNA molecules confirmed that two 
PhoB molecules bind in tandem on the pho box. PhoB recognises the TGTCA 
sequence in the major groove of the DNA with an a-helical region and contacts the 3' 
site out of this TGTCA sequence within the minor groove in a non-specific but 
stabilising manner ( 191 ). Each PhoB within the dimer binds to the DNA sequence 
about 11 nucleotides apart, which is slightly greater than one tum in the standard B-
form DNA conformation, enhancing DNA bending in this region. It is proposed that 
phosphorylated PhoB and the cr 70 subunit from RNA polymerase holoenzyme are 
positioned close to each other (159). 
The promoter regions of several genes induced by the pho regulon contain multiple 
copies of the pho box (280). The psiE promoter contains two pho boxes, one over the 
-3 5 region and a second four bases upstream of the first. Both sequences are protected 
from DNaseI in the presence of PhoB. A binding site for cAMP-CRP covers the 
putative -35 region and overlaps the downstream pho box. In low glucose, low 
phosphate conditions, when both phosphorylated PhoB and cAMP-CRP would be 
present in high concentrations, in vivo data suggests PhoB binding predominates (124). 
The phoE promoter also contains two pho boxes in a similar arrangement to the ps iE 
promoter. Both are required for full expression of PhoE during phosphate starvation. 
Optimisation of the -10 region created a mutant with high basal levels of expression 
under high phosphate conditions. This expression was partly dependent on the 
presence of the phoB gene. Only the downstream pho box was necessary for full phoE 
induction of this mutant under low phosphate conditions. Thus regulation of this 
promoter is carefully balanced by deviations from the optimal -10 region and by the 
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presence of several copies of the pho box, which enhance expression under phosphate 
starvation (236). 
Most research has concentrated on the genes activated by the pho regulon. The 
mechanism of repression for pho regulon genes has yet to be determined. Significant 
evidence for an inhibitory role for PhoB has only recently been published and will be 
discussed in detail in Chapter 5. 
1.5 Mechanisms of membrane transporters 
1.5.1 Classification of membrane proteins by their 
mechanism of transport 
Many transporters in the cytoplasmic membrane couple transport with the input of 
energy, as they often function to concentrate compounds within the cell. There are four 
basic classifications for these transporters based on the presence or nature of the energy 
source. These are: 
1 facilitated diffusion 
2 secondary active transport 
3 group translocation 
4 primary active transport 
(See Figure 1.4) 
Facilitated diffusion allows a compound to diffuse down its concentration gradient until 
equilibrium concentrations are achieved. There are very few of these transporters in E. 
coli, with the glycerol facilitator GlpF being one example (93, 187). These are 
sometimes classified as the uniporter subgroup within secondary transporters. Many 
secondary active transporters couple the uphill transport of a substrate to the 
electrochemical potential of the membrane by the downhill transport of an ion. This 
may occur by symport ( e.g. the influx of H+ or Na+ with substrate) or antiport ( e.g. the 
export of Pi coupled to the import of substrate). Group translocation systems tightly 
couple the import and phosphorylation of a sugar to the breakdown of intracellular 
phosphoenolpyruvate (PEP). The only family in this category is the 
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Figure 1.4 
Mechanisms of cytoplasmic membrane transporters. 
Facilitated diffusion is a passive process, while the re1naining mechanis1ns of 
transport are active, requiring energy input fro1n either ATP hydrolysis or a 
substrate 1noving down its electrochemical gradient. 
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phosphoenolpyruvate (PEP) phosphoryl transfer-driven group translocators. Primary 
active transport uses ATP hydrolysis to energise transport. One example is the 
periplasmic binding protein dependent systems. These translocators have high affinity 
for their substrates, particularly when compared to secondary transport systems specific 
for the same substrate. For example, Pst is an active transporter (Km,..., 2µM), while Pit 
is a secondary transporter (Km,..., 25 µM). Substrates are bound by a periplasmic binding 
protein and delivered to a membrane transporter that contains four modules. These 
have two membrane spanning regions and two nucleotide binding domains which may 
be fused as one, two or four peptides. Other types of primary active systems include 
pumps such as the Na+/ ATPase and ABC transporters without binding proteins. 
1.5.2 Secondary active transporters 
Secondary transporters use an electrochemical potential to drive the uptake or efflux of 
substrates across the membrane. Bacteria develop an electrochemical potential by 
using chemical, light or redox energy to translocate ions across the cytoplasmic 
membrane. Usually protons are exported, but a number of bacteria can also use sodium 
ions. The difference in concentration of these ions on each side of the membrane 
creates an electrochemical gradient, which has an electrical potential, and a chemical 
potential (pH for protons, pNa for sodium ions). Secondary transport systems convert 
the electrochemical energy of one solute into the electrochemical energy of another 
solute. This may be done by coupling the downhill transport of protons or sodium ions 
with the uphill transport of solute (symport). 
There are three groups of secondary transport proteins. Uniporters catalyse the 
transport of only one solute down an electrochemical gradient and these solutes are 
usually neutral or positively charged. Symporters couple the transport of two or more 
solutes (with one usually being a proton or sodium ion) in the same direction. 
Anti porters couple the import of one solute to the export of another. Usually one solute 
is a proton or sodium ion, but other ions such as phosphate are also used ( e.g. the GlpT 
Pi-linked antiporter). Under certain conditions secondary transport systems can reverse 
their direction of transport, building up the proton ( or sodium) motive force by letting 
the substrate move down its concentration gradient. 
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Secondary transporters often import nutrients such as sugars, amino acids and ions, and 
account for approximately 40% of the active transport in E. coli and S. typhimurium 
(163). Currently the Transport Commission Database, set up by the Saier Laboratory 
Bioinformatics Group (University of California, San Diego), has 80 different families 
listed in the porter subclass of secondary transporters. The largest family is the Maj or 
Facilitator Superfamily, which currently contains over 1000 sequenced members, 
including lactose permease. Another family is the Inorganic Phosphate Transporter 
(PiT) family, to which PitA and PitB belong. 
1.6 The PiT family 
The PiT family contains transporters belonging to a wide variety of organisms such as 
Gram-positive and Gram-negative bacteria, archaea, yeast, fungi, plants and animals 
(121, 174,226). The Transport Commission has defined the PiT family as containing a 
signature sequence (226) and this sequence forms part of domain PD 1131 (ProDom 
database - (3 7)) which is usually duplicated within each protein (229). Most PiT 
family members which have been functionally characterised catalyse inorganic 
phosphate (Pi) uptake energised by either H+ or Na+ symport - depending on which ion 
can be used to develop an electrochemical membrane potential in the particular 
organism (21, 122, 168, 192,211,270,289,293). PitA and PitB from Escherichia coli 
have been shown to import Pi as a neutral divalent metal ion complex (268). Currently, 
only cysP from Bacillus subtilis, which is a sulfate permease, has a different substrate 
profile. Inorganic sulfate is structurally quite similar to Pi and the ability of cysP to 
also transport Pi has yet to be determined (167). While the majority of active transport 
systems in bacteria, fungi and plants use the proton-motive force, several Pit proteins in 
these organisms can be coupled to the sodium-motive force, sometimes exclusively (21, 
168). The sodium-motive force is used by animal PiT genes ( 122, 192). 
Several PiT family phosphate transporters from varied organisms seem to serve as the 
general Pi importer for Pi used to sustain normal cellular function. These include PitA 
from Escherichia col~ type III NaPi transporters (PiT-1 and PiT-2) in mammalian 
tissues and Pht2;1 in the vascular plant Arabidopsis thaliana (211, 122, 47, 192, 293). 
Other members are more specialised, such as Pho89 from Saccharomyces cerevisiae, 
and Pho4 from Neurospora crassa which require alkaline conditions to function (168, 
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274). Thus Pit regulation can be quite varied. Pit may be constitutive (289), or 
expression may be stimulated (21, 34, 121, 168) or repressed (9) by phosphate 
starvation. Modulation of activity may also be caused by pH (168, 274), by molecules 
such as insulin-like growth factor 1 (194) or by the binding of retroviral envelope 
glycoprotein (133, 174, 190). The mammalian transporter PiT-2, which seems to exist 
in active or inactive conformations, associates with the actin cytoskeleton network and 
forms high molecular-weight complexes when Pi concentrations are low. This suggests 
post-translational changes may be important for function (207). 
Some species, such as humans, rats, the nematode Caenorhabditis elegans and a 
growing number of prokaryotes such as Pseudomonas aeruginosa, and Listeria 
monocytogenes have several different but related Pit transporters (122, 272) (NCBI 
Blast analysis performed at SIB (1)). In rats PiT-1 and PiT-2 have distinctive, but 
overlapping, expression in a wide variety of tissues, and over-expression of PiT-2 in rat 
fibroblasts severely repressed PiT-1 synthesis transporters (122) (121). Genetically 
unrelated Pi transporters are also present in these organisms, so analyses of organisms 
with multiple Pit genes and multiple Pi transporters are revealing complex and subtle 
interactions. 
1. 7 The structure of membrane proteins 
1.7.1 The basic structural motifs of membrane proteins 
Membrane proteins need to traverse a lipid bilayer that has a strongly hydrophobic 
core, (i.e. a very low dielectric constant), where it is energetically costly to place 
charged and polar residues. Polypeptide chains, which can hydrogen bond with water 
in an aqueous environment, need alternate sources of hydrogen bonds in a lipid 
environment. There are two conformations of polypeptide chains that maximise the 
number of hydrogen bonds - a-helices, which bond internally, and ~-sheets, where the 
bonds form between different strands (214). Sequence analysis of cytoplasmic 
membrane proteins has found that many have regions containing hydrophobic residues 
which also have a high propensity for forming a-helices that are long enough to cross 
the cytoplasmic membrane. Recently determined atomic structures of the prokaryotic 
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potassium channel, KcsA (50), and the E. coli lipid flippase, MsbA (32), are just two 
examples of structural studies which support a consensus protein topology of 
hydrophobic and amphipathic a-helices connected by hydrophilic loops. In contrast, 
crystallographic studies on outer membrane proteins suggest that most of these proteins 
form anti-parallel ~-sheets which are arranged in a barrel conformation (130). This 
~-sheet structure allows outer membrane · proteins to have, in general, a low overall 
hydrophobic content, as only alternate side chains need to be exposed to the lipid 
bilayer. It has been proposed that these characteristics allow outer membrane proteins 
to be translocated through the cytoplasmic membrane into the periplasm, whereas the 
more hydrophobic a-helical sequences of inner membrane proteins may be retained by 
the cytoplasmic membrane (240). 
1.7.2 The general structure of outer membrane ~ -barrel 
proteins 
High resolution structures of 6 outer membrane protein families show all form 
~-barrels with an even number of ~-strands. Each ~-strand lies adjacent to the next 
~-strand in the sequence, and these motifs are connected to each other by loops. 
Despite these similarities in secondary structure, the cross-sectional shapes of these 
~-barrels vary considerably. Analysis of 11 outer membrane proteins whose atomic 
structures have been determined shows the length of these ~-strands vary between 6 
_(the minimum needed to span the membrane) and 25 amino acids, with an average 
length of 12.3 residues (130). Interestingly, while these ~-strands start at the 
periplasmic boundary of the outer membrane, they often extend out into the external 
environment. The loops exposed to the outer environment are often long (2-46 
residues) and hydrophilic, and display considerable sequence variability within 
families. This variability is most probably an adaptation to the role these regions play 
as receptors for phages or bacteriocins (130). On the periplasmic side of the membrane 
~-strands are connected by short ( 1-12 residues) peptide loops. The general porins are 
stable as homotrimers, while other outer membrane proteins may be monomeric. In 
general, the outside of a ~-barrel, contacting the lipid bilayer, is covered by non-polar 
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side chains (with a clear preference for large hydrophobic residues such as 
phenylalanine, leucine, isoleucine and valine ), while the interior cavity is much more 
hydrophilic (263 ). The residues which form the transmembrane (TM) ~-strands are 
highly conserved within families, particularly those lining the interior of the ~-barrel 
(130). 
1.7.3 The general structure of cytoplasmic membrane 
proteins 
Cytoplasmic membrane proteins may consist of more than one subunit and may have 
associated proteins or subunits with large periplasmic or cytoplasmic domains. The 
integral membrane components of most cytoplasmic membrane proteins are predicted 
to contain an arrangement of a-helices connected by hydrophilic loops. Experimental 
studies using biophysical techniques such as circular dichroism (67), and fusion 
proteins (54, 70, 166, 185) together with the recently determined 3D crystal structures 
(32, 50, 53) support this hypothesis. The minimum length required for an a-helix to 
cross the cytoplasmic membrane is 19 residues, but TM helices are often longer as they 
may be tilted away from the vertical or extend beyond the membrane, as illustrated in 
the structure of the prokaryotic potassium channel, KcsA (50). Alternatively, some 
a-helices may not fully traverse the membrane, as seen in the crystal structure of the 
CIC chloride channel from E. coli (53) (Figure 1. 7). As mentioned previously, TM 
helices usually contain hydrophobic amino acids for stability within the hydrophobic 
core of the lipid bilayer. However, a-helices may be amphipathic, exhibiting more 
polar residues along a face of the helix that may contact other TM helices within the 
protein complex (77) or be adjacent to an aqueous pocket, such as in the prokaryotic 
KcsA potassium channel (50, 77). Occasionally, charged residues that are functionally 
or structurally important may also be located within these membrane spanning 
a-helices (43, 44,223,296, 307). 
X-ray crystal structures and topological predictions suggest that these TM a-helical 
regions are connected by hydrophilic loops. von Heijne et al (276) discovered that in 
E. coli cytoplasmic loops with less than 60 residues have four times the number of 
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positively charged lysine and arginine side chains than periplasmic loops of similar 
size, while the ratio of negatively charge side chains remained similar in each set of 
loops ('positive inside' rule). Large loops (greater than 60 residues) however, do not 
retain this charge ratio. Many of these extra-membranous loops are not required for 
folding or function. Lactose permease is just one example of a membrane protein that 
can be expressed in vivo as two segments to create a functional transporter (17, 201). 
The membrane component of many transport proteins is predicted to contain 12 TM 
a-helices. These can consist of two proteins containing 6 predicted a-helical regions 
that may be different subunits or a homodimer. Alternatively, one protein may contain 
12 predicted a-helices which have sequence similarity between the N-terminal and C-
terminal domains, suggesting that these proteins arose from the duplication of an 
ancestral gene to give a "6 + 6" topology. Several of these proteins, such as the 
prokaryotic CIC channel, the mammalian PiT2 phosphate transporter and the 
Arabidopsis Pht2; 1 phosphate transporter, have been shown to have an anti-parallel 
structure where the second domain has the opposite orientation in the membrane (53) 
(47,229). 
While individual a-helices are stabilised by internal hydrogen bonding and interactions 
with the lipid bilayer, it is the interactions between different TM helices and loops 
which are believed to be important to the overall tertiary structure and mechanism of 
membrane proteins (144, 200). Popot et al (201) suggest that the interactions favouring 
specific helix associations include the coordination of favorable Van der Waals contacts 
over complementary surfaces and the binding of prosthetic groups. Single strong 
interactions, via hydrogen bonds, covalent links or ion pairs are rarely seen between 
such helical arrangements. Studies derived from the crystal structures of 7 integral 
membrane proteins and 3 7 soluble proteins show that, in general, membrane protein 
a-helices pack together more tightly (higher packing values) than in soluble proteins 
(57). The smaller amino acids such as glycine, alanine, serine and threonine seem to 
stabilise the tight association of these TM helices. Interhelical regions that are more 
loosely packed often contain polar residues and provide the binding sites for substrates 
and ligands (57). Analysis of membrane proteins with known structures has also found 
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that: I) helices almost always pack against neighbors in the sequence, 2) helix packing 
in an anti-parallel orientation is more prevalent than a parallel orientation, 3) there is no 
preference for the positioning of the point of closest contact along the length of the 
helices, 4) most helices are tilted with respect to the bilayer (by an average of 21 
degrees in one study) ( 19). 
The increasing number of membrane proteins with experimentally determined 
topologies or structures has allowed various analyses of more specific amino acid 
motifs and distributions within the a-helical domains. Russ et al (216) used a 
randomised sequence library based on the glycophorin A structure to identify a GxxxG 
TM helix packing motif that promotes dimerisation in this system and is present in the 
TM domains of many membrane proteins. While glycine residues are noted helix 
breakers in soluble proteins, they are moderately common in TM a-helices, and do not 
tend to disrupt the a-helical backbone dihedral angles. Glycine residues are 
predominantly angled towards helix-helix interfaces, and are highly predominant at 
helix crossing points, serving as molecular 'notches' for orienting multiple helices in 
the tertiary structure (105). 
Proline residues are also known to be helix breakers in soluble proteins. Prolines can 
cause kinks in helical secondary structure (24). This characteristic has lead to 
suggestions that prolines may function as molecular hinges that enable conformational 
transitions, such as opening the internal cavities in rhodopsin and bacteriorhodopsin for 
the binding of the retinal prosthetic group ( 48, 252, 287). The involvement of prolines 
in conformational changes within the E. coli Pst phosphate transport system has been 
demonstrated by mutagenesis experiments. The PstC and PstA membrane components 
contain paired praline residues that occur at about the same position within the 
membrane in adjacent helices. A double praline to alanine PstC mutant (P123A, 
P183A) caused a permanently 'open' conformation in the Pst system while the 
equivalent double pro line mutation in PstA (P 132A, P 166A) represented a permanently 
'closed' configuration (284). In membrane proteins with multiple helices, kinks seem 
to be more predominant when sequences contain more than one praline or a 
combination of pro line and glycine spaced four residues apart, such as in cytochrome c 
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oxidase ( 105). However, studies on model peptides show that the structural effects of 
praline are strongly dependent on its environment, and that this residue can even 
stabilise helical structures under certain conditions (57, 146). 
Other amino acid patterns have been observed with the subsequent structural 
determination of membrane proteins. The amphipathic aromatic residues tyrosine and 
histidine are preferentially found at the lipid/water interfaces, where they are proposed 
to anchor the proteins into the membrane through an interaction of their aromatic rings 
with the lipid head groups (263). Charged residues are preferentially found at the 
interfacial regions and water accessible regions of proteins. Those charged residues 
inserted within the membrane are usually in the form of salt bridges and/or are involved 
in function, such Glu-325 in lactose permease, which is proposed to form part of the 
proton translocation pathway (223). 
1.8 Methods to determine membrane protein 
structure 
1.8.1 Direct methods for the determination of 
membrane protein structure 
When studying the mechanism of a protein it is helpful to know the three dimensional 
(3D) protein structure, so that residues likely to be involved in the mechanism can be 
identified and examined experimentally. With soluble proteins this structure can often 
be determined at atomic resolution through the purification, crystallisation and analysis 
by X-ray diffraction of the protein. By contrast, the structural determination of 
membrane proteins is notoriously difficult at all stages of this process. Membrane 
proteins have regions of high hydrophobicity and require the presence of detergent 
and/or lipids to remain soluble and to retain their 3D structure through the purification 
and crystallisation process. Crystallisation is hindered by the disorder created by the 
presence of this detergent or lipid and the subsequent decrease in protein-protein 
interactions these compounds cause. Replacement of nativ.e lipids by detergent may 
also disturb the natural conformation of the protein. The inherent mobility of many 
membrane proteins, which have evolved to function in a fluid membrane environment, 
also works against crystallisation. As a consequence, even when crystals are formed 
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these can often lack the order needed for resolution to be at the level where the 
polypeptide backbone and side chains can be precisely mapped (below 4A, preferably 
around 2A) (32, 305). 
Despite these challenges, the structures of a number of membrane proteins have 
recently been solved using X-ray crystallography at resolutions approaching atomic 
levels. Many bacterial outer membrane porins with stable trimeric homo-oligomer 
structures, such as OmpF, OmpA and PhoE, have proven amenable to this technique 
( 42, 195, 201 ). The 3D structures of bacterial cytoplasmic membrane proteins, such as 
photosynthetic reaction centres, chloride and potassium channels, and cytochrome c 
oxidase have also been resolved at less than 3.5A (49, 50, 53, 193,201). 
A number of specific approaches have assisted in the preparation of well ordered 
crystals. Formation of the protein-protein lattice contacts needed during crystallisation 
is strongly influenced by variations in the surface residues of a protein. Site-directed 
mutagen es is has been used to make proteins more conducive to crystal formation. For ' 
example, the long surface-exposed loops of the outer membrane protein OmpA were 
predicted to form unfavorable protein-protein contacts that could limit crystal growth. 
When these loops were reduced in size by mutagenesis well ordered crystals were 
formed (195). The prokaryotic KcsA potassium channel was also crystallised without 
the C-terminus (Residues 126 to 158) following limited proteolysis - a method often 
employed in crystallography trials (50). An alternative method for optimizing lattice 
interactions is to purify and attempt to crystallise a number of natural homologues of 
the desired protein. Chang et al (32, 33) have successfully used this approach to 
determine the crystal structure of the mechanosensitive ion channel from 
Mycobacterium tuberculosis, Tb-MscL, to 3.5A resolution and the E. coli lipid flippase, 
MsbA, to 4.5A resolution. 
Site-directed mutagenesis has also been used to assist in protein purification by the 
addition of purification tags, such as six histidine residues. However, even the 
availability of large amounts of pure protein does not guarantee success with ~DX-ray 
crystallography, so a number of innovative alternatives have been used. Membrane 
proteins are more amenable to the formation of two-dimensional (2D) crystalline 
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arrays. While these are too thin to diffract X-rays, electron microscopy can be used to 
obtain a diffraction pattern. 2D protein-lipid crystals are exposed to a low intensity 
beam of electrons and images are formed through the summation of conserved patterns. 
3D pictures are obtained by combining images taken at different tilt angles. To obtain 
high resolution images, specimens need to be frozen in amorphous ice and analysed 
under these conditions, in a process called cryo-electron microscopy ( cryo-EM). This 
preserves the integrity of the protein in its lipid bilayer, reduces radiation damage to the 
protein and reduces movement or heating of the sample while it is exposed to the 
electron beam. Although it is easier to form these 2D crystalline arrays the resolution 
of cryo-EM is usually lower than that of X-ray crystallography. This lower resolution 
is due mainly to diffraction patterns becoming difficult to obtain once the sample is 
tilted beyond 60 degrees. Consequently the lack of data from the remaining 30 degrees 
reduces the final overall resolution (anisotropic data). High tilt data also has a loss of 
clarity caused by membrane crystals often lacking uniform thickness (251 ). The 
resolution of this technique is currently around 7 to 9A, such as for the E. coli Na+ /H+ 
antiporter, NhaA. At this resolution the identification and basic arrangement of 
ex-helices can be determined, but no information can be derived regarding the peptide 
backbone and side chain arrangements (286). The structure of the eukaryotic light-
harvesting complex II has been resolved to 3 .4A using anisotropic data from well 
ordered 2D crystals formed from detergent solubilised protein (136, 201). Cryo-EM 
has also solved the structure of bacteriorhodopsin to 3 .OA resolution (201 ). The key to 
this protein's success has been that it forms pseudo 3D crystals, where 2D arrays of 
purple membranes stack on top of one another, thus giving an additional level of 
information. 
Cryo-EM can also be carried out on membrane proteins that form tubular rather than 
flat crystals. The advantage of this tubular arrangement is that it supplies a complete 
set of 3D images of the protein by the very nature of the tubular packing, hence no 
tilting of the sample is necessary. The main problems associated with tubular arrays 
arise from distortion and variation within the tubes (251). Cryo-EM of tubular arrays 
has been used to determine the structure of the nicotinic acetylcholine receptor at 4.6A 
resolution in the closed state and 9 A in the open state, and also the calcium A TPase at 
8A resolution (175, 264, 306). Single particle analysis, where the protein is simply 
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solubilised and then analysed by cryo-EM, is a prom1s1ng technique for large 
complexes. Thousands of images need to be collected from particles in different 
orientations, thus building up the 3D image. The inherent flexibility of many 
macromolecules and the heterogeneity of the purified sample are some of the major 
limitations to this technique (251 ). Cryo-EM is also suited to the study of conformation 
changes, as the determined structure is from complexes trapped in solution under 
conditions similar to those used for biochemical and kinetic characterisations (225). 
For example, the nicotinic acetylcholine receptor has been imaged in both the open and 
closed states and with the continued improvement in data collection and processing a 
higher resolution of data will be forthcoming. Thus insight will be gained into how this 
ion channel transmits a binding signal into the opening of a pore through the membrane 
resolution (175, 264). 
While solution nuclear magnetic resonance (NMR) has been successfully used to 
determine the structure of the 40 amino acid Glycophorin A TM region, this technique 
is usually limited to soluble proteins with molecular weights of less than 50000 Daltons 
(158). Solid-state NMR of proteins in hydrated but anisotropic environments is 
becoming a promising technique now that more membrane proteins are able to be 
purified in high quantities ( 5-10 mg), particularly if the sensitivity of the instruments 
continues to improve (72). 
Proteins that have been analysed by both X-ray crystallography and cryo-EM, such as 
bacteriorhodopsin, show each technique produces consistent structures (225). This has 
set the stage to allow the combination of low resolution cryo-EM maps of large 
complexes that do not form good 3D crystals with the atomic structures of smaller 
domains or subunits determined by X-ray crystallography or NMR. This combination 
of techniques provides a powerful tool. Structural determinations for eukaryotic 
potassium and chloride channels and members of the multi-drug resistance family of 
transporters have been greatly enhanced by the X-ray crystal structures of their 
bacterial homologues (50, 53, 32). These bacterial proteins have simpler architecture 
( e.g. prokaryotic KcsA has 2 TM regions rather than the 6 TM regions found in the 
Drosophila (Shaker) and vertebrate eukaryotic potassium channels (50)). As a 
consequence, these are also easier to over-express and crystallise (132). 
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While over 40 membrane protein structures with atomic resolution better than 4A are 
now available, including bacterial chloride and potassium channels, outer membrane 
porins and photosynthetic reaction centres (50, 53, 263), none is an ion-coupled 
transporter. In the absence of a high-resolution structure researchers have had to rely 
on indirect methods to obtain the structural constraints needed for an educated guess at 
the structure/function relationships of ion-coupled transporters. (An overview of the 
methods used to analyse lactose permease is presented in Section 1.9.2.) 
1.8.2 Indirect methods for the determination of 
membrane protein structure 
Consensus prediction programs are used to propose a secondary structure for putative 
membrane proteins from the amino acid sequence. While these began as simple 
determinations of regions of hydrophobicity, the increase in the number of membrane 
proteins with experimentally determined topologies has led to increasingly 
sophisticated and varied algorithms. Nilsson et al ( 185) tested five prediction methods 
on 60 E. coli inner membrane proteins with experimentally determined topologies. 
They found a greater than 90% success rate if at least four of the five methods agreed, 
which occurred for around 5 0% of inner membrane proteins. Thus these programs are 
commonly used to develop one or more topological models. 
Using such a topological model the putative secondary structure of a membrane protein 
can then be tested, for example, by the introduction of tags into proposed cytoplasmic 
or periplasmic loops. These tags can include epitopes modified by reagents that cannot 
penetrate the membrane, such as monoclonal antibodies, protease cleavage sites, and N-
linked glycosylation sites. Such methods have their limitations as membrane proteins 
can be quite resistant to proteolysis and antibody binding studies can be difficult to 
interpret (2 77). The preparation of protein fusions with reporter domains that function 
differently on each side of the membrane have been very successful with prokaryotic 
proteins. The most commonly used reporter proteins are alkaline phosphatase (PhoA), 
~-lactamase (Bla) and ~-galactosidase (LacZ). phoA and bla are only active in the 
periplasm of E coli, while Lacz is only active in the cytoplasm ( 54, 70, 166). PhoA or 
Bla genes devoid of their N-terminal signal sequences can be fused to predicted 
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periplasmic or cytoplasmic domains, replacing the C-terminal portion of the membrane 
protein being studied. It has been shown that approximately half of an 'outward' TM 
domain is needed to translocate the PhoA moiety through the membrane to the 
periplasm ( 118). Lacz fused to cytoplasmic domains forms a functional protein, while 
periplasmic domain fusions cause it to become trapped within the inner membrane (70). 
Complementary studies combining the use of PhoA and Lacz fusions have been carried 
out ( 165). A number of methods have been designed to create these fusions, including 
a method to insert alkaline phosphatase within a protein so that the C-terminus of the 
protein is retained. This preserves any topological determinants in the C-terminal 
sequence (260), providing a more accurate representation of membrane protein 
topology than that supplied by simple fusion proteins (55). Proteins analysed by these 
methods include lactose permease (28), sn-glycerol-3 phosphate permease (78), the 
phenylalanine-specific permease (198) and the penicillin binding protein 1B (54). 
Site-directed mutagenesis and second site suppressor analysis of amino acids identified 
as important from the topological model ( e.g. charged or polar residues buried in the 
membrane) or from chemical modification studies can reveal potential interactions 
between residues. These relationships lead to the refinement of this secondary 
structure and to proposed interactions that may be necessary for determining the tertiary 
structure. However more precise structural information is needed. The use of site-
directed mutagenesis to engineer membrane proteins for biophysical measurements is 
emerging as a powerful means of determining structure and structural dynamics. A 
protein mutated to contain a single Cys residue can be chemically modified with 
alkylating agents (such as N-ethylmaleimide) or labeled for fluorescence spectroscopy 
to measure the exposure of this position to the external environment or the lipid phase 
of the membrane (300). A number of fluorophores of different sizes and 
hydrophobicity, plus a variety of quenching agents can be used for these 
determinations. These single Cys residues can also be modified with a nitroxide spin 
label that is analysed in conventional electron paramagnetic resonance experiments to 
determine solvent exposure, electrostatic potentials and ( depending on experimental 
design) the orientation and movement of individual segments of membrane protein 
(102). 
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Proteins engineered to contain two Cys residues can be used to establish the proximity 
of two residues through thiol cross-linking, excited state dimer fluorescence or spin 
labeling experiments. Double spin labeling allows the distance, and in some cases the 
relative orientation between the two spin labels to be defined. Engineered metal 
binding sites created by the introduction of two His residues have also been used to 
determine the proximity of two side chains (92). Defining spatial relationships, such as 
adjacent a-helical surfaces, is necessary for the establishment of a proteins' tertiary 
structure. Spin labeling can also be used to study protein dynamics, such as 
conformational changes caused by ligand binding ( 102). 
1.9 The functional analysis of membrane 
proteins 
1.9.1 Methods for the functional analysis of membrane 
proteins 
The 3D structure of a polypeptide chain plays an important role in defining a protein's 
mechanism. Therefore many of the indirect methods used for structure analysis, 
described above, are also used for the determination of a protein's mechanism of action 
when its atomic structure has yet to be elucidated. 
An additional technique used to locate functional motifs within a protein is the analysis 
of chimeras formed between two closely related proteins. A region of one protein is 
replaced with the corresponding segment of another similar protein. Analysis of the 
resulting chimeras may allow particular characteristics of a transporter, such as 
substrate range or substrate affinity, to be located within a particular amino acid 
sequence. This method has successfully characterised the functional domains of outer 
membrane porins such as PhoE, OmpF and OmpC (176, 186, 258, 265, 303), and the 
dopamine and the norepinephrine transporters of mammalian cells (27). A region in the 
amino acid transporter AroP which can confer the ability to transport tryptophan on a 
predominantly PheP (high-affinity phenylalanine transporter) protein has also been 
located, allowing the identification of an AroP residue, Tyr-103, that is important in 
tryptophan transport (38). However, results from indirect methods must be carefully 
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interpreted. Substrate recognition sites may involve different parts of the transporter 
and chimeric proteins may distort these or other structures. For example, while 
chimeras of the melibiose carrier from E. coli and Klebsiella pneumoniae led to the 
identification of an AS 8N mutation in the K. pneumoniae protein that could change its 
ion selectivity from protons to sodium ions, at least two regions of the E. coli carrier 
seem to be involved in sodium ion recognition (85). 
1.9.2 Structural and functional analysis of lactose 
permease 
Lactose permease from E. coli is encoded by the lac Y gene, and catalyses the coupled 
stoichiometric translocation of protons and galactosides. This was the first membrane 
protein to be cloned, sequenced, over-expressed and purified, with the purified protein 
shown to be functional as a monomer (224, 275). It has become a paradigm for 
secondary transport proteins and has been extensively studied using site-directed 
mutagenesis and various biophysical and chemical modification techniques. While 
attempts are being made to produce well-ordered crystals for X-ray crystallography, 
this is a notoriously difficult task, and it is through indirect methods that the structure 
and function of lactose permease is slowly being revealed. 
Hydropathy analysis predicted lactose permease to be a membrane protein containing 
12 a-helices with both the N- and C-termini in the cytoplasm. Circular dichroism 
measurements indicating the protein is 75-80% helical are consistent with this proposal. 
A number of techniques, such as laser Raman and Fourier transform infrared 
spectroscopy, immunological studies using monoclonal antibodies, limited proteolysis 
and chemical modification, were used to show the N- and C-termini as well as the 
putative second and third cytoplasmic loops are exposed to the cytoplasm. However it 
was not until the analysis of this protein with lactose permease-alkaline phosphatase 
fusions that the 12 TM region topology was confirmed (118). 
This model for secondary structure gave a framework for the analysis of amino acid 
residues important for structure or function. Charged and polar side chains proposed to 
be within the membrane environment were the first to be targeted by chemical 
modification. Site-directed mutagenesis was then used on side chains whose 
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modification disrupted activity, replacing them with various charged, polar and neutral 
amino acids. These mutants were characterised by assays for active transport, 
facilitated diffusion (with either coupled or uncoupled translocation of protons), efflux, 
exchange or counterflow. Thus different functional roles were defined for the mutated 
amino acids. Charged or polar amino acids that the model suggested might be within 
the vicinity of disruptive mutants were also modified. Initial mutagenesis studies led to 
the proposal that His-322 and Glu-325 may be components of a charge relay system 
coupling lactose and proton transport ( 117). Second site suppressor experiments were 
also important for identifying interactions between charged and polar residues (127, 
142, 143). However, mutational analysis is not necessarily clear cut. King et al (128) 
found replacing His-322 with the aromatic groups Tyr or Phe, which cannot be 
protonated, gave no active transport but produced coupled facilitated diffusion of 
lactose or melobiose (i.e. while proton cotransport occurred, lactose or melobiose could 
not be transported against their concentration gradients). These experiments suggest 
that His-322 is important for energy transduction (and also high substrate affinity), but 
does not need a dissociable proton or electronegative atom, as initially proposed by 
Kaback' s laboratory. 
The preparation of a functional lactose permease devoid of eight native Cys residues 
has allowed analysis of the permease in a number of ways. Each residue in lac 
permease has been replaced with a single Cys residue, demonstrating that only six 
amino acids in the permease are irreplaceable with respect to active transport, with all 
of these being charged. Four of these are thought to be involved in proton translocation 
and coupling with substrate translocation (Glu-269, Arg-302, His-322 and Glu-325) 
while G lu-126 and Arg-144 are indispensable for substrate binding, and are also likely 
to form a charged pair (273 ). It is proposed that one guanidino -NH2 group on Arg-144 
ion pairs with Glu-126, while the other guanidino group H-bonds with the galactoside 
moiety of the substrate. The conservative substitution R144K prevents substrate 
binding and was much more detrimental than the E 126D mutant, giving some support 
to this theory (220). Creating double Cys mutant combinations of charged residues that 
disrupted transport (without totally inhibiting it) showed that the neutralisation of two 
Lys-Asp pairs allowed lactose uptake, suggesting they may form salt bridges. (See 
Chapter 6 introduction, Section 6.1, for more details). 
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It became obvious that static and dynamic information at a high resolution was needed 
in order to define the transport mechanism. The Cys-free permease and the single Cys 
mutants have been important for the use of spectroscopic approaches to establish 
proximity relationships between TM helices, and to study the molecular dynamics of 
the protein. Site-directed chemical labeling with thiol reactive agents such as NEM and 
fluorescence labeling (MIANS, pyrene maleimide) used in conjunction with various 
hydrophilic or hydrophobic quenching agents of single Cys mutants has been used to 
show that ligand binding increases the reactivity of V315C, E269C and H322C (112, 
113) and also causes a conformational change in the N-terminus of TM I (298). These 
techniques were also used to highlight the presence of two substrate binding sites ( one 
high and one low affinity) which can be occupied at the same time. Proximity 
relationships have been determined by pyrene maleimide labeling of double Cys 
mutants, which has led to a proposed tertiary model for the C-terminal half of lactose 
permease (114 ). Spatial relationships have also been confirmed by engineering 
divalent metal-binding sites (bis-His residues) within the permease, and through the use 
of site-directed spin labeling and thiol cross-linking experiments (92, I 16,278,301). 
Hydropathy analysis, and even the more sophisticated predictive algorithms available 
today do not take into account charge pairing. Thus the secondary structure model was 
altered to include charged pair residues Asp-237 and Asp-240 in TM 7. The charge 
pair Glu-126 and Arg-144 also needed to be moved into the membrane (296, 307). 
The helix-loop boundaries of lactose permease have been more tightly defined by the 
use of single amino acid deletions. Wolin et al (296, 297) showed that deletion of 
single or multiple amino acid residues within extramembranous loops had little effect 
on protein activity. However deletion of single residues over a narrow range of 
positions near the boundary of helical domains greatly decreased activity. In typical 
Kaback laboratory style, all the lactose permease helix-loop boundaries were mapped in 
this way. This approach caused some a-helices in the topological model predicted by 
the HMMTOP 1.1 algorithm to be moved by as much as IO residues, although most 
were in general agreement. Unexpectedly, deletion analysis of the whole of TM 6 
showed the deletion of only three residues abolished activity. This TM domain is 
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predicted to be on the periphery of the 12-helix bundle and may make few functionally 
important contacts (297). 
Recently the pH dependence of ligand binding by mutants in the four residues that are 
considered to be key participants in either proton translocation or the coupling between 
sugar and proton translocation (Glu-269, Arg-302, His-322 and Glu-325), was studied. 
A very sensitive binding assay involving the substrate protection of Cys-148, ( which is 
not essential for transport but is located in a ligand binding site (299)), against 
alkylation was crucial to the success of this project. Wild type permease bound ligand 
with a pKa of 8.1 indicating that the permease needs to be protonated for binding. 
Neutral and charged substitutions at Glu-325 and Arg-302 had little effect on substrate 
binding, while mutations at His-322 and Glu-269 greatly reduced the binding of 
substrate at any pH. The pKa of 8.1 is greater than that of histidine, suggesting the 
proton may be shared with Glu-269. This information was combined with the 
structural and dynamic information previously determined ( e.g. the face of TM 7, 
containing Glu-269, undergoes a ligand induced conformational change (69)), allowing 
Kaback's group to propose the following mechanism for lactose permease: 
In the ground state (see Figure 1.5 from Sabin Toth et al (223)) the permease is 
protonated, with the proton being shared between His-322/Glu-269, while Arg-302 and 
Glu-325 are charge paired. Substrate binding on the periplasmic surface with relatively 
high affinity causes a conformational change, leading to the transfer of the proton from 
His-322/Glu-269 to Glu-325 and the reorientation of the sugar binding site to the 
cytoplasmic surface with a decrease in substrate affinity, releasing the sugar. These 
changes lead to deprotonation of Glu-325 as it re-associates with Arg-302. The cycle is 
returned to the original state by His-322/Glu-269 being reprotonated from the 
periplasmic surface (223). The role of Arg-302 in this model was subsequently tested 
by characterising small neutral and polar substitutions. These (R302A, R302S) were 
defective in active uptake of lactose and downhill influx or efflux, but catalyse 
equilibrium exchange - similar to neutral replacements for Glu-325. This lends strong 
support for the argument that Arg-302 interacts with Glu-325 to facilitate deprotonation 
of the carboxylic acid at the cytoplasmic face of the membrane. It is interesting to note 
that replacing Arg-302 with the larger amino side chain Leu produced a mutant 
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Figure 1.5 
Proposed mechanism for lactose permease by Kaback's research 
group. 
This diagram is from Sahin-Toth et al (223). For clarity, only 6 of the 12 helices in 
the pennease are shown. Glu-126 (helix IV) and Arg-144 (helix V) are charge 
paired and with Cys-148 (helix V) comprise the major components of the substrate 
binding site. Arg-302 (helix IX) is charge paired with Glu-325 (helix X), while 
protonated His-322 (helix X) interacts with Glu-269 (helix VIII). Thus the relevant 
H+ is shared by His-322 and Glu-269. Also shown are the charge pair between 
Asp-240 (helix VII) and Lys-319 (helix X), which are not essential for the 
mechanism. The mechanism is explained in detail in Section 1.9.2. 
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defective in all aspects of transport, as did the conservative R3 02K replacement, 
indicating the potential complexity of interpretation involved in mutagenesis studies 
(221 ). This mechanism may also explain the results of King et al' s ( 128) aromatic 
replacements of His-322. The Phe or Tyr substitutions may be able to hold a proton 
with Glu-269, allowing low levels of ligand binding, without allowing proton 
trans location. 
However there are mutagenesis studies that argue against the above model. Brooker's 
laboratory propose that an alternative mechanism of lactose permease cation binding 
and transport may occur, possibly involving the hydronium ion (H30+) ( 110), an idea 
also put forward by Kaback ( 115). This is based on the characterisation of a 
K3 l 9N/E325Q mutant that catalyses a sugar-dependent proton leak. Thus, an acidic 
residue at position 3 25 is not required for proton transport, which argues against an 
essential role for Glu-325 in proton binding (109). Several suppressor mutants at His-
332 prevented this proton transport with lactose. However if the substrate was changed 
to ~-d-thiodigalactoside (TDG) several of these mutants continued to allow the proton 
leak, and the triple mutant K319N/H322Q/E325Q catalysed strong proton transport 
with TDG. It would be hard to identify potential hydronium ion binding sites via site-
directed mutagensis studies as backbone carbonyl groups may be involved in forming a 
coordination complex ( 110). 
Brooker' s laboratory has also taken a different approach to solving the mechanism of 
lactose permease. They propose that the 'internal repeat' of 6 TM domains found in the 
Major Facilitator Superfamily (MFS), of which lactose permease is a member, may 
represent the transformation of a functional dimer into a single protein, allowing each 
half of the dimer to evolve independently. Sixty-five members of this family were 
analysed by a predictive program (MEMSAT (111)) to identify putative TM a-helices. 
The least hydrophobic TM region exhibiting high amphipathicity, (which are more 
likely to be potential channel-lining domains) were then identified, and patterns within 
the family were noted. The lengths of hydrophilic loops connecting TM a-helices 
were then compared throughout the family, with short loops connecting adjacent 
helices and long loops allowing distant arrangements in the tertiary structure. This data 
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was combined with information on potential salt bridges and other helical interactions 
proposed by the mutagenesis and cross-linking studies described earlier to develop a 
model where lactose permease consists of two halves that fold in a rotationally 
symmetrical manner. Movement of these two moderately rigid domains of 6 TM 
helices changes the solute binding site from the outside to the inside of the cell (Figure 
1.6)(77). 
This lactose permease model suggests that TM 2 slides against TM 11 and TM 8 slides 
against TM 5. Subsequently a conserved motif in the MFS that is found at the interface 
of TM 2 and the 2/3 cytoplasmic loop, and is repeated in cytoplasmic loop 8/9 has been 
analysed. Mutations in the first two conserved amino acids inhibit or substantially 
decrease the rate of lactose transport without affecting substrate affinity ( 107, 108). 
This motif is proposed to play a general role in conformational changes rather than 
playing a role in substrate recognition. Mutations along the face of TM 2 and TM 8, 
which align with the first residue in this conserved sequence, were the most defective in 
lactose transport (80). 
Thus a crystal structure of lactose permease would greatly clarify the tertiary structure 
and mechanism. Attempts to crystallise lactose permease from E. coli include the 
insertion of the small soluble protein Cytochrome b562 into the central hydrophilic 
loop of lactose permease to increase protein-protein interactions (202). This 'red 
· perm ease' has been solubilised in detergent and reconstituted into vesicles and well-
ordered 2D crystals. Cryo-EM using both single particle analysis and 2D crystal 
analysis has been carried out, but the resolution is quite low, only revealing the basic 
shape of this crystallised lac permease protein (311 ). 
1.9.3 The success of indirect techniques in structure ana 
function predictions 
Now that some membrane protein structures have been solved at the atomic level the 
success of indirect methods at structure/function analysis can be examined for 
individual proteins. 
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Figure 1.6 
Proposed mechanism for lactose permease by Brooker's research 
group. 
This diagram is from Jessen-Marshall et al (108). The three dimensional arrange-
ment of transmembrane domains has been proposed by the methods explained in 
Section 1.9.2. The channel lining segments are TM-1, TM-2, TM-4, TM-5, TM-7, 
TM-8, TM-10, TM-11, while the scaffolding segments are TM-3, TM-6, TM-9 and 
TM-12. The two halves of the protein exhibit rotational symmetry around a central 
axis. The C 1 conformation has its solute binding site accessible from the outside 
while the same site in the C2 conformation is accessible from the inside. 
(The highlighted residues in loop 2/3 form part of a conserved motif discussed in 
Chapter 7.) 
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Bacteriorhodopsin, a light driven proton pump from Halobacteria, was extensively 
studied with spectroscopic and mutagenic techniques. While this gave some conflicting 
data (25), the model and proposed mechanism was in general agreement with the 
structure produced by cryo-EM of purple membranes (82, 126). Interestingly, atomic 
resolution X-ray diffraction of crystals produced two quite different structural models, 
with one being more strongly supported by the independent data ( 140). These atomic 
structures revealed features important in defining the mechanism such as bound water 
molecules and hydrogen bond interactions. 
Several mechanisms have been suggested for substrate translocation by the multi-drug 
resistance transport family, based on labeling and mutagenesis data for a number of 
different proteins. The 'flippase' model proposed that lipid substrates are accepted 
laterally from the inner leaflet of the cytoplasmic membrane and flipped to the outer 
leaflet (95). The hydrophobic vacuum cleaner model suggests that drugs may be 
accepted laterally from the inner leaflet and then released directly into an aqueous 
chamber exposed to the external environment (79). The substrate binding site may 
move between the inner lipid and outer lipid/aqueous environments by either a tilting or 
rotational conformational change (96). The atomic structure of the lipid flippase MsbA 
from E. coli (32) is generally consistent with the biochemical data for the flippase 
model with a tilting conformational change, while revealing additional insights such as 
the linking structure between the transmembrane and the nucleotide binding domains. 
However, MsbA crystals, which were formed in the absence of lipid, consist of a 
homodimer with a large cytoplasmic cavity that is closed to the external environment. 
This conflicts with evidence from low resolutions structures for P-glycoprotein and 
MRPl that have chambers exposed to the external environment (96), and cross-linking 
studies which suggest a different arrangement of a-helices (153). This closed chamber 
may be an artifact, the result of a different dynamic conformation or may be due to 
different mechanisms of action within this family. The targeted use of site-directed 
mutagenesis and other methods can now be used to test this mechanism in MsbA and 
other related proteins in the multi-drug resistance-ABC transporter family. 
The atomic structure of the Streptomyces lividans KcsA potassium channel is in 
excellent agreement with results from functional and mutagenesis studies on eukaryotic 
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K+ channels. These studies had defined many of the amino acids involved in the pore 
opening, and the critical K+ signature sequence which forms the K+ selectivity filter, as 
predicted ((50) and references therein). The generally hydrophobic character of the 
pore lining was anticipated by hydrophobic cation binding studies ( 5) and the proposed 
presence of multiple ions queuing inside a long narrow pore in single file, seems true 
for the selectivity filter. However from the X-ray crysta~ structure it was apparent that 
it is the main chain carbonyl oxygen atoms on the residues of the K + signature sequence 
that coordinate with the K+ ions, not the actual side chains. These side chains seem to 
be important for constraining the size of the selectivity channel, so that a dehydrated K+ 
ion fits with proper coordination but the Na+ ion is too small to undergo dehydration. 
The presence of a wide water filled cavity after the narrow selectivity filter was also not 
anticipated from indirect methods. The 3D structure revealed the basic KcsA channel 
architecture of four identical subunits forming a pore which narrows to a selectivity 
filter, then opens into a wide water filled cavity lined with hydrophobic amino acids 
(50). The structure also helped in the understanding of how the channel could be 
highly selective for K+ over Na+ while maintaining a throughput rate approaching the 
diffusion limit. The mechanism of action of the selectivity filter has been further 
defined by crystal structures obtained at 2A resolution which were carried out with 
different concentrations of K+ (310). 
Indirect techniques have not been so successful at defining the mechanism and structure 
of chloride channels. Mutational, electrophysiological and biochemical analyses 
confirmed that CIC chloride channels consist of a dimer with two separate channels. 
However, further structural definition remained ambiguous as mutations that changed 
ion permeation properties were scattered over much of the amino acid sequence and 
their affects were not very pronounced. The crystal structures of two prokaryotic CIC 
chloride channels revealed that several a-helices stop mid-membrane to form part of 
the ci- ion selectivity filter and that many of the a-helices are often severely tilted 
within the membrane (~3) (Figure 1.7). Many residues that line the hour-glass shaped 
pore were identified in earlier mutation studies. However, the antiparallel symmetry 
and a negatively charge glutamate side chain located just above the ci- binding site 
(which may act as a gate) _were not predicted from these studies. This chloride channel 
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Figure 1.7 
Structure of the Salmonella enterica serovar typhimurium CIC 
chloride ion channel. 
This diagram is from Dutzler et al (53). 
A Helices 
The helices are drawn as cylinders with the extracellular region above and the 
intracellular region below. The two halves of the subunit are green and cyan, and 
regions forming the chloride ion selectivity filter are red. Partial charges at the end 
of helices involved in chloride ion binding are indicated by+ and - (end charges) to 
indicate the sense of the helix dipole. 
B Stereo view of the three dimensional structure. 
This view is from within the plane of the membrane from the dimer interface with 
the extracellular solution above. The helices are drawn as cylinders, loop regions as 
cords (with the selectivity filter in red), and the chloride ion as a red sphere. 
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has a very different architecture to the KcsA potassium channel, which has parallel 
symmetry and a large aqueous cavity at one side of the pore (Figure 1.8). 
Non-crystallographic approaches correctly predicted the membrane topology of the 
small outer membrane protein OmpA (178), and were fairly close with PhoE (266). 
However, the predicted models of LamB (guided by the OmpF structure) and FhuA 
(with a predicted loop instead of a plug domain) were not close to the structures 
determined by crystallography. Predictions failed to identify many functionally 
important features of various outer membrane proteins, such as the transverse electric 
field inside the general porins, the LamB substrate translocation pathway - which 
consists of a row of' greasy slide' aromatic amino acids lined up by an "ionic track" of 
polar residues (173) and the 'plug' domain in the TonB-dependent receptors (130, 150). 
These results indicate that when no direct structural evidence is available, the success 
of indirect techniques at predicting structure is variable, even when some residues 
important for function have been identified. Atomic structures reveal new and unique 
\ 
architectures that are difficult to conceptualise through indirect techniques, particularly 
if they are subtle and involve residues from disparate regions of the polypeptide 
sequence. Atomic structures are also able to confirm and refine protein arrangements 
that have been proposed through the information provided by indirect techniques. In 
turn, functional evidence that supports structures revealed through X-ray 
crystallography, cryo-EM or NMR lends support for these structures having some 
physiological significance. Indirect techniques such as site-directed mutagenesis can 
help refine the models for individual proteins when an atomic structure is available for 
one protein within a family. These techniques also provide a powerful arsenal for 
examining the dynamics and putative mechanisms of known structures. For example, 
low resolution cryo-EM of P-glycoprotein isolated at different stages of the transport 
cycle supported by biophysical and mutagenic experiments suggest that ATP binding 
causes a large reorganis~tion of the TM domains of this multi-drug resistance 
transporter, probably through rotation of the a-helices (213 ). Therefore these two sets 
of techniques are complementary, and are both required if we are to fully understand 
how membrane proteins function. 
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Figure 1.8 
Comparison of the architecture of the CIC c1- channels with the 
prokaryotic KcsA K+ channel. 
This diagram is from Dutzler et al (53). 
A CIC c1- channel 
The antiparallel architecture of the CIC ci- channels contains structurally similar 
halves with opposite orientations in the membrane (arrows). This architecture 
permits like ends (same dipole sense) of helices to point at the membrane centre 
from opposite side of the membrane. 
B KcsA K+ channel 
The parallel or barrel stave architecture of the KcsA K+ channel contains structurally 
similar or identical subunits with the same membrane orientation (an·ows). Helices 
point at the membrane centre from the same side of the membrane. Helices are 
depicted as dipoles with blue (positive) and red (negative) ends. 
Anti=paralilel 
a 
Parallel (barrel stave) 
b 
1.10 Aims of the project 
Pit is the low affinity inorganic phosphate (Pi) transporter of E. coli. The seed for this 
project was sown when a second E. coli Pit transporter was isolated and sequenced by 
the Cox laboratory (JCSMR, ANU). These genes, subsequently named pitA and pitB, 
have a putative amino acid identity of 81 % and preliminary experiments indicated that 
the proteins have significantly different Km app values for Pi. Therefore PitA and PitB 
form a good comparative system where relationships between the kinetic parameters, 
amino acid sequences and the Pi translocation mechanism of a membrane transporter 
may be systematically explored. 
The aim of this project was to characterise the structure and function of Pit through 
analysis and comparison of PitA and PitB. The kinetic parameters of the PitA and PitB 
proteins were to be measured, and purification of each protein was atte·mpted to allow 
N-terminal sequencing of the mature protein, thus defining the open reading frames of 
each gene and providing protein for future experimentation. The nature of the 
relationship between the pitA and pitB genes were also explored (i.e. are they 
independent genes or alleles?). 
Targeted site-directed mutagenesis of PitA may be carried out to identify key amino 
acids in the MePO4/proton translocation mechanism that are shared by both proteins. 
Preparation of PitA/PitB chimeras may be engineered to identify which variable 
region/s of these sequences confer the difference in substrate affinity. 
However, while previous research had found Pit activity to be constitutive (290, 131, 
211 , 212), results from the above experiments suggested that pitB is regulated. Thus, 
the aims of the project shifted towards defining the expression and mechanism of 
regulation for the pitB gene on plasmids and the genome. This included exploring the 
possibility that the repression of pitB was mediated by the phoB-phoR two component 
regulatory system. 
37 
Chapter two 
Experimental Procedures 
Chapter two 
Experimental Procedures 
2.1 Bacterial strains and plasmids 
The bacterial strains used in this study were all derivatives of Escherichia coli K-12 or 
K-10 and their relevant characteristics are listed in Tables 2.1 and 2.2. The plasmids 
and bacteriophages used and constructed are described in Tables 2.3 and 2.4. 
Short-term storage of strains was on solid medium at 4°C. Long term storage of strains 
was carried out by resuspending a freshly grown lawn of bacteria from solid medium 
into Luria Bertani media containing 30% glycerol. These suspensions were stored in 
vials at -7 0°C. 
The cell density of liquid cell cultures was measured as turbidity, against a blank of the 
liquid medium, using a Klett-Summerson colourimeter (Klett Manufacturing, NY, 
USA). Cell densities are expressed as Klett units, where 108 cells/ml is approximately 
equivalent to a reading of 40 Klett units. 
2.2 0/igonucleotide sequences 
Oligonucleotides used in this study for sequencing, site-directed mutagenesis and 
polymerase chain reactions are listed in Table 2.5. 
2.3 Growth media 
Strains were grown in the rich media of Luria Bertani (157), 2xTY, SOB or Z broth. 
Luria Bertani media consisted of 1 0g tryptone, 5 g yeast extract and 5 g NaCl per litre, 
adjusted to pH7 with aqueous 1 OM NaOH. This was supplemented with 33mM 
-
glucose after sterilisation by autoclaving at 121 °C for 45 min. 2xYT medium contained 
16g Bacto-tryptone, 10g yeast extract and 5g NaCl, adjusted to pH7 with aqueous l0M 
NaOH, and sterilised as described above. SOB medium contained 20g tryptone, 5g 
yeast extract, 0.6g NaCl and 0.5g KCl per litre. This is sterilised and just before use 
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Strain K-12 
E. coli K-12 MG 1655 was sequenced by the Blattner laboratory because it approximates 
wild-type E. coli and "has been maintained as a laboratory strain with minimal genetic 
manipulation, having only been cured of the temperate bacteriophage lambda and F 
plasmid by means of ultraviolet light and acridine orange, respectively." (18). The 
mutations listed in the genotype are present in most K-12 strains and were probably 
acquired early in the history of the laboratory strain. MG1655 was derived and named by 
Mark Guyer from strain W1485, which was derived in Joshua Lederberg's lab from a 
stab-culture descendant of the original K-12 isolate. This original E. coli strain K-12 was 
obtained from a stool sample of a diphtheria patient in Palo Alto, CA in 1922 
(Bachmann, B. , pp. 2460-2488 in Neidhardt et al.1996, Escherichia coli and Salmonella: 
Cellular and Molecular Biology, ASM Press). 
Strain K-10 
Information is from the CGSC database (CGSC#: 4234) 
http: // cgsc. biology. yale. edu: 8 0/ cgi-bin/ sy b gw / cgsc/Strain/9448 
K-10 is a spontaneous pit-JO derivative of strain CS101 (CGSC#: 5107) 
(Skaar et al, see *) 
TABLE 2.1: Description of E. coli strains used in this study 
Strain Relevant characteristics 
AN248 pit+ pst+ K-12 strain 
AN259 pit+ arg- entA-
AN346 pit+ arg- entA- ilv- pyrE Strr Mur 
AN3066 pitAJ L1pstC345 srl::Tnl O recA Tcr 
AN3901 pitB::Catr derivative of JC7623 
AN3902 pitA 1 pitB: :Catr L1pstC345 
AN3926 pitB::Catr L1pstC345 
AN4080 pitAI pitB::Catr 
AN4081 pitAJ L1pstC345 L1(phoB-phoR) Kanr 
AN4085 pitAJ pitB::Catr L1pstC345 iJ(phoB-phoR) Kanr 
ANCHl iJ(phoB-phoR) Kanr 
HR152 pstA zhg::Tnl O proC purE thyA gyrA metB his 
pyrFTcr 
AN2537 
~pstC345 
AN3020 pitAJ L1pstC345 
GS5 pitAI pstAproC purE thyA gyrA metB his pyrF 
HR187 pitAI pstAproC purE thyA gyrA metB his pyrF 
sr!A::Tnl O recA Tcr 
K-10 pitAJ 
JC7623 recB21 recC22 sbsBI 5 sbcC201 thr-1 ara-14 
leub6 lacYJ tsx33 supE44 ga!K2 hisG4 rjbDJ 
rpsL21 kdgK51 xyl-5 mtl-1 argE3 thi-1 iJ(gpt-
proA)62 not sure if 62/ G2 or his64/G4 
M15 NaZS Str Rif thr lac- Ara+ gal+ Mt! F recA 
Uvr+ Lon+ 
JS5 araDJ 39 ~(ara leu)7697 ~(lac)X74 ga!U galK 
hsdR2(rk- mk-) ,ncrBC rpsL (Strr) thi 
recAJIF::Tnl O (Tet~tproAB lacfl lacZ ~MIS 
HB101 F leu b6 pro A2 recAJ 3 thi-1 ara-14 lac YI 
ga!K2 xyl-5 n1tl-l rpsL20 supE44 hsdS20 
K-12 F lambda- ilvG- rfb-5 0 rph-1 
(MG1655) 
K-10 Hfr garBJO jhuA22 ompF62 7(T2R) 
fadL 701 (T2R) re!Al pit-IO spoTJ metBJ 
rrnB-2 mer Bl creC510 
Construction/ 
Reference 
(211) 
Laboratory strain 
Laboratory strain 
(284) 
By recombination 
Pl AN3901 X AN3020 
Pl AN3901 X AN2537 
Pl KIO X AN3902 
Pl ANCHl X AN3020 
Pl ANCHl X AN3902 
(304) 
(59) 
(253) 
(284) 
(59) 
(59) 
(284) 
(137) 
Q IA express data sheet 
Life Technologies 
Life Technologies 
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(284, 289) and see 
below* 
* Skaar, P.D., A. Garen 1956. The orientation and extent of gene transfer in 
Escherichia coli. Proc.Natl.Acad.Sci.USA 42:619-624 
Koch, J.P., H. Hayashi, E.C.C. Lin 1964. The control of dissimilation of 
glycerol and L-alpha-glycerophosphate in Escherichi coli. J.Biol.Chem. 
239:3106-3108 
TABLE 2.2: Description of E. coli strains containing plasmids referred to in this study 
Strain Plasmid Background Construction/ 
strain Reference 
AN3514 pBR322 control pitAJ 1J.pstC345 pBR322/ AN3066 
AN3135 pitB+ - long upstream pitAJ 1J.pstC345 pAN656/AN3066 
AN3171 pitA+ pitAJ 1J.pstC345 pAN686/AN3066 
AN353 l pitA + ( opposite orientation) pitAJ 1J.pstC345 pAN920/ AN3066 
AN3511 pitA H225Q pitAJ 1J.pstC345 pAN906/ AN3066 
AN3512 pitA D229N pitAJ 1J.pstC345 pAN907 I AN3066 
AN3513 pitA K.232Q pitAJ 1J.pstC345 pAN908/ AN3066 
AN3776 pitA G213D pitAJ 1J.pstC345 pAN1121/AN3066 
AN3778 pitA 1413D, G414L pitAJ iJ.J}StC345 pAN1123/AN3066 
AN3937 pitA I PCR from AN3066 pitAJ 1J.pstC345 pAN1243/AN3066 
AN3938 pitA G220D pitAJ 1J.pstC345 pAN1244/AN3066 
AN3903 pBR322 control pitAJ pitB: :Catr pBR322/AN3902 
1J.pstC345 
AN3904 pitA+ pitAJ pitB::Catr pAN920/ AN3902 
1J.pstC345 
AN3905 pitB+ 
- short upstream pitAJ pitB::Catr pANl l 16/AN3902 
1J.pstC345 
TABLE 2.3: Description of E. coli plasmids used in this study 
Plasmid Relevant ~haracteristics Construction/Reference 
pBR322 4.36 kb high copy number cloning (208) 
vector, pMB 1 replicon: Apr, Tcr 
pAN686 pitA+ Cla 1 / Sph 1 fragment from 
pCE27 ((59)) in pBR322 
pAN906 pitA(H225Q) Sall/BamHI fragment from 
pitA (92-147) SDM in 
pBR322 
pAN907 pitA(D229N) Sall/BamHI fragment from 
pitA (92-148) SDM in 
pBR322 
pAN908 pitA(K232Q) Sall I BamH 1 fragment from 
pitA (92-149) SDM in 
pBR322 
pAN920 pitA + ( opposite orientation to pAN686) Sall!BamHI fragment from 
pAN686 in pBR322 
pAN910 pitA::hexahis (pitA + with a C terminal EcoRVBglII fragment from 
hexahistidine tag), in pQ E60 with own pitA (91-62/93-20) SDM in 
ribosomal binding site EcoRVBglII of pQE60 
pAN683 pGEX vector with 30 bases of the A.J.W. Rodgers - this 
spinach chlorplast £-subunit fused to C laboratory 
terminal of GST. 
pAN909 pitB+ piggy backed behind the GSTE- Eco RI fragment from pitB 
30 fusion gene (91-70) SDM in EcoRI of 
pAN683 
pAN730 pitB+ in the opposite orientation to Eco RI fragment from pitB 
pAN909 (91-70) SDM in Eco RI of 
pAN683 
pAN914 pitA::hexahis (no promoter) piggy Eco RI/ PvuII fragment from 
backed behind the GSTs-30 fusion gene pAN910 in EcoRI of pAN683 
pAN915 pitA:: hexahis in opposite orientation to EcoRl/ PvuII fragment from 
pAN914 (ie no read through from tac pAN910 in EcoRI of pAN683 
promoter) 
pAN918 pitA::hexahis in pBR322 Mlul/ PvuII fragment from 
pAN910 in MluI/PvuII of 
pAN686 
pAN919 pitA+ Remove PvuII fragment from 
pAN686 
pAN656 pitB+ - long upstream region ( 1403 Clal!BamHl fragment from 
nucleotides) AN2538 in pBR322 
pANl 116 pitB+ - short upstream region (206 Sspl /Clal fragment from 
nucleotides) pAN656 in EcoRV!Clal sites 
ofpBR322 
pANl 121 pitA G213D mutation, Bglll site Bglll site at A213 in pAN686 
pANl 123 pitA 1413D, G414L mutation, Egli] site Bglll site at 1413 in pAN686 
pANI243 pitAJ 
pAN1244 pitA G220D mutation 
PCR product from AN3066 
in pBR322 
Site-directed mutagenesis of 
G658A inpitA+ ORF on 
pAN686 
TA~LE _2.4: Description ofbacteriophages used in this study 
Bacteriophage 
M13mp18 
M13mp19 
Plkc 
Relevant characteristics 
7 .25 kb, lacpoZ' 
7.25 kb, lacpoZ' 
Derivative of bacteriophage P 1 
which forms relatively clear 
plaques but is able to lysogenise 
bacterial hosts 
Source/Reference 
(188) 
(188) 
(103) 
TABLE 2.5: Description of oligonucleotides used in this study (sorted by function) 
Name Sequence {5' to3'} a 6 c Function Source/Ref. 
95-87 ctgaggatccgccgcgttcatgtcct PCR full pitA Sections 3.3, 
+ strand 4.2 
95-88 tgacggATCcgttttggtgcgtacgattacag PCR full pitA Sections 3 .3, 
- strand 4.2 
95-89 gtcaggatccatgcgtccgttcgtaattc PCR full pitB Sections 3.3, 
+ strand 4.2, 5.2 
95-90 cgccggatccgggcattttcaggaag PCR full pitB Sections 3.3, 
- strand 4.2, 5.2 
97-73 agagGgatCCtgaaccgttaattg PCR full pitB plus Section 4.2 
upstream 3 19 bp 
97-74 cactgga T cC ggtgttggttgatg PCR full pitB plus Section 4.2 
upstream 3 19 bp 
91-62 gataatgcgcc gAAttcatgtcc EcoRI SDM to insert Section 3.4 
pitA in pQE60 
93-20 cagttcctgA Gate Ttacgcaccaaaac Bglll SDM to insert Section 3.4 
pitA in pQE60 
93-107 cgtaacgtcctG tgctacatttg SDM pitA start Section 3.5 
(ATG to GTG) 
93-108 c gtaacgtcctCtg ctacatttg SDMpitA start Section 3.5 
(ATG to CTG) 
93-135 atctaatatG tgctaaatttatttg SDMpitB start Section 3.5 
(ATG to GTG) 
93-136 atctaatatCtgctaaatttatttg SDMpitB start Section 3.5 
(ATG to CTG) 
94-55 ccaacgccgtgT Aaaccgttatcta SDMpitA in frame Section 3.5 
TAA stop at 118bp 
94-56 gctgggtggtT Agagtgttgcc SDM pitA in frame Section 3.5 
TAG stop at 208bp, 
pitA sequencing S'ection 4.2 
94-57 atatggga tAgtctcatggcctt SDMpitA in frame Section 3.5 
TAG stop at 268bp, 
pitA sequencing Section 4.2 
95-99 tcgacaaagtggtgaagatg pitA sequencing Section 4.2 
94-104 accgtgaccagcattctg pitA sequencing Section 4.2 
94-102 gttgcctatgccattgtcc pitB sequencing Section 4.2 
94-105 tcggcctggtcattgcgg pitB sequencing Section 4.2 
94-106 aacatgaatgc gtcc ggc pitB sequencing Section 4.2 
93-130 ctagcgaaactgccaggc pitB sequencing Section 4.2 
95-5 cagtgtctatcggtcttgc pitB sequencing Section 4.2 
95-101 tccgctatcgAcgtggcgttttc SDMpitA G220D, Section 4.3 .2 
recreating G to A at 
658 bp inpitA ORF 
(pitA l) 
92-147 cgttttcgcaGggcgcgaacg SDM pitA H225Q Section 6.3 .1 
92-148 cggcgcgaacAatggtcagaa SDMpitA D229N Section 6.3.1 
92-149 c gatggtcagCaaggcattgg SDMpitA K232Q Section 6.3 .1 
Name Sequence {5' to3 '2 a 5 c Function Source/Ref. 
96-02 cccgcgcgatgcgAGAtcT gctcgccgtgg SDM pitA S50D, Section 6.3.2 
ttatg Q51L 
(BglII site in loop I) 
95-25 atatgggatcAGAtcTtggccttgcc SDM pitA S91D, Section 6.3.2 
H92L 
(BglII site in loop 2) 
95-26 ccatctctcaA GA Tctgattggcgcga SDM pitA Hl22Q, Section 6.3 .2 
Tl23D 
(BglII site in loop 3) 
96-28 ccgaaagtattaagtatAGATCTttctctgat SDM pitA FI56D, Section 6.3 .2 
cgtttccc Gl57L 
(BglII site in loop 4) 
96-01 gcgtcgctactggagAgATCTcaagaaacg SDM pitA S 182R, Section 6.3 .2 
cgcccg G183D, Tl84L 
(BglII site in loop 5) 
94-51 ctggacgc gtatAgA Tctgatcctttccgc SDMpitA A213D Section 6.3.2 
(BglII site in loop 5) 
94-52 gaagaaactgaagtcAga TCtgcttagcacca SDMpitA Ml 75L Section 6.3 .2 
tcg (BglII site in loop 
6/7) 
94-53 cgactatcggtgagaaaGA TCTtaagaaag SDM pitA I413D, Section 6.3 .2 
gcatgacctacgc G414L 
(BgllI site in loop 
7/8) 
95-83 gtctatcggcctggcAGAtCTtaccgggatg SDMpitA S438D, Section 6.3.2 
ccggtttc Y439L 
(BglII site in helix 
8/9) 
95-28 aaccgtgacAGA TCttctgatggcctgg SDMpitA S472D, Section 6.3 .2 
I473L 
(BgllI site in loop 
8/9) 
95-84 ctggctctccttgcaAGA Tctgtaatcgtacg SDMpitA F498D Section 6.3 .2 
cacc 
· (BglII site at C-
terminus) 
92-150 gcttcgtg gtTaacatgaatgc pitA Hpa 1 at V251, Section 6.4.1 
pitA sequencing Section 4.2 
92-151 cgcgctggcCttaggtatcggt pitA Saul at L394, Section 6.4.1 
pitA sequencing Section 4.2 
93-18 gcttcgtcgtTaaCatgaatgcgtc pitB Hpa 1 at V25 l Section 6.4.1 
92-153 ggtagcactggcCTtAggcattggcacc pitB Saul at L394 Section 6.4.1 
93-76 c gc gctgttGacc ggctcatc pitB Aflpal at L138 Section 6.4.1 
93-77 ctggaacctgggCacGtggtactttggtttac pitA BbrPl at G 110 Section 6.4.1 
93-78 ggaacctggg Cacgtggttcttc g pitB BbrPI at G 110 Section 6.4.1 
93-79 ggtctgattttcttgctT cgAAgGtactggagc pitA Sful at Rl 78 Section 6.4.1 
ggcacc 
93-80 gatattcctgctTc gaAggtactggagc ggg pitB Sfu 1 at RI 78 Section 6.4.1 
94-29 ttaccaacttT gaacactacc pitB i::l.Sfu I at F270 Section 6.4.1 
a Recognition sequences for restriction endonucease enzymes are underlined. 
b Altered bases in site-directed mutagenesis oligonucleotides are capitalised. 
c Bold nucleotides indicate the focal sequence for the site-directed mutagenesis. 
1 0mM MgC12 and 1 0mM MgSO4 was added. Glucose-Z broth consisted of Luria 
Bertani media plus 33mM glucose and 2.5mM CaC12• 
The minimal media used was the half-strength Medium 56 of Monod et al (177), 
consisting of 30mM KHPO4 , 20mM NaH2PO4, 0.4mM MgSO4 and 8mM NH4 SO4 . 
Trace elements, prepared as a 1000 fold stock were added to this medium immediately 
prior to sterilisation, to give final concentrations of 13.9µM ZnSO4 , 1.0µM MnSO4 , 
4.69µM H3BO3, 0.68µM CoSO4, 2.45µM CaC12 and 1.78µM FeC13 (75). 
Soft agars were prepared by adding 1 mM MgC12 and 8g Bacto-agar per litre of minimal 
media (made as described above). Soft H top agar was prepared with 1 0g tryptone, 8g 
NaCl and 15g Bacto-agar per litre of water. H plates were prepared by increasing the 
Bacto-agar to 15g. 
"Pi media" was an inorganic phosphate free media supplemented with 500µM 
NaH2PO4 . This consisted of l00mM Tris-HCl pH7.4, l0mM KCl, 15mM (NH4) 2SO4, 
lmM MgC12 , 0.1 % Casamino acids, 3µM thiamine and 33mM glucose. When 
appropriate 50µg/ml chloramphenicol, or 70µg/ml ampicillin were added. Auxotrophic 
requirements which were supplied where necessary included 0.008% arginine, 0.002% 
uracil, 30µM 2,3-dihydroxybenzoate, 0.17mM methionine, 0.008% glycine, 0.003% 
valine and 0.003% isoleucine (211). lmM a-glycerol-3-phosphate (G3P) was used as 
an organic phosphate source for potential Pi auxotrophs. 
Solid media was prepared by the addition of 20g Bacto-agar per litre liquid media prior 
to sterilisation. 
TE buffer consists of l0mM Tris-HCl and lmM EDTA, pH8.0, sterilised by 
autoclaving. 
Antibiotics were prepared as stock solutions and stored at -20°C. Ampicillin stocks 
were 1 00mg/ml in H20, and were normally used at 1 00µg/ml in culture and solid media. 
Chloramphenicol was prepared at 60mg/ml in ethanol, and was often used at 1 00µg/ml 
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in culture and solid media, although weaker dilutions were also prepared. Kanamycin 
was stored at I 00mg/ml in H2 0, and the standard dilution was to 50µg/ml. 
Streptomycin stock was 1 00mg/ml in H20, and was used at 200µg/ml unless otherwise 
stated. Tetracycline was stored at I 0mg/ml in 70% ethanol, and diluted to I 0µg/ml. 
2.4 General molecular biology techniques 
2.11.1 Small scale purification of plasmid DNA or 
replicative form M13 DNA 
Small scale isolation of plasmid or M 13 replicative form (RF) DNA was carried out 
using the Magic and Wizard Minipreps DNA Purification Systems (Promega 
Corporation, Madison, WI, USA) following the manufacturers instructions. Strains 
containing plasmids were grown to stationary phase at 3 7°C in 5ml of Luria Bertani 
medium with the appropriate antibiotics/supplements. Alternatively, Ml3 RF DNA was 
purified from plaques by inoculating 5mls of TG 1 cultured in 2x YT media with a single 
Ml3 plaque or 1 0µl of phage stock, then incubating this culture at 37°C with shaking 
for 3.5 hours. 1.5ml of either the plasmid or M13 RF culture was transferred into a 
polypropylene microcentrifuge tube and pelleted by centrifugation for I min at 
l 4000xg in an Eppendorf microcentrifuge. The cells were resuspended in 200µ1 of cell 
resuspension solution (50mM Tris-HCI (pH7.5), I0mM EDTA, I00mg/ml RNase A). 
200µ1 of cell lysis solution (0.2M NaOH, I% SDS) was gently mixed through the 
suspension by inverting the tube several times until the solution became clear. A thick 
white precipitate formed after addition of 200µ1 of neutralisation solution (1.32M 
potassium acetate, pH4.8) and after thorough mixing this was pelleted by centrifugation 
at l 4000xg for 5 mins. The supernatant was transferred to a new tube and I ml of 
Magic or Wizard Minipreps DNA purification resin was added. The DNA/resin 
mixture was loaded onto a minicolumn attached to a vacuum manifold via a disposable 
syringe barrel, and the resin was washed with 2ml of column wash solution (84mM 
NaCl, 8.4mM Tris-HCl (pH7.5), 5mM EDTA, 55% v/v ethanol). The minicolumn was 
then attached to a microcentrifuge tube and briefly centrifuged to remove all wash 
solution. A fresh microcentrifuge tube was attached to the minicolumn, which was 
incubated with 50µ1 of preheated (65°C) water for I min, before eluting the DNA by 
centrifugation at 14000xg. 
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2.lJ..2 Large scale purification of plasmid DNA by 
Caesium chloride (CsCI) density gradient 
The method used for the large scale preparation of high purity plasmid or M 13 
replicative form (RF) DNA was a modification of Selker et al (23 8). A 1 litre culture 
of the appropriate E. coli strain was grown to stationary phase in Luria Bertani media 
plus the appropriate antibiotics and supplements. Bacteria were harvested by 
centrifugation at 8000xg ( 5 000rpm in GSA Sorvall rotor) for 5 mins at 4 °C, and the 
bacterial pellet was resuspended in 20ml of buffer containing 50mM Tris-HCl (pH8) 
and 25% sucrose, and incubated on ice for 5 mins. 8ml of lysozyme solution (l0mg/ml 
in 0.25M Tris-HCl, pH8) was gently swirled into the cell suspension, which was left on 
ice for 5 mins. An addition of 4ml 0.25M EDTA was made, with swirling, and the 
spheroplasts were incubated on ice for a further 5 mins. 32ml of Triton lysis buffer 
(50mM Tris-HCl (pH8), 62.SmM EDTA, 0.3% v/v Triton X-100) was added and 
stirred for 5 mins to lyse the spheroplasts. Cell debris was pelleted by centrifugation 
for 20 mins at 48000xg at 4°C. One quarter volume of 5M NaCl was added to the 
supernatant with stirring, followed by one quarter volume of 50% PEG-6000 in 50mM 
Tris-HCl (pH8). This was mixed gently in ice, and incubated on ice for at least 2 hrs to 
precipitate the plasmid DNA. The precipitate was collected by centrifugation at 
3 000xg at 4 °C for 5 mins, and the pellet was resuspended in 7ml TE buffer ( 1 0mM 
Tris-HCl (pH8), lmM EDTA) and transferred to a Sorvall SE12 centrifuge tube. 7.2g 
CaCb was dissolved into this solution and centrifuged for 20 mins at 2300xg at room 
temperature. The layer of protein at the top of the tube was removed with a spatula and 
the remaining solution was transferred into a 50Ti Beckman centrifuge tube and 300µ1 
of 1 0mg/ml ethidium bromide was added. The tubes were protected from light, filled 
with paraffin oil, sealed and centrifuge at 140000xg at 15°C for approximately 42hrs 
(brake off). The lower band containing supercoiled plasmid DNA was removed with 
an 18 gauge needle attached to a syringe through the side of the tube. Ethidium 
bromide was removed by the addition of isopropanol (stored over NaCl-saturated TE) 
followed by vortexing, and this extraction was repeated 5 times, or until all red 
colouration had been removed from the aqueous phase. Dialysis against 1 litre of TE 
buffer at 4°C was used to remove CsCl, and the plasmid solution was stored at 4°C. 
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Z.11.3 Purification of chromosomal DNA from E coli 
Genomic DNA from E. coli strains was isolated from a stationary phase culture by 
resuspending the cells pelleted from 1.5mls of culture in 567µ1 TE, then adding 30µ1 of 
10% SDS and 3 µl of 20mg/ml proteinase K, giving a final concentration of 1 00µg/ml 
proteinase K in 0.5% SDS. This was mixed thoroughly and incubated 1 hr at 3 7°C. 
100µ1 of SM NaCl was added to this viscous solution to prevent nucleic acids 
precipitating with the cell wall debris, denatured protein and polysaccharides upon the 
addition of hexdecyltrimethyammonium bromide (CTAB). 80µ1 of 10% CTAB in 
0.7M NaCl was added to this mixture and incubated 10 min at 65°C. An approximately 
equal volume ( ~0.8ml) of 24: 1 chloroform/isoamyl alcohol was added, mixed 
thoroughly and spun 5 mins in a microcentrifuge. The aqueous supernatant was placed 
in a fresh tube and an equal volume of 25 :24: 1 phenol/chloroform/isoamyl alcohol was 
added, mixed thoroughly and spun in a microcentrifuge for 5 min. The supernatant was 
transferred to a fresh tube and 0 .6 vol isopropanol was added to precipitate the nucleic 
acids, which become visible upon shaking as a stringy white DNA precipitate. This 
DNA was transferred to a fresh tube containing 70% ethanol, spun for 5 mins at room 
temperature to pellet the DNA, and dried in a vacuum desiccator. The chromosomal 
DNA was then resuspend in 100µ1 TE buffer. 
Z.11.11 Preparation of single•stranded M13 DNA 
Single stranded DNA used in site-directed mutagenesis or DNA sequencing was 
prepared from M 13 clones by the method of Sanger et al (231) as described in the 
technical notes for the Oligonucleotide-directed in vitro mutagenesis system version 2.1 
(Amersham). 50µ1 of a fresh overnight culture of TG 1 grown in 2x YT medium was 
added to 5ml 2xYT media. This was inoculated with either a single M13 plaque grown 
on a lawn of TG 1 cells, or 1 0µl of phage stock, and cultured for 5 hrs at 3 7°C. Cells 
were transferred to 5 microcentrifuge tubes and pelleted by centrifugation for 5 mins in 
a benchtop centrifuge. The supematants were transferred to 5 fresh tubes, being careful 
to keep these free of whole cells, and 200µ1 of PEG/NaCl (20%w/v polyethylene glycol 
6000, 2.5M NaCl) was added, shaken and then left to stand for 15 mins . After 
centrifugation for 5 mins, the supernatant was discarded and the tubes were centrifuged 
another 2 mins to facilitate removal of all traces of PEG. Pellets were resuspended in 
100µ1 TE buffer and contaminants were extracted with phenol followed by diethyl 
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ether. The single-stranded M13 DNA was then precipitated with 1 0µl 3M sodium 
acetate, pH6, and 250µ1 ethanol, and the precipitate was collected by centrifugation. 
The resulting DNA pellets were washed with ethanol, dried in a vacuum desiccator and 
resuspended in a total volume of 100µ1 TE buffer. 
2.4.5 Spectrophotometric analysis of ONA 
Appropriately diluted DNA was assayed at 260 and 280nm using a Hitachi U-1100 
Spectrophotometer. An absorbance of 1.0 at 260nm was taken as equivalent to a 
concentration of 5 0µg/ml for double stranded DNA and 20µg/ml for oligonucleotides. 
DNA purity was assessed by dividing A260 by A280 , which gives a ratio of between 1.8 
and 2.0 for DNA uncontaminated by RNA or protein (230). When a more exact 
oligonucleotide concentration was required 15 .6 A2 60 units/µl per base of 
oligonucleotide was considered equivalent to lpmol/µl DNA (from Amersham 
Sculptor TM in vitro mutagenesis manual). 
2.4.6 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments by size. Generally an 
agarose concentration of 0.8% was used in TAE buffer (40mM Tris-HCI, 20mM 
sodium acetate, 1 mM EDTA, pH7 .8), although the agarose concentration could vary 
between 0.8 and 2%. Loading dye (470mM sucrose, 0.75mM bromophenol blue, 
48mM EDTA) was used at a ratio of approximately 1 :5, with sample volumes of 10 -
20µ1. Gels were run at a constant current of approximately 180mA, until the 
bromophenol blue dye front had migrated three-quarters of the length of the gel. DNA 
was stained in 1 µg/ml ethidium bromide solution for 20 mins and visualised by 
exposure to ultra-violet light. 
2.4.7 "Rapid cracking" of phage or colonies 
This method was used as a rapid screen for the desired DNA product after a subcloning 
reaction ( checking for the presence of insert in the phage/plasmid) and was used when 
the expected efficiency of the ligation reaction was low. A small amount of cells from 
a single colony or 1 0µl of the phage supernatant from a culture greater than 5 hrs old 
was suspended in 40µ1 colony cracking buffer (50mM NaOH, 10% glycerol, 5mM 
EDTA, 0.5% SDS, 0.025% bromocresol green) and heated to 70°C for 30-60 mins. 
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This was then run on an 0.8% agarose gel and DNA bands were visualised as described 
in Section 2.4.6. 
2.J/..8 Synthesis and preparation of oli9onucleotiaes 
Oligonucleotides were synthesised by the Biomolecular Resource Facility at the ANU 
and were supplied as 40nmol oligonucleotide in an ammonia solution. These were 
freeze-dried and resuspended in 600µ1 water for purification by HPLC on a MAC7Q 
ion exchange column. The HPLC column was equilibrated with 40mM Tris-HCl pH8 
before loading 300µ1 of oligonucleotide solution. A gradient of zero to IM NaCl was 
applied, and the absorbance at 280nm was used to monitor the elution of the 
oligonucleotide, which usually formed a discrete peak. The collected DNA solution 
(max volume 2.5ml) was desalted and freeze dried overnight. This DNA was 
resuspended in approximately 400µ1 of a 10 times dilution of TE, and DNA 
concentration was determined by sphectrophotometry as described in Section 2.4.5. 
When necessary oligonucleotides were phosphorylated, as described in Section 2.5.4. 
2.J/..9 Polymerase chain reaction (PCR) 
Polymerase chain reactions (180, 228) were performed in a Perkin Elmer Cetus 
Thermal Cycler. Taq polymerase supplied by Promega, was used as the thermostable 
DNA polymerase in experiments where fidelity in the sequence was not an absolute 
requirement ( such as when screening for the presence or absence of a gene). However 
the high base incorporation error rate associated with this enzyme (2.0 x 10-5 (156)) 
precluded its use when accuracy in the DNA sequence was vital. Pfu polymerase, 
supplied by Stratagene, has been show to have a 12-fold lower error rate (1.6 x 10-6 
(156)) and was used to produce DNA fragments whenever sequence fidelity was 
important. 
A typical reaction mixture, using 2 units of Taq polymerase, contained 20pmol of each 
oligonucleotide primer, 250ng template DNA, 200µM of each dNTP, buffer (supplied 
with the enzyme -50mM KCI, l0mM Tris-HCI pH9.0, 0.1 % Triton X-100) and 2.5mM 
MgC12 in a total volume of 50 µI. Pfu polymerase reactions were as above, using 2 
units enzyme, buffer (supplied with enzyme - 20mM Tris-HCl pH8.2, 1 0mM KCl, 
6mM NH4SO4, 2mM MgC12, 0.1 % Triton X-100, 1 Ong/ml nuclease free Bovine Serum 
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Albumin). Mineral oil was overlaid to prevent evaporation. An estimate of the 
optimum annealing temperature for a primer was calculated by adding 2 °C for each A 
and T nucleotide present in the primer and 4 °C for each G and C nucleotide, and 
subtracting 5°C from the result. Generally 30 cycles of denaturation, annealing and 
extension were performed. Denaturation was at 94°C for 1 min, annealing at 55-65°C 
( depending on the sequence of the oligonucleotide primers) for 1 min and extension at 
72°C for 2 mins. 
The pitA and pitB genes were amplified from genomic DNA, which was either purified 
(Section 2.4.3) or supplied by using approximately 2µ1 of a small amount of a single E. 
coli colony mixed in I 00µ1 of water. 
2.J/..10 Purification of PCR products 
All traces of mineral oil were removed from PCR reactions by running the solutions 
over a clean sheet of Parafilm® laboratory film. The oil adheres to the film, allowing 
the aqueous solution to be isolated. Purification was carried out using a BresaClean Kit 
(Bresatech). Three volumes of Nal solution was added to the DNA solution, followed 
by 5 µl of resuspended BresaClean silica resin. The suspension was mixed and 
incubated for 5 mins, then centrifuged for 5 secs in a bench top centrifuge and the 
supernatant was discarded. The silica/DNA pellet was resuspended in 500µ1 of 
BresaClean wash solution followed by centrifugation. The wash solution was removed 
as completely as possible and the pellet was dried and then resuspended in sterile 
distilled water and incubated for 5 mins at 50°C. The silica resin was pelleted by 
centrifugation for 1 min at top speed, and the supernatant containing the PCR products 
was transferred into a fresh tube and centrifuged again to ensure complete removal of 
any residual silica resin. 
2.J/..11 Site-directed mutagenesis 
Site-directed mutagenesis was carried out using either the Oligonucleotide-directed in 
vitro mutagenesis system version 2.1 (Amersham), or the more recent Sculptor™ in 
vitro mutagenesis system (Amersham). These systems are based on the 
phosphorothioate technique of Fritz Eckstein (234 ). The methods are described in 
detail in the handbooks accompanying the kits, and are summarised as follows. A 
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phosphorylated mutagenic oligonucleotide was annealed to single-stranded DNA 
(ssDNA) template. Elongation and ligation of the second strand of DNA was carried 
out using the Klenow fragment (Version 2.1) or T7 DNA polymerase (Sculptor™) and 
T4 DNA ligase, plus dATP, dGTP, dTTP and dCTPaS. Any remaining ssDNA (non-
mutant) was removed either by filtration (Version 2.1) or digestion with TS 
exonuclease (Sculptor™). The non-mutant strand of the double-stranded DNA 
( dsDNA) template was then nicked with Neil, as the incorporated thionucleotide 
dCTPaS protects Neil sites on the mutant DNA strand. Exonuclease III was used to 
remove the majority of the nicked non-mutant DNA, leaving primers for 
repolymerisation by DNA Polymerise I followed by ligation with T4 DNA ligase. The 
dsDNA was transformed into competent TG 1 cells, and ssDNA was isolated and 
sequenced from single plaques, as described in Sections 2.4.4, 2.4.12 and 2.4.13. 
2.11.12 Manual sequencing of ONA 
Nucleotide sequencing of single-stranded and double-stranded DNA was carried out 
with the T7 Sequencing Kit (Parmacia) which uses the dideoxynucleotide chain 
termination method of Sanger et al (232). Sequencing reactions were performed 
according to the methods described in the handbook accompanying the kit, and are 
summarised below: 
For single stranded DNA, the annealing reactions contained 1.5-2µg template, and 
2-4pmol oligonucleotide primer in annealing buffer. Double stranded DNA template 
was denatured with NaOH as described in the handbook, using 1.5-2µg DNA. This 
DNA was ethanol precipitated and resuspended in water. 5-1 0pmol of primer was used 
in the annealing reaction. Labeling reactions were carried out using a mixture of dGTP, 
dTTP, dCTP and [3 5S]dATPaS with the enzyme T7 DNA polymerase. Chain 
termination reactions were commenced by transferring aliquots from this tube into 4 
labeled tubes, each containing the 4 deoxynucleoside-5 '-triphosphates, and one of the 
dideoxynucleoside-5 '-triphosphates. Reactions were halted by the addition of stop 
solution, which contained formamide, EDTA, xylene cyanol and bromophenol blue. 
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Electrophoresis gels were prepared using Long Ranger™ gel solution (AT Biochem) 
which is stated by the manufacturer to contain a modified acrylamide, a co-monomer 
and a cross-linker (unspecified). To prepare 50ml of gel solution 21g of urea was 
dissolved in 6ml 1 0xTBE (Tris-Borate-EDT A buffer), 5ml Long Ranger™ solution, 
and water to 50ml. l0xTBE buffer consisted of 108g Tris Base, 55g Boric acid, 40ml 
of 0.5M EDTA pH8 and water to 1000ml. The gel solution, containing a final 
concentration of TBE buffer at 1.2x, was polymerised by the addition of 25µ1 TEMED 
and 300µ1 of 10% ammonium persulphate. 
Electrophoresis gels were run in a Base Runner Nucleic Acid Sequencer (!BI/Kodak) 
between 21.6cm x 45cm or 21.6cm x 60cm glass plates, using 0.4mm spacers. Gel-
Slick solution (!BI/Kodak) was applied to one plate to prevent adherence of the gel. A 
flat 0.4mm spacer was placed in the top of the poured gel, which was allowed to 
polymerise for one hour at room temperature. The gel was pre-run with lxTBE buffer 
in the buffer reservoir tanks at 30W (for 21.6cm x 45 cm plates) or 45W (for 21.6cm x 
60cm plates) for 30 mins to pre-warm the gel. A sharks tooth comb was then place at 
the top of the gel to allow loading of up to 32 samples. 
Samples were heated at 100°C for 2 mins to denature the DNA and 3 µl of each sample 
was loaded onto the gel, which was electrophoresed, using the conditions described 
above for up to 5 hrs, depending on the length of sequence to be read. Where 
appropriate, second applications of the samples were made 2 hrs after the initial 
loading, to increase the length of DNA sequence able to be read from this gel. Also 
5 0ml of 3M sodium acetate could be added to the bottom buff er tank 90 mins before 
the expected finish of the electrophoresis to compress the bands at the bottom of the 
gel, thus increasing the length of readable sequence. 
The gel was then adhered to 3MM chromatography paper (Whatman), and dried under 
vacuum at 80°C for 2 hrs. Autoradiography was carried out using Hyperfilm MP 
autoradiography film (Amersham) for 20-25 hrs, then developed in an X-omat M20 
automatic processor (Eastman Kodak). 
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2.11.13 Automated sequencing of DNA 
Double-stranded DNA ( dsDNA) was prepared for sequencing on an Applied 
Biosystems DNA Sequencing System using the PRISM™ Ready Reaction 
DyeDeoxy™ Terminator Cycle Sequencing Kit (Applied Biosystems). Primer and 
template ( usually dsDNA from either 'minipreps', see Section 2.4.1, or Cs Cl purified 
plasmid DNA, see Section 2.4.2 or single-stranded DNA (ssDNA), see Section 2.4.4) 
are added to supplied reagents to perform fluorescence-based dideoxy sequencing 
reactions with the thermally stable enzyme AmpliTaq® DNA Polymerase. Reactions 
were prepared as described in this protocol, except the amount of primer used for 
dsDNA templates was increased from 3 .2pmol to 6pmol. Cycle sequencing was carried 
out on a Perkin-Elmer Cetus thermal cycler for 25 cycles using the program 
recommended in this manual. Phenol/choloroform extraction was carried out as 
described, except that the mineral oil used during the thermocycling was removed by 
rolling the reaction mixture plus 80µ1 H20 down a piece of clear Parafilm® laboratory 
film. The oil sticks to the film, so the aqueous solution can easily be removed with a 
pipette. 
Electrophoresis and imaging was carried out by the Biomolecular Resources Facility at 
the John Curtin School of Medical Research, ANU. 
2.5 Recombinant DNA techniques 
2.5.1 Restriction endonuclease digestion of DNA 
Restriction endonuclease digestion of DNA was used to prepare suitable 'blunt' or 
'sticky' 5' and 3' ends for subcloning DNA fragments into suitable vectors, to screen 
for successful subclonings, and to verify certain DNA sequences or site-directed 
mutagenesis experiments. Digestion of DNA for analytical purposes was usually 
carried out using 0.1-1 µg DNA in a 20µ1 volume. Restriction endonucleases were at 
0.5-5 units per reaction in the appropriate buffer supplied by the manufacturer, and 
were normally incubated at 37°C for 60 mins. 5-1 0µl was then analysed by agarose gel 
electrophoresis (Section 2.4.6). Preparative scale digestion of DNA was usually carried 
out in 50-100µ1 volume with 1-1 0µg DNA and 1-10 units of restriction endonuclease in 
the appropriate buffer. These reactions were incubated at 3 7°C for between 1 and 3 hrs 
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and when required specific DNA fragments were isolated using agarose gel 
electrophoresis (Section 2.4.6). 
2.5.2 Elimination of 5' and 3' protruding ends 
DNA fragments with protruding · 5' termini were converted to blunt ends by filling the 
ends in with the DNA polymerase activity of the Klenow fragments of E. coli DNA 
polymerase 1. Up to 1 µg of DNA was incubated with 1-2 units of the Klenow 
fragment, 25 µM dNTPs in a volume of 50µ1. The reaction was incubated at room 
temperature for 10 mins, the stopped by heating to 70°C for 5 mins to inactivate the 
enzyme. The DNA was then purified with the BresaClean method as described in 
Section 2.4.10. 
Removal of protruding 3' termini was carried out with bacteriophage T4 DNA 
polymerase, which can also fill in protruding 5' termini with a 5' to 3' polymerase 
activity. T4 DNA polymerase was added directly to the DNA after restriction 
endonuclease digestion at a concentration of 2 units per µg DNA, along with the 
desired dNTPs at 0.lmM. The mixture was incubated at 12 for 15 mins, then heated to 
7 5°C for 10 mins to heat kill all enzymes. 
2.5.3 
DNA 
Removal of terminal phosphates from linearised 
Terminal phosphates were removed from linearised vector DNA to minimise religation 
of the vector DNA. Linearised vector DNA was dephosphorylated by adding 
approximately 1 unit shrimp alkaline phosphatase per microgram DNA to the 
completed restriction endonuclease digestion (as this enzyme is active in almost all 
buffer conditions) and this mixture was incubated at 3 7°C for 60 mins, then heat killed 
by incubation at 65°C for 15 mins. The DNA was then purified using the BresaClean 
method as described in Section 2.4.10. 
2.5.LJ. Phosphorylation of oli9onucleotiaes 
When necessary oligonucleotides were phosphorylated using 2-4.5 units of T4 
Polynucleotide kinase (Pharmacia), kinase buffer (l00mM Tris-HCl pH8.0, l0mM 
MgC12, 7mM dithiothreitol, 1 mM ATP) and 48pmol oligonucleotide for 15 mins at 
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3 7°C, followed by heat inactivation at 70°C for 10 mins. The phosphorylated 
oligonucleotide was used immediately or stored at -20°C. 
2.5.5 Purification of DNA fragments from agarose gels 
DNA fragments were separated by agarose gel elecrophoresis and visualised via 
staining with ethidium bromide, as described in Section 2.4.6. The appropriate DNA 
band was excised from the gel using a sterile scalpel and transferred into a tube 
wrapped in tin foil. Purification of the DNA was carried out using the BresaClean Kit 
(BresaTech). NaI solution was added to the gel slice at 1 ml per gram and this was 
incubated at 55°C with occasional mixing until the gel slice had dissolved. 5µ1 of 
resuspended BresaClean resin was added, and the DNA was isolated as described in 
Section 2.4.10. 
2.5.6 Ligation of DNA 
'Sticky ' ends 
DNA fragments with sticky ends were ligated with a molar ratio of 1 part vector per 2 
to 15 parts insert with T4 DNA ligase (0.5 to 1 unit) in a total volume of 20µ1. The 
reaction mix, which also contained 30mM Tris-HCl pH7 .8, 1 0mM MgC!i, 1 0mM DTT 
and lmM ATP was incubated at 16°C overnight, or at room temperature for 4-5 hrs. 
'Blunt ' ends 
Blunt end ligations were carried out with approximately 1 00ng dephosphorylated 
vector and a 10 to 20 fold molar excess of insert. The buffer contains 50mM Tris-HCl 
pH7.6, l0mM MgC12, 5% PEG 8000, lmM DTT and lmM ATP in a total volume of 
20µ1. Approximately 6 units of T4 DNA ligase was added, and this mixture was 
incubated at l 6°C overnight, then the enzyme was heat killed at 65°C for 15 mins. 
2.5. 7 Preparation of competent E coli 
Competent cells were prepared by several methods. When small amounts of an unusual 
strain were needed, fresh competent cells were prepared using the CaC1 2 method 
described in the Amersham oligonucleotide-directed in vitro mutagenesis system 
version 2.1 booklet. However, for standard strains where it was convenient to prepare 
and store large volumes of cells either a large scale CaC1 2 method or the RbCl method 
50 
(Amersham oligonucleotide-directed in vitro mutagenesis system version 2.1 booklet) 
was used, depending on the bacterial strain being prepared. 
CaCI2 competent cells for use within 24 hours 
40mL of 2x YT medium was inoculated with 400µ1 of an overnight culture of the 
appropriate strain, and shaken at 37°C until the Asso was approximately 0.3. Cells were 
pelleted by centrifugation at 3000xg for 5 mins, resuspended in 20ml ice cold 50mM 
CaCh and left on ice for 20 mins. Cells were spun down at 3000xg for 2 mins, 
resuspended in 4ml cold CaC12 and incubated on ice for several hours before use. 
CaCI2 competent cells for long term use 
The appropriate strain was inoculated into 200ml 2xYT media plus any required 
supplements, and incubated with shaking at 37°C until an A600 of 1 was obtained. The 
culture was chilled on ice for 10 min and cells were harvested by centrifugation at 
8000xg for 10 min. The supernatant was removed and cells were gently resuspended in 
20ml of cold 0. IM CaC12 and incubated in an ice/water bath for 20 min. These were 
then pelleted by centrifugation at 8000xg for 5 min, and gently resuspended in 2ml of 
cold 0. IM CaC12 :glycerol (85: 15).~ Aliquots of 50µ1 were made into pre-chilled 
eppendorf tubes, snap frozen in liquid nitrogen and stored at -70°C. 
RbCI competent cells for long term use 
The appropriate strain was inoculated into 30mL SOB media and grown overnight. 
8ml of this culture was then transferred into 200ml SOB and grown to an Assa of 
approximately 0.3. The culture was divided between four tubes, chilled in an 
ice/salt/water bath and incubated on ice for 15 min. The cells were pelleted by 
centrifugation at 3 000xg for 5 min at 4 °C and each pellet was resuspended in 16ml of 
transformation buffer 1 (100ml contains 1.2g RbCl, 0.99g MnC12 .4H20, 3ml of IM 
potassium acetate, pH7.5, 0.15g CaCh.2H20 and 15g glycerol adjusted to pH5.8 with 
acetic acid and filter sterilised). This suspension was incubated on ice for 15 min and 
pelleted by centrifugation at 3000xg for 5 min at 4°C. The cells were then resuspended 
in a total of 16ml of transformation buffer 2. (100ml contains 2ml of O.5M MOPS 
pH6.8, 0.12g RbCl, I. lg CaC1 2.2H20 and 15g glycerol. Adjust the final pH to pH6.8 
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with NaOH and then filter sterilise). 300µ1 aliquots were snap frozen in liquid nitrogen 
and stored at -70°C. 
2.5.8 
DNA 
Transformation of competent E coli with plasmid 
CaC12 competent cells (for use within 24 hours) 
3 00µ1 of fresh competent cells were aliquotted into chilled eppendorf tubes. Plasmid 
DNA (0.01-0.lµg) or ligation mix (5-20µ1) was added to these cells and incubated on 
ice for 40 min. Cells were heat shocked at 42 °C for 45 secs and placed on ice for 5 
min. 1 mL Luria Bertani media was added and the suspension was allowed to stand at 
3 7°C for 1 hour. Cells were pelleted by centrifugation at 5000rpm for 2 min, gently 
resuspended in 250µ1 of Luria Bertani media or minimal media and spread onto the 
appropriate solid media. 
CaC12 competent cells (long term use) 
A 50µ1 aliquot of frozen competent cells was thawed on ice for 5 mins, then 0.9ml of 
cold O. lM CaCh was added to each tube. 5-20µ1 of ligation mix, or the appropriate 
amount of plasmid DNA (0.1-0.1 µg) was gently mixed into a 100µ1 aliquot of cells, 
and incubated on ice for 30 min. Cells were heat shocked at 43.5°C for 45 secs and 
immediately placed on ice for 5 min. 1 mL Luria Bertani media was added and the 
mixture was allowed to stand at 3 7°C for 1 hour. Cells were pelleted by centrifugation 
at 5000rpm for 2 min, gently resuspended in 250µ1 of Luria Bertani media or minimal 
media and spread onto the appropriate solid media. 
RbCl method 
300µ1 aliquots of competent cells were thawed on ice, and the appropriate amount of 
plasmid DNA or mutagenised phage (20µ1) was added as described above. These were 
left on ice of 15 mins, heat shocked at 42 °C for 2 min, then placed on ice for another 15 
mins. Incubation in 5mls Luria Bertani media was carried out for an hour at 3 7°C to 
allow the expression of plasmid markers. The cells were pelleted by centrifugation, 
resuspended in a small volume of Luria Bertani media or minimal media and then 
plated out on the appropriate solid media. Transfection with M 13 derivatives was 
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carried out by resuspending the cells in minimal media and plating them onto solid H 
plates with H top agar overlays containing 200µ1 of mid-exponential phase TG 1 cells. 
2.6 Genomic recombinant DNA techniques 
2.6.1 Genetic recombination on the £ coli genome 
The genetic recombination method of Oden et al (189) was used to replace genes on the 
E. coli genome via double crossover events utilising plasmid DNA. The recBC sbcBC 
strain JC7623 is deficient in the recBC nuclease, which degrades linear DNA, and the 
sbcBC genes which make the cell "recombination proficient" by derepressing the recF 
gene (98). A plasmid containing the desired form of a particular gene was transformed 
into a recBC sbcBC strain (JC7623 - see Table 2.1) and this was plated onto solid 
selection media to screen for recombinants, which normally take 2 days incubation at 
3 7°C to appear. The ORF of the selected gene was amplified by PCR (Section 2.4.9) 
from a number of these isolates, to identify those which contained only the modified 
gene. Restriction endonuclease digestion was also used to verify the PCR products 
(Section 2.5.1). Phage transduction (Section 2.6.2) was then used to transfer the 
modified gene from JC7 623 into the desired background strain. 
2.6.Z Bacteriophage Plkc transduction 
Determination of phage titer 
Recipient cells were cultured in 10ml glucose-Z broth (Luria Bertani media, 2.5mM 
CaC12) to Klett 100 (about 2.5x10 8 cells/ml), and the bacteriophage Plkc lysate was 
diluted in glucose-Z broth to 10-3, 10-5, 1 o-7 and 10-9. 950µ1 cells were aliquotted into 
pre-warmed tubes at 3 7°C, 5 0µl of diluted P 1 lysate was added and the mixture was 
incubated at 3'?C for 30 mins to allow adsorption of the phage to the recipient cells. 
200µ1 of each incubation was mixed with 2ml soft agar at 45°C, and poured onto pre-
warmed glucose-Z plates (5g Bactotryptone, 5g NaCl, 2.5g Yeast Extract, 5g Bacto-
agar made up to 500ml pH7 and autoclaved, then after cooling add 5ml 0.25M CaC}z, 
10ml 2M glucose). Plaques were counted after 6 hrs incubation at 3 7°C. The phage 
titer, measured in plaque forming units per ml lysate (PFU/ml) was equal to the plaque 
count divided by the phage dilution (i.e. 1 o-7), multiplied by 100. 
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Preparation of transducing phage lysate 
Donor cells were grown to Klett 100 in 20mls of glucose-Z broth. The cells were 
pelleted (2000rpm for 10 mins in a bench top centrifuge) and resuspended in 1 ml 
glucose-Z broth. P 1 phage was spun down and the aqueous phase degassed for 
chloroform by incubation at 3 7°C with shaking for 1 hr. Between 3 00µ1 and 1 ml of 
phage lysate was added to 500µ1 of cells, using glucose-Z broth in the control tube, and 
these were incubated at 3 7°C for 30 mins to allow adsorption of phage onto the cells. 
400µ1 aliquots of the cells were mixed into 6ml pre-warmed soft agars at 45°C and then 
overlaid on pre-warmed glucose-Z plates. These were incubated at 3 7°C for 6 hrs and 
stored overnight at 4 °C before preparing the phage lysate. To isolate the phage 4ml 
glucose-Z broth was added to each plate and the soft agar layer was scraped into sterile 
SS34 tubes. Chloroform was added at 100µ1 per 4mls lysate and vortexed thoroughly 
for several minutes, then left at room temperature for 2 hrs. Centrifugation was carried 
out at room temperature at 6000xg (7500rpm in SS34 rotor, Sorvall centrifuge) for 20 
mins. The supernatant was carefully decanted and the remaining cell debris was 
removed by filtration through a Millipore 0.2µm low protein binding filter. A few drops 
of chloroform were added to the phage lysate before storage at 4 °C. The phage titer 
was then determined for this lysate, and 100µ1 was plated out on the appropriate media 
to verify the absence of viable donor cells. 
Generalised transduction 
The recipient strain was grown in 40ml of glucose-Z broth plus the appropriate 
antibiotics and auxotrophic requirements to Klett 100, and cells were pelleted by 
centrifugation at 500xg (2000rpm in SS34 rotor, Sorvall centrifuge) for 10 mins. The 
recipient cells were resuspended in 2ml glucose-Z broth. Phage lysate was spun down 
and residual chloroform was evapourated from the aqueous phase by incubation at 3 7°C 
with shaking for 1 hr. The required amount of phage lysate to give approximately 1-12 
PFU/bacterium (up to a maximum of 1.5ml) was added to 500µ1 of cells, with glucose-
z broth used for the control, and these tubes were incubated at 3 7°C for 30 mins. 20µ1 
of 1 M citrate was then added to each tube to chelate Ca 2+ and stop further infection of 
P 1, followed by 2 volumes of Luria Bertani media. The cultures were incubated with 
shaking at 3 7 °C for 3 0 mins. The cells were pelleted by centrifugation as described 
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above, resuspended in l00mM Tris-HCl pH7.4 and aliquots of 100µ1 were plated out 
onto the appropriate selective media and incubated at 37°C for two days. 
2. 7 Protein biochemistry techniques 
2.7.1 Gel electrophoresis of proteins 
SDS-polyacrylamide gel electrophoresis was carried out according to the method of 
(139) using either pre-cast 10% discontinuous or 4-12% gradient Novex 
polyacrylamide gels with a Novex Xcell-II apparatus, or manually poured 
discontinuous polyacrylamide gels with a Bio-Rad Mini-PROTEAN® II 
Electrophoresis Cell. Denaturing conditions ( containing SDS) were used for all gels. 
Novex gels buffered with Tris-Glycine were run in 24mM Tris base (pH8.3), 192mM 
glycine and 0.1 % SDS. The NuPAGE™ MES system uses NuPAGE gels buffered 
with MES SDS running buffer, pH7.2 (50mM 3-(N-morpholino) propane sulfonic acid 
(MES), 50mM Tris base, 3.5mM SDS, lmM EDTA). The 2x loading buffer was 
composed of 40mM Tris-HCl (pH6.8), 10% (w/v) glycerol, 1.6%SDS and 4% 
~-mercaptoethanol. Electrophoresis was carried out at a constant voltage of 125V for 
approximately 100 minutes. Manually poured gels consisted of a 4% stacking gel layer 
and a 9%-10% resolving gel layer, using a 29: 1 acrylamide:bisacrylamide ratio. The 
stacking gel buffer contained 37.SmM Tris-HCl (pH8.8) and 0.1 % SDS, while the 
resolving gel buffer consisted of 12.SmM Tris-HCl (pH6.8) and 0.1 % SDS. APS and 
TEMED were added to initiate polymerisation of the acrylamide. Electrophoresis was 
carried out at a constant current of 3 5mA for approximately 40 mins. Protein samples 
were mixed with 0.lM fresh DTT and SDS/Z buffer (200mM Tris-HCl (pH6.8), 50% 
glycerol, 8% SDS and 0.01 % bromophenol blue) in a ratio of 1 part buffer to 4 parts 
sample prior to loading. Low weight makers and prestained molecular weight markers 
were from Biorad and Novex (SeeBlue™). 
2. 7.2 Coomassie staining of polyacrylamide gels 
Protein gels were stained with Coomassie dye using 1.25% w/v Coomassie R-250 
(PhastGel™ BlueR, Pharmacia Biotech), 10% v/v acetic acid 50% v/v methanol and 
25% v/v ethanol, and destained overnight in 25% v/v ethanol, 8% v/v acetic acid. Gels 
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to be dried were desalted in water and equilibrated in gel drying solution (5% w/v 
glycerol, 30% v/v methanol) then dried between sheets of cellophane pre-soaked in the 
drying solution using a Novex gel drying frame. 
2. 7.3 Measurement of protein concentration 
Measurements of protein concentration were carried out using the Bio-Rad protein 
assay system, based on the dye-binding assay method of Bradford (23) using either the 
full-scale or microtitre process. All assays were performed in duplicate, using bovine 
serum albumin (BSA) to prepare a standard curve of 0, 20, 40, 60, 80 and 1 00µg 
protein. The full scale method mixed 100µ1 of suitably diluted sample with 5mls 
diluted dye reagent (1 :4 reagent:water). After 2-5 mins the absorbance at 595nm was 
measured and the protein concentrations were calculated by reference to the BSA 
standard curve. The microtitre assay involved aliquotting 50µ1 of diluted protein 
sample/BSA sample into square bottomed microtitre plates, adding 200µ1 diluted dye 
reagent and measuring the absorbance between 405nm and 630nm after 5-30 minutes in 
a microtitre plate counter spectrophotometer, using the zero protein sample as the 
blank. 
2. 7.4 Detection of protein by Western blot 
The membrane fraction of various E. coli strains was solubilised at 200µg/ml protein 
(PitA western blots) or lmg/ml protein (PitB western blots) by 3 cycles of vortexing for 
1 min then boiling for 3 mins. Electrophoresis was carried out using a 10% SDS 
polyacrylamide gel, as described in Section 2. 7 .1. The proteins were then transferred 
onto polyvinylidene difluoride (PVDF) membrane by semi-dry electroblotting using a 
Multiphor®II elecrophoresis system (Pharmacia) as follows. Sheets of 3MM paper 
were cut to the size of the gel and presoaked in semi-dry transfer buffer (39mM 
glycine, 48mM Tris/HCI pH7.5, 0.0375% w/v SDS, 20% v/v methanol). 6 sheets of 
filter paper were layered in the apparatus, followed by the PVDF membrane, the gel 
and 6 more sheets of filter paper. Electrophoretic transfer proceeded at 0.8mNcm2 for 
50-120 mins. Non-specific sites on the PVDF blot were protected by incubation in 
blocking buffer (10% milk powder, l0mM Tris/HCl pH7.5, 0.9% NaCl) and the PVDF 
membrane was then washed in Tris-buffered saline (l0mM Tris/HCl pH7.5, 0.9% 
NaCl). The primary antibody was applied by incubation with either polyclonal 
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antipeptide PitA antibody diluted 1/500 in blocking buffer or polyclonal antipeptide 
PitB antibody at 1/100 dilution at either 4 °C overnight or 2 hrs at room temperature. 
The blot was washed in Tris-buffered saline prior to incubation with goat anti-rabbit 
immunoglobulin conjugated to alkaline phosphatase (DAKO), diluted at 1/1500 (PitA) 
or 1/1000 (PitB) in blocking buffer. The blot was washed with Tris-buffered saline and 
then immunostained with Western Blue® stabilized alkaline phosphatase substrate 
(Promega). The blot was then washed in water and air dried. 
2.7.5 Preparation of cytoplasmic membranes from £. 
coli by centrifugation 
Cytoplasmic membranes were isolated by centrifugation of cells broken open by a 
Sorvall Ribi Cell Fractionator. Strains were inoculated into 1 litre of rich media (Luria 
Bertani media, 34mM glucose, appropriate antibiotics and/or growth requirements) and 
grown to a cell density of around 250 Klett units ( approximately 6x 108cells/ml). Cells 
were pelleted by spinning at 5900xg for 15 mins at 4°C and were then washed with 
potassium phosphate buffer containing the protease inhibitor phenyl-
methansulfonylfluoride (PMSF) (0.05M KHPO4 , lmM PMSF, pH8). This wash and 
spin was repeated. On occasion the protease inhibitors aprotinin (2mg/ml), leupeptin 
(0.5µg/ml) and pepstatin (0.7µg/ml) were also added. The washed cell pellet was then 
resuspended in 3 0ml phosphate buffer and cells were broken open by passage through a 
Sorvall Ribi Cell Fractionator. Unlysed cells and cell debris was separated by 
centrifugation at 39000xg for 30 mins at 4°C. The supernatant, containing both 
membrane vesicles and the soluble cytoplasmic fraction, was collected. 
Membrane vesicles were separated from the cytoplasm by ultracentrifugation at 4 °C for 
two hours at 360000xg. The cytoplasm was removed and stored at -20°C. The 
membrane pellet was resuspended in less than 2.5mls of phosphate buffer and stored in 
0.5ml aliquots. The protein concentration of the cytoplasmic membranes was assayed 
as previously described (Section 2.7.3). 
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2. 7.6 Preparation of cytoplasmic membranes from E. 
coli by ammonium sulfate precipitation 
Cytoplasmic membranes were isolated through selective ammonium sulfate 
precipitation as described by Cox et al. ( 45). Strains were inoculated into 2 litres of 
rich media and the cells were grown, pelleted and fractionated as described above 
(Section 2.7.5) except that the phosphate buffer used was 0. lM potassium phosphate, 
pH7 and cells were resuspended in 25mls of buffer before fractionation. The 
supernatant of the centrifugation was saved and either used immediately or stored at -
20°c. 
The cytoplasmic membranes were selectively precipitated by adding solid (NH4) 2S04 
slowly to five 30% saturation at 4 °C. The mixture was stirred for a further 30 mins, 
followed by centrifugation at l 4500rpm for 15 mins in an SS34 rotor of a Sorvall 
centrifuge (25000xg). The pellet was carefully isolated and resuspended in 1 ml of 
phosphate buffer per original 1 g wet weight of cells. The protein concentration was 
determined, and the membrane samples were aliquotted and stored at -20°C. 
2.7.7 Solubilisation of cytoplasmic membranes 
Cytoplasmic membrane fractions were diluted to approximately 5mg/ml protein in 
phosphate buffer (50mM KHPO 4 , 300mM NaCl, pH8.0). Solubilisation was carried 
out by adding detergent (such as 0.5% Triton X-100, or 1.35% octylglucoside) and 
incubating 1 to 3 hrs at 4°C with gentle agitation, until there was no further clearing of 
the solution. This solution was diluted approximately two-fold and the solubilised 
cytoplasmic fraction was separated by a 360000xg centrifugation for one hour at 4°C. 
The supernatant was carefully isolated, the pellet was resuspended in approximately 
100µ1 of phosphate buffer, and both the supernatant and pellet were stored at -20°C. 
2.8 Over-expression ana purification of protein 
using the 6xHistiaine affinity tag 
An affinity tag of six consecutive histidine residues was attached to the C-terminus of 
the putative pitA ORF using the QIAGEN vector pQE60. The resulting plasmid was 
transformed into the host strain MC 15, which contains pREP4, a plasmid which 
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constitutively expresses the lac repressor at high levels. This gives tighter control of 
protein expression, which is often needed for hydrophobic proteins (QIAexpress® 
product guide). 
Protein expression was carried out by growing cultures in rich media (Luria Bertani 
media, 34mM glucose, 25µg/ml kanamycin and l00µg/ml ampicillin) to Klett 100-200, 
and then inducing protein production from the plasmid by the addition of 0. lmM 
Isopropyl-~-D-thiogalactopyranoside (IPTG), ( one tenth of the IPTG concentration 
recommended by QIAGEN.) Cells were grown for a further 1-2 hours before 
harvesting by centrifugation at 5900xg for 15 mins at 4°C. The preparation of 
cytoplasmic membranes, and isolation of the various cell fractions was carried out as 
described in Section 2.7.5. The protein concentration of cytoplasmic membrane 
fractions were determined (Section 2. 7 .3 ), and membrane fractions were then 
solubilised (Section 2. 7. 7). 
Purification of 6xHis tagged protein from solubilised membrane fractions was carried 
out by chromatography using Ni-NTA metal-chelate resin, as described in the QIAGEN 
Expressionist manual. (Triton X-100 up to 2% is compatible with the Ni-NTA-6xHis 
interaction.) A 0.45ml Ni-NTA column was prepared (0.15ml bed volume per ml of 
solubilised protein solution - ( 151 )) and the column was pre-incubated with pH8 
phosphate buffer (0.05M KHPO4, 300mM NaCl) containing 0.25% Triton X-100. (All 
subsequent buffers contain 0.25% Triton X-100.) After loading the membrane fraction, 
the column was washed with more than 20 volumes of pH8 phosphate buffer and 20 
volumes of pH6 phosphate buffer. Elution was carried out with 5 volumes each of 
0. lM imidazole, pH6, and 0.5M imidazole, pH6 in phosphate buffer. Alternatively, 
10% glycerol was added to the pH6 wash and all subsequent buffers and/or the Triton 
X-100 concentration was increased to 0.5%. The elution was also carried out in more 
graduated steps using 5mls (approximately 10 column volumes) each of 0. lM, 0.25M 
and 0.5M imidazole, or O. lM, 0.2M, 0.3M and 0.5M imidazole in pH6 phosphate 
buffer. Eluted samples were concentrated in Centricon 10 concentrators at 4°C until 
volumes were reduced about I 0-fold. 
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2.9 In vitro 
plasmid DNA 
transcription ftra ns lat ion of 
The E. coli S30 Extract System for Circular DNA (Promega) was used to confirm the 
expression of protein from genes cloned into plasmid vectors. Only plasmids purified 
using caesium chloride equilibrium density gradient centrifugation (Section 2.4.2) were 
used as templates for this procedure. The S30 extract was prepared from E. coli by 
modifications of the method described by Zubay (312) and contain all the components 
needed for protein synthesis, except the DNA template. The amino acid premix used 
also lacks methionine, so [35 S]-methionine can be used to label the protein. The 
Promega handbook describes the method in detail, which is summarised as follows: 
The synthesis of labeled protein was carried out by combining 2µg of DNA template 
with the S30 extract, amino acid premix (minus methionine) and [35S]-methionine, and 
incubating this mixture at 37°C for 60 minutes. The whole volume (50µ1) was then 
prepared for SDS Gel analysis of the translation products by acetone precipitation. The 
dried pellet was resuspended in 100µ1 SDS loading buffer ( 40mM Tris-HCI (pH6.8), 
10% (w/v) glycerol, 1.6%SDS and 4% ~-mercaptoethanol), heated at 100°C for 2 mins 
and 1 0µl was loaded onto a 9% or 10% SDS acrylamide separating gel with a 5% 
stacking gel (Section 2.7.1). Electrophoresis was carried out at 35mA constant current 
for around 40 mins. Visualisation of protein bands was sometimes carried out by 
staining with Coomassie blue dye (Section 2.7.2) followed by drying the gel for 
autoradiography. Otherwise the gel was dried directly after electrophoresis (2 hrs at 
60°C under vacuum in a gel drier) and autoradiography was carried out by exposure to 
Hyperfilm MP autoradiography film (Amersham) for between 8-20hrs and then 
developed in an X-omat M20 automatic processor (Eastman Kodak). 
2.10 Identification of E coli cells able to 
transport inorganic phosphate (Pi) 
Pi uptake from genes located on the chromosome was carried out using the particular E. 
coli strain. Plasmid-borne genes were tested for Pi uptake by transforming the plasmid 
of interest into a Pi auxotrophic background strain - initially AN3066 (pitAJ t1pstC345) 
and then AN3902 (pitAJ pitB::Catr t1pstC345). Transformed cells were always 
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cultured in the presence of lmM a-glycerol-3-phosphate (G3P) to prevent selection 
pressure for Pi transport, until the Pi uptake phenotype of the strain was known. Pi 
uptake was selected for by plating individual colonies onto solid minimal media 
containing 5 00µM Pi plus any required antibiotics or supplements (Pi media - described 
in Section 2.3). All isolates were also plated onto Pi media containing lmM G3P, to 
confirm that these strains could grow on minimal media when there was no requirement 
for Pi uptake. Control strains with/without Pi uptake were present on all media plates, 
to allow accurate comparisons of cell growth. 
2.11 Inorganic phosphate (Pi) transport assay 
Cells were grown overnight in a 50% dilution of minimal media ( described in Section 
2.3) supplemented with 20mM glucose, 1.5µM thiamine, 5% Luria Bertani media plus 
the addition of 1 mM cx-glycerol-3-phosphate and/or 50µg/ml ampicillin where 
appropriate. Phosphate free buffered "uptake media" was then used in all cell washes, 
dilutions and assays. This consisted of 50mM triethanolamine, 15mM KCl, 1 0mM 
(NH4) 2SO 4, and either 1.8mM MgSO 4 or 1 0mM MgSO 4 . Citric acid was used to alter 
the pH to either pH6.6 or pH7.0. Uptake media, at 37°C, was used to wash cells three 
times and to dilute them to an absorbance (660nm) of 0.35. These washed suspensions 
were then incubated at 3 7°C with shaking for 2 hours to deplete any internal stores of 
Pi, and were again diluted to an absorbance (660nm) of 0.35. Cell suspensions were 
sometimes stored at 4°C for less than 30 mins, but were usually assayed immediately. 
Cells were diluted into the uptake media (usually to a cell density (660nm) of 
approximately 0.035) and preincubated at 37°C with shaking for 5 mins. 33Pi (NEN) at 
approximately 0.035 mCi/ml in a 2.5mM K2HPO4 (PitB) solution which may then be 
diluted to 0.5mM K2HPO4 (PitA) was filtered through a 0.22µM membrane, stored at 
4°C and refiltered before each experiment. Uptake assays were started by the addition 
of the appropriate 33 Pi solution to the preincubated cells. Samples taken at 15 and 25 
secs were immediately filtered onto 0.45µM membrane filters and washed twice with a 
wash solution consisting of 50mM triethanolamine-HCl, l0mM KCl, lmM MgSO4 and 
1 0mM (NH4) 2SO 4 at either pH6.6 or pH7 .0. Damp filters were placed in 5ml of 
Emulsifier Safe (Packard) scintillation cocktail for aqueous samples and counted for 2 
min. Uptake by cells was carried out under conditions in which Pi uptake was linear 
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over time. Pi concentrations for Kmapp and V maxapp determinations were 1-15µM Pi 
(PitA), 10-1 00µM Pi (PitB long) or 2-50µM Pi (PitB short). Data from these kinetic 
experiments was analysed by non-linear regression using the Michaelis-Menten 
equation and the Graphpad Prism program. Most individual experiments had at least 
two measurements of around 5 Pi concentrations. 
2.12 phoA alkaline phosphatase assay 
Retention of pst mutations by recipient strains was tested by screening colonies for 
constitutive synthesis of phoA-encoded alkaline phosphatase on agar plates as described 
by Bracha et al. (22). This rapid spray assay relies on the fact that expression of phoA 
is repressed by Pi but negatively controlled by genes comprising the pst operon ( 162). 
Therefore strains carrying a pst mutation will synthesise alkaline phosphatase 
constitutively on high phosphate media. 
Single cells grown overnight on rich media (Luria Bertani media, 34mM glucose, and 
lmM G3P where appropriate) were transferred to filter paper and sprayed with a 
mixture of fast blue B salt (50mg fast blue B salt in 5ml H20) and a naphthol salt of 
phosphate (10mg a-naphthol phosphate in 5ml IM Tris-HCl pH8) which were freshly 
made and mixed immediately before use. A colour change occurs immediately, with 
purple indicating the presence of phoA alkaline phosphatase activity, and yellow 
indicating the absence of phoA activity. 
2.13 Production of antipeptiae polyc/onal 
antibodies 
2.13.1 Peptides used for raising antibodies 
The PitA peptide ARIHL TP AEREKKDC ( from A 188 to D201) and the equivalent 
sequence in PitB, DRIHRIPEDRKKKKC (from D188 to K201) are from an 
extramembraneous loop in the putative folded structure (Figure 3 .15). This region is 
highly charged (theoretically more antigenic) and exhibits significant sequence 
variability between PitA and PitB. C-terminal cysteines were added to each sequence 
to allow chemical conjugation to the core matrix or carrier protein (see below). 
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2.13.2 
Peptides 
pitA. 
Immunisation of rabbits with Multi-Antigenic 
Rabbits were immunised with the PitA peptide coupled to a poly-lysine core matrix via 
a C-terminal cysteine. The multiple antigen peptide system (MAP) uses a high molar 
ratio of peptide antigen attached to the immunogenically inert core, removing the need 
for a carrier protein to elicit an antibody response (154, 256). The PitA peptide-MAP 
conjugate was prepared by the Biomolecular Resources Facility, John Curtin School of 
Medical Research. It was dissolved in phosphate buffered saline (PBS), emulsified 
with an equal volume of Freunds adjuvant (68) and 200µg was injected subcutaneously. 
Standard sampling and injecting protocols were followed (88), including the 
preparation of pre-immune sera by bleeding the rabbit prior to the first injection of 
MAP conjugate. Sera were allowed to clot at 37°C for an hour. The clot was shrunk 
by separating the clot from the sides of the tubes followed by storage at 4°C overnight. 
Sera were then isolated by centrifugation at 1 0000xg for 15 min, and the supernatant 
was stored at -20°C. 
PitB 
The PitB peptide was attached to Imject® maleimide activated keyhole limpet 
hemocyanin (peptide-KLH, Pierce) following the manufacturer's instructions, after 
attempts using a PitB peptide-MAP conjugate which had been prepared by the 
Biomolecular Resources Facility produced no PitB antigenic response in several 
rabbits. 200µg of conjugate was partially dissolved in dimethylsulfoxide with 
sonication, then diluted with one volume of phosphate buffered saline (PBS). 
Injections and screenings were carried out as previously described for the PitA peptide. 
2.13.3 Detection of antipeptiae polyclonal antibodies in 
rabbit serum 
The sera from rabbits injected with either PitA or PitB peptide-MAP conjugates were 
initially screened for positive responses to the relevant peptide by enzyme-linked 
immunosorbent assay (ELISA) (64). The wells of 96 well micro-titre plates were 
coated with the appropriate peptide by incubating 50µ1 of 50mg/ml peptide in PBS 
overnight at 4 °C or for 2 hrs at room temperature, with control wells being exposed to 
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PBS only. All wells were washed twice with PBS, then 50µ1 serial dilutions of the pre-
immune and post-immune sera were added to the control and peptide coated wells. 
Dilutions were prepared over a range of 1: 10 to 1: 1000 in PBS. These were incubated 
at room temperature for 1 hr, then washed twice with PBS, then once with a freshly 
prepared pH9.5 buffer (I0mM diethanolamine, 0.5mM MgC12). 50µ1 of alkaline 
phosphatase substrate (lmg/ml p-nitrophenylphosphate in pH9.5 buffer) was added to 
each well. After incubation at room temperature the optical density between 405nm 
and 630nm was recorded in a micro-titre plate reader. 
Western blotting against the membrane fractions of AN353 I (PitA) AN3135 (PitB) and 
AN3 514 ( control) was then used to assess the antigenicity of the sera to either the PitA 
or PitB membrane protein. The sera from the PitB peptide-KLH conjugate was only 
assessed by Western blot. 
2.13.1/- Purification of potyctonal antipeptiae antibodies 
from serum by immunoaffinity chromatography 
Sera containing PitA antipeptide antibody were not purified. The PitB equivalent was 
isolated from sera by immunoaffinity purification (SulfoLink® Kit, Pierce) following a 
two-stage ammonium sulfate precipitation (88) and dialysis against PBS. The synthetic 
peptide column was prepared following the manufacturer's instructions, and the 
dialyzed PitB antipeptide antibody solution was passed through the column 3 times . 
2.14 Analysis of DNA sequences • using 
MacTargsearch 2.0 
MacTargsearch is used to identify DNA sequences that are putative matches to a 
' target' sequence. It provides several target sequences including the E. coli promoter 
consensus sequence. Target sequences can also be customised. This is a compiled 
Microsoft BASIC program created by James A. Goodrich, William R. McClure and 
Michael L. Schwartz in 1989 at Carnegie Mellon University, and modified by Dr Peter 
Markiewicz, UCLA. 
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E. coli promoter consensus sequence 
This target sequence was used to search for the putative promoter sequence/s in PitA 
and PitB. This sequence is listed at the top of Table 5.3 and consists of two regions of 
base pair scores separated by a spacer region of variable length. These regions contain 
the -3 5 and -10 hexamers respectively, but are larger than the hexamers, so the printed 
spacer length is 6bp shorter than the true spacer length between the -10 and -3 5 
regions. Similarity scores for each base and spacer length are calculated as described in 
( 179) and (7 6). 
Pho box consensus sequence 
MacTargsearch was used to identify putative pho boxes in and around the putative 
promoter regions of PitA and PitB. This sequence contains 18 nucleotides and is listed 
at the top of Table 5 .4. The weighting for every nucleotide in each position was 
calculated from the information content provided for 10 pho box consensus sequences 
((280) and references therein). 
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Chapter three 
Escherichia coli has two pit genes with 
distinct characteristics 
3.1 Introduction 
The Pit transport system was first reported by Willsky et al (289) when mutations in the 
Pst system of several E. coli K-12 strains revealed the presence of a second Pi 
transporter, named Pit. Introduction of pst mutations into strain K-10 produced no 
measurable Pi transport, indicating that K-10 has a mutation that effects Pit Pi transport. 
This lesion mapped at minute 77.1-77.3 on the E.coli genome (249, 59). All known pit 
mutations mapped in this locus of the E. coli chromosome and, as described below, 
Elvin et al ( 5 9) showed that these mutations were complemented by transformation 
with a plasmid carrying a small fragment of DNA which directs the synthesis of the 
PitA protein. 
pitA was originally isolated from E. coli K-12 by transforming cosmid DNA from HR152 
(pstA) into the Pi auxotrophic strain GS5 (pit pstA) (59). The cosmid containing wild type 
pitA was selected by its ability to allow strain GS5 to grow on minimal media 
supplemented with 500 µM Pi. In an attempt to re-isolate the pitA gene from E. coli 
K-12 Dianne Webb transformed cosmid DNA from AN2537 (!).pstC345) (253) into 
AN3020 (pit i1pstC345) (284), cloning a gene with a similar but distinct DNA sequence 
to pitA (89). Thus, the pitB gene was isolated and shown to transport Pi. 
The presence of a second Pit transporter had not been suspected until the discovery of 
the pitB gene, and led to two possible alternatives. pitB may be an allele of pitA, or 
may represent a second previously undetected pit gene on the E. coli genome. 
This chapter examines whether pitA and pitB are alleles or individual genes. It defines 
and compares individual characteristics of pitA and pitB, including nucleotide and 
amino acid sequences, and the kinetic parameters Kmapp and V max app. Over-expression 
and isolation of the PitA and PitB proteins is attempted. 
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3.2 Comparison of the nucleotide sequences of 
pitA and pitB 
The DNA fragments containing pitA and pitB Pi uptake activities were previously 
reduced to 2.27kb and 3.06kb fragments, respectively, and sequenced (59, 89). These 
two nucleotide sequences were then compared using the DNA Pustell Matrix algorithm 
(Figure 3 .1 ), which revealed a high degree of similarity in sequence coinciding with an 
open reading frame (ORF) of 1500 nucleotides found in each DNA fragment. These 
ORFs are located at 573-2073bp in the pitA DNA fragment and 1404 - 2903bp in the 
pitB DNA fragment. Some patches of sequence similarity also occur upstream of these 
ORFs in the putative promoter regions of each gene. While other ORFs are present 
these are the two longest ORFs, and the 75% sequence identity between them makes 
these the most likely candidates for pitA and pitB (Figure 3 .2). 
3.3 Are pitA and pitB genes or alleles? 
The method used to isolate pitA and pitB could not distinguish whether these sequences 
were alleles or distinct genes, although it does indicate that they are unlikely to form an 
operon, as each gene was expressed individually. There is no previous evidence for the 
presence of two distinct pit loci. However, the 75% sequence identity between the 
putative pitA and pitB ORFs, is much less than that found in most alleles and the lack of 
sequence identity in the surrounding DNA indicates that pitA and pitB are likely to be 
found at separate loci, therefore are distinct genes. To clarify this, PCR experiments 
were carried out to detect the presence of pitA and/or pitB on the genomes of various E. 
coli strains. AN236 and AN259 were selected because they were used in the 
preparation of strain HR152, which supplied the wild type pitA gene subsequently 
sequenced and analysed by Elvin et al (59). AN248 is a K-12 strain with wild type pit 
and pst genes. K-10 is the strain where the pit mutation was first detected, while 
HRl 87 is a recA derivative of GS5 (pit pstA), the Pi auxotrophic recipient strain used 
for isolating wild type pitA. AN3066 is a recA derivative of AN3020 (pit '1.pstC345), 
the background strain for expression of the pitB gene. Thus there are three strains that 
may have wild type pit transport (AN236, AN259, AN248) and three strains with 
known defects in Pit transport (HR187, AN3066, K-10). Genomic DNA was purified 
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Figure 3.1 
Postell DNA Matrix alignment of the sequences containing pitA 
andpitB. 
The sequenced DNA fragments containing the pitA and pitB genes were 
compared by the Pus tell DNA Matrix algorithm (Mac Vector 6.0), using a 
window size of 30, a minimum score of 65 %, a hash value of 6 and a jump value 
of 1. Both strands were analysed. 
Highlights the large open reading frame found in each DNA fragment. 
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Figure 3.2 
DNA alignment of the putative open reading frames of pitA 
andpitB. 
The DNA alignment was carried out using the program ClustalW (Mac Vector 6.0) with 
an open gap penalty of 10, extending gap penalty of 5 and weighted transitions. Each 
putative open reading frame (ORF) contains 1500 bases, with pitB containing a single 
addition relative to pitA at nucleotide 978 in the ORF, and a deletion at nucleotide 1021 
(which forms part of the large variable region between PitA and PitB in the deduced 
amino acid sequences). 
A Identical bases between pitA and pitB. 
A Nucleotides unique to the putative pitA ORF. 
A Nucleotides unique to the putative pitB ORF. 
The DNA alignment of the upstream sequences ofpitA andpitB is illustrated in 
Figure 5.9, with the putative RNA polymerase promoter sequence highlighted. 
pitA 
pitB 
1 ATGCTACATTTGTTTGCTGGCCTGGATTTGCATAC CGGGCTGTTATTATT 
1 ATGCTAAATTTATTTGTTGGCCTTGATATATACACAGGGCTTTT GTTATT 
****** **** **** ****** *** * * ** ***** ** ***** 
50 
50 
pitA 51 GCTTGCACTGGCTTTTGTGCTGTTCTACGAAGCCATCAATGGTTTCCATG 100 
pitB 51 GCTTGCTCTGGCATTTGTGTTGTTCTACGAAG CA ATCAATGGTTTT CATG 100 
****** ***** ****** ************* *********** **** 
pitA 101 ACACAGCCAACGCCGTGGCAA CCGTTATCTATACCCGCGCGATGC GTTCT 150 
pitB 101 ACACGGCGAATGCGGTGGCAGCCGTTATTTATACTCGTGCCATGC TACCA 150 
**** ** ** ** ****** ******* ***** ** ** **** * 
pitA 151 CAGCTCGC CGTGGTTATGGCGGC GGTATTCAACTTTTTGGGTGT TTT GCT 200 
pitB 151 CAACTTGC TGTGGTGATGGCGGCAT TTTTTAACTTTTTT GGCGT GTTATT 200 
** ** ** ***** ******** * ** ******** ** ** ** * 
pitA 201 GGGTGGTCTGAGTGTTGCCTATGCCATTGTG CATATGCTGCCGACGGATC 2 5 0 
pitB 201 GGGCGGACTTAGCGTTGCCTATGCCATTGTC CATATGTTGCCAACCGATT 250 
*** ** ** ** ***************** ****** **** ** *** 
pitA 251 TGCTGCTTAATATGGGATC GT CTCATGGCCTTGCCATGGTGTT CTCTATG 300 
pitB 251 TGTTGCTGAATATGGGGTCAACCCACGGCCTGGCGATGGTCTTTTCCATG 300 
** **** ******** ** * ** ***** ** ***** ** ** *** 
pitA 301 TTGCTGGCGGCGATTATCTGGAACCTGGGI' ACCTGGTACTTTGGTTTACC 350 
pitB 301 CTGCTGGCGGCGATTATCTGGAACCTGG CA AC GTGGTTCTTCGGTTTACC 350 
**************************** ** **** *** ******** 
pitA 351 TGCATCCAGCTC TCATAC GCTGATTGGCGCGATCATCGGGATTGGTTTAA 400 
pitB 351 GGC CTCCAGTTCGCACACCTTGATTGGT GCGATTATCGGCATCGGTTTAA 400 
** ***** ** ** ** ******* ***** ***** ** ******* 
pitA 401 CCAATGCGTTGATGACCGG GACGTCAGTGGTGGATGCAC TCAATATCCCG 450 
pitB 401 CCAACGCGCTGTTAACCGGCTCATC GGTGATGGATGC GT TAAACC TGC GT 450 
**** *** ** * ***** * ** *** ******* * ** * * 
pitA 451 AAAGTATTAA GTATTTTC GGT TCTCTGATCGTTTCCCCTATT GTCGGCCT 500 
pitB 451 GAAGT GACCAAAATTTTCTCCTC GCTGATTGTTTCCCCTATCGTCGGCCT 500 
**** * ****** ** ***** *********** ******** 
pitA 501 GGT GT TTGCTGGCGGTCTGATTTTCTTGCTGCGTCGCTACTGGAGCGGCA 550 
pitB 501 GGT CATTGCGGGAGGCCTGATATTCCTGCTGCGACGCTACTGGAGCGGGA 550 
*** **** ** ** ***** *** ******* ************** * 
pitA 551 CCAAG}\AACGCGCCCGTATCCACCTGACCCCAGCGGAGCGTGAA1\AGAAA 600 
pitB 551 CGAAAAAGCGTGACCGTATTCACCGCATT CCGGAAGATCGCAAAAAGAAA 600 
* ** ** ** * ****** **** * ** * ** ** ******** 
pitA 601 GACGGCAAGAAAAAG CCGCCGTTCTGGACGCGTATTGCGCTGATCC TTTC 650 
pitB 601 AAA GGCAAACGTAAACCGCCATTCTGGACGCGTATTGCGCTGATTGTTTC 650 
* ***** ** ***** *********************** **** 
pitA 651 CGCTATCGGCGTGGCGTTTTCGCACGGCGCGAACGAI:'GGTCAGAAAGGCA 700 
pitB 651 CGCT GCGGGCGTGGCGTTTTCGCACGGCGCGAACGJC GGACAAA.l\AGGGA 700 
**** ***************************** ** ** ***** * 
pitA 701 TTGGTCTGGTTATGTTGGTATTGATTGG CGTCGC GCCAGCAGGCTTCGTG 750 
pitB 701 TCGGCCTGGTAATGCTGGTACTGGTGGG GATTGCCCCTGCTGGCTTCGTC 750 
* ** ***** *** ***** ** * ** * ** ** ** ******** 
pitA 751 GT GAACATGAATGC CACTGGCTACGAAATCACCCGTACCCGT GATGCCAT 800 
pitB 751 GT CAATATGAATGC GT CCGGCTATGAAATTACCCGTACCC GC GATGCCGT 800 
** ** ******** * ***** ***** *********** ****** * 
pitA 801 CAA CAACGTCGAAGCT TACTTTGAGCAGCATCCTGCGCTGCTCAAACAGG 850 
pitB 801 TACCAACTTCGAACAC TACCTGCAACAGCATCCTGAACTGCCGCAGAAGT 850 
* **** ***** *** * * ********** **** * ** 
pitA 851 CTACCGGTGCT GATCAGTTAGTACCGGCTC CGGAAGCTGGCGCAACGCAA 900 
pitB 851 TGATTGCGATGGAACCTCCATTGCC TGCAGCATCGACTGATGGCACGCAA 900 
* * ** * * * ** ** * *** * ****** 
pitA 901 CCTGCGGAGTTCCACTGCCATCCGTCGAATACCATTAACGCGCTCAACCG 950 
pitB 901 GTAACAGAGTTTCACTGTCATCCGGCAAATACCTTTGATGCTATTGCGCG 950 
* ***** ***** ****** * ****** ** * ** * ** 
pitA 951 CCTGAAAGGTATGTTGACCACCGAT GT- GGAAAGCTACGACAAGCTGTCG 999 
pitB 951 CGTTAAAACGATGCTGCCAGGCAATATAGGAAAGTTACGAGCCGTTAAGC 1000 
* * *** *** ** * * ** * ****** ** *** * * 
pitA 1000 CTTGATCAACGTAGCCAGATGCGCCGCATTATGCTGTG CGTT TCTGACAC 1049 
pitB 1001 GTGAG TCAGCGCAGCCAGCTG- GCCGCATTATGCTGTG C'ATC TCTGATAC 1049 
* *** ** ****** ** ***************** * ***** ** 
pitA 1050 TAT CGACAAAGTGGTGAAGATGCCTGGCGTGAGT GCT GACGATCAGCGCC 1099 
pitB 1050 CTCCG CGAAGCTAGCGAAACTGCCAGGCGTCAGTAAAGAAGACCAGAACC 1099 
** ** * * *** **** ***** *** ** ** *** ** 
pitA 1100 TGTTGAAGAAACT GAAGTCCGACATGCTTAGCACCATCGAGTATGCACCG 1149 
pitB 1100 TGCTGAAAAAACT TCGCAGCGATATGTTAAGCACCATTGAGTACGCTCCG 1149 
** **** ***** *** *** * ******** ***** ** *** 
pitA 1150 GTGTGGATCATCATGGCGG'ICGCGCTGGCGTTAGGTAT CGGTACGATGAT 1199 
pitB 1150 GTGTGGATCATCATGGCGGTI\. GCACTGGCGCTCGGCAT TGGCACCATGAT 1199 
******************** ** ****** * ** ** ** ** ***** 
pitA 1200 TGGCTGGCGCCGTGTGGCAACGAC TATCGGTGAGAAA ATCGGTAAGAAAG 1249 
pitB 1200 TGGCTGGCGTCGTGTAGCGATGAC CATCGGTGAGAAGATTGGTAAGCGCG 1249 
********* ***** ** * *** *********** ** ****** * 
pitA 1250 GCATGACCTACGC TCAGGGGATGTCTGCCCAGATGACGGCGGCAGTGTCT 1299 
pitB 1250 GCATGACGTATGCGCAAGGCATGGCGGCACAAATGACGGCGGCAGTGTCT 1299 
******* ** ** ** ** *** * ** ** ****************** 
pitA 1300 ATCGGCCTGGC GAGTTATACCGGGATGCCGGT TTCCACTACTCACGTACT 1349 
pitB 1300 ATCGGTCTTGCCAGTTATATTGGGATGCCCGTCTCCACAACACACGTCCT 1349 
***** ** ** ******* ******** ** ***** ** ***** ** 
pitA 1350 CTCCTCTTCTGTCGCGGGGACGATGGTGGTA GATGGTGGCGGCTTACAGC 1399 
pitB 1350 CTCGTCTGCAGTTGCAGGGACGATGGTGG TG GACGGCGGTGGGTTACAGC 1399 
*** *** * ** ** ************** ** ** ** ** ******* 
pitA 1400 GTAAAACCGTGACCAGCATTCTGATGGCCTGGGTGTTTAC CCTTCCGGCT 1449 
pitB 1400 GTAAAACGGTAACCAGCATCCTGATGGCGTGGGTATTTAC TT TACCGGCG 1449 
******* ** ******** ******** ***** ***** * ***** 
pitA 1450 GC GGTACTGCTTTCCGGCGGGCTGTACTGGCT CTCCTTGCAGTT CCTGTAA 1500 
pitB 1450 GCAATTTTTCTTTCTGGTGGGCTGTACTGGATAGCATTGCAGTT GATTTAA 1500 
** * * ***** ** ************ * * ******** * *** 
as described in Section 2.4.3. PCR amplification of the putative open reading frames 
I 
for each gene was carried out using Taq polymerase (primers 95-87 /95-88 for pitA and 
95-89/95-90 for pitB, see Table 2.5 for primer details, Figure 4.1 for amplification 
details), and the PCR products were separated and visualised on a 1 % agarose gel 
(Figure 3.3, Table 3.1 ). 
While the water blanks contained no DNA bands, all strains tested produced DNA of 
approximately 1.5kb when oligonucleotides for either pitA or pitB genes were used. 
Thus pitA and pitB DNA approximating the putative ORF size of 1500 nucleotides was 
present in all strains, including those with known defects in pit transport. All these 
PCR products were purified and restriction endonuclease digestion was used to identify 
the putative pitA and pitB gene products, to ensure no cross contamination occurred. 
Thus it was shown that all the strains tested contain approximately full sized putative 
pitA and pitB ORFs (Figure 3 .4 ), indicating that pitA and pitB are separate genes, and 
that the pit mutation/sin K-10, AN3066 and GS5 do not involve large deletions. 
3.4 Over-expression and purification of PitA 
Attempts were made to over-express and purify PitA and PitB to allow identification of 
the translation start of the genes by N-terminal sequencing of the proteins and to 
provide protein for further experimentation. 
An affinity tag of six consecutive histidine residues was added to the C-terminus of the 
putative pitA ORF using QIAGEN vector pQE60, to allow the over-expression and 
purification of a PitA6xHis protein which retains its native N-terminus. This plasmid, 
pAN910, (Figure 3.5) was screened for potential pitA protein products by in vitro 
transcription/translation using the E. coli S30 Extract System for Circular DNA (Figure 
3.6). The insertion of putative pitA DNA into plasmid pQE60 produced a strong 
protein product at approximately 46kDa, with some possible degradation products. The 
expected molecular weight of the putative pitA::6xHis protein is 54kDa, but many 
membrane proteins undergo anomalously fast migration during electrophoresis, so this 
difference is not unusual. The 46kDa protein band was isolated and N-terminal 
sequencing was attempted by the Biomolecular Resource Facility at the ANU, but the 
amount of protein present was too low to produce a clear result (results not shown). 
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Figure 3.3 
Screening for the presence of pitA and pitB DNA in various strains 
using PCR. 
A. I% agarose gel analysis of the PCR products from reactions using primers for the 
proposed pitA open reading frame (95-87, 95-88 - see Table 2.5 for details) and the 
genomic DNA of the strains listed below in Table 3 .1. Each lane represents a separate 
PCR reaction, including a water blank control. 2µ1 of reaction mix was loaded per well. 
The 1.5kb product representing an approximately full-length putative pitA open reading 
frame is indicated with an arrow. 
B. As above, except primers for the proposed pitB open reading frame were used 
(95-89, 95-90 - see Table 2.5 for details). The 1.5kb product representing an 
approximately full-length putative pitB open reading frame is indicated with an arrow. 
Table 3.1 
Strains tested for the presence of pitA and pitB DNA by PCR 
Lane Strain Inorganic phosphate transport PCR products 
Phenotype Known genotype pitA pitB 
(kb) (kb) 
1 water 1.5 1.5 
2 HR187 pit pstA 1.5 1.5 
3 K-10 + pit 1.5 1.5 
4 AN3066 pit _pstC345 1.5 1.5 
5 AN248 + wild type 1.5 1.5 
6 AN259 + wild type 1.5 1.5 
7 AN236 + wild type 1.5 1.5 
A Presence of the pitA open reading frame. 
Size 
kb 
3.1 
2.0 '"" 
1.6 
1.0 
Pi uptake 
1 2 3 4 5 6 7 
+ - + + + 
B Presence of the pitB open reading frame. 
Size 
kb 
3.1 
1.0 
Pi uptake 
1 2 3 4 5 6 7 
+ - + + + 
1.5 kb 
1.5kb 
Figure 3.4 
Restriction endonuclease analysis of genomic pitA and pitB 
PCR products amplified from wild type and pit- phenotype 
strains. 
The PCR products from wild type (AN248) and pir phenotype (AN3066) 
genomic DNA using primers for the open reading frames of either pitA 
(95-87/95-88, see Table 2.5 for details) or pitB (95-89/95-90) were 
digested with either HindITI or Stul then separated on a 0.8% agarose gel. 
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Figure 3.5 
Plasmid diagrams for pAN910 and vector pQE60 
pitA without its putative promoter region was ligated into vector pQE60 
(QIAGEN), to give pitA with its native open reading frame start and a 
C-terminal 6xhistidine tag. 
An EcoRl site was introduced 31 nucleotides uptsream of the putative ATG start 
codon and a Bglll site was introduced at the TAA stop of the putative open 
reading frame by site-directed mutagenisis ( oligomers 91-62 and 93-20, see 
Table 2.5 for details). The pitA EcoRl/Bglll fragment was ligated into 
EcoRl/Bglll cut pQE60, which removes the engineered ribosomal binding site of 
this vector, but leaves the TS promoter region. Thus pitA would be expected to 
use the TS promoter and its own ribosomal binding site. 
Putative pitA promoters are listed in Table 5.3 and the putative pitA promoter 
region is shown in Figure 5.9. 
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Figure 3.6 
Gel analysis of in vitro transcription/translation products 
from pitA+, PitA::6xhis+ and pitB+ plasmids. 
In vitro transcription/translation products from caesium chloride 
prepared plasmids labeled with [35S]-methionine were separated by 
PAGE on a 9% gel, and visualised by autoradiography with an 8 hour 
exposure. 
Size 
kb 
49.5· 
PitA: :6~is • .-"··· 
P1tA • ,, 
32.5-
27.5-
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Plasmid Pit Genotype 
pAN918 PitA:: 6xHis 
pAN919 PitA 
pQE60 
pAN910 PitA::6xHis 
pAN683 
pAN914 PitA::6xHis 
pAN683 
pAN909 PitB 
+ PitB 
Purification of pitA: :6xHis was attempted. A variety of conditions were used for both 
the induction of protein expression by Isopropyl-~-D-thiogalactopyranoside (IPTG) and 
the subsequent purification of 6xHis tagged protein with nickel-NT A chromatography 
(See Section 2.8). Coomassie stained SDS-PAGE did not reveal any obvious over-
expression or purification of protein between 40kDa-55kDa (results not shown). At 
this point in time there was no simple mechanism to specifically identify PitA protein, 
as commercial antibodies for the 6xHis tag were not yet available and the PitA 
polyclonal antibody had not been prepared. 
Plasmid pAN910 was also transformed into the Pi auxotroph AN3 066, to determine if 
the PitA6xHis protein was able to produce a functional Pi transporter. Several 
independent experiments showed approximately half of the transfonnants were able to 
grow on 500µM Pi minimal media supplemented with an IPTG gradient. Thus it is 
possible that this plasmid allows Pi transport but may also be detrimental to cell health. 
A number of other PitA6xHis plasmids were constructed. The pitA: :6xHis gene lacking 
the putative pitA promoter region was subcloned into pGex plasmid pAN 683 ( constructed 
by Andrew Rodgers) behind a glutathione-S-transferase fusion gene (GSTE30) and in the 
same orientation as this gene (pAN914 - Figure 3. 7). (This approach had been 
successfully used for other membrane proteins in the laboratory.) The pAN915 control 
was made by inserting the pitA::6xHis gene in the opposite orientation to the 
GSTE30 gene. pitA::6xHis with a wild type pitA promoter region (Figure 5.9) was also 
subcloned into vector pBR322, creating pAN918 (Figure 3.8). A wild type pitA control 
plasmid was also prepared (pAN919). 
In vitro transcription/translation of pAN918 and pAN919 showed that pAN919 (pitA) 
has a protein at 45kDa and pAN918 (pitA::6xHis) produces a protein of 46kDa, clearly 
indicating that PitA protein and the slightly larger PitA6xHis are expressed by these 
plasmids. This result also suggests that even though these proteins appear smaller than 
their molecular weights (PitA is 53kDa while PitA6xHis is 54kDa), they are full-length 
products. In vitro transcription/translation was also carried out on pAN914 and vector 
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Figure 3.7 
Plasmid diagrams for pAN914 and pAN915. 
pitA: :6xhis without its putative promoter region was ligated into pAN683 behind 
the glutathione-S-transferase fusion gene (GST£30) in the same orientation 
(pAN914) and opposite orientation (pAN915) as this fusion protein. 
The pitA PvulI/EcoRl fragment from pAN910 was ligated into the EcoRl site of 
pAN683, and restriction endonuclease digestion was used to select plasmids 
with pitA: :6xhis in either orientation. 
Gstc30 
pAN914 
7kb 
\: EcoRI 
pitA 
EcoRI/Pvull 6xHis 
Gstc30 
pAN915 
7kb 
/ EcoRI/ Pvull 
6xHis 
BgAI 
pitA 
Figure 3.8 
Plasmid diagrams for pAN918 and pAN919. 
pitA: :6xhis with was transferred into pBR322 so it was expressed using its wild 
type promoter (pAN918), and an equivalent pitA control strain was also 
constructed (pAN919). 
The C-terminal part of pitA::6xhis was isolated from pAN910 by digestion with 
Mlul/PvuII. This was ligated into pitA plasmid pAN686 digested with 
Mlul/PvuII to remove the N-terminal half of pitA, creating pAN918. 
A similarly sized control plasmid was made by digesting pAN686 with PvuII and 
re ligating the large fragment, to create pAN919. 
pAN918 
5.1 kb 
\ 
Pvull 
pAN919 
4.8kb 
/ 
/ BamHI 
pitA 
Mlul 
BgAI 
6xHis 
/ BamHI 
pitA 
\ Pvull 
pAN683 (Figure 3.6). Unfortunately the lac repressor protein appears to run in an 
identical location to the PitA6xHis protein, so there is no definitive proof of protein 
expression for this construct. 
pitA::6xHis plasmid pAN918 transformed into the Pi auxotrophic strain AN3066 was 
unable to grow on Pi media. However AN3066 transformed with the wild type pitA 
control (pAN919) was able to grow on Pi media, suggesting that the C-terminal 6xHis 
tag has a detrimental effect on the activity of PitA. This inhibition of growth by the 
6xHis tag is not consistent across all plasmids. pitA:: 6xHis in pGex plasmid pAN914 
allowed growth of AN3066 on Pi media that was induced by IPTG, indicating a link 
between gene expression and Pi uptake. The pAN915 control showed negligible 
growth on Pi media (results not shown). Thus different pitA::6xHis plasmid constructs 
induced different Pi uptake phenotypes. 
No attempts were made to purify PitA6xHis from pAN918. Induction and purification 
of PitA6xHis from pAN914 produced no obvious protein product between 45kDa and 
5 5kDa using a variety of growth and purification conditions. Thus it was decided to 
leave the purification at this stage of development until the PitA6xHis protein could be 
specifically identified. 
Attempts to over-express pitB by removing its putative promoter region and placing it 
behind the GSTc30 fusion gene in pAN683, to create pAN909 (Figure 3.9), produced a 
protein by in vitro transcription/translation experiments at approximately 45kDa which 
seemed negligible in pAN683 (Figure 3.6). Therefore PitB is a similar size to the wild 
type PitA protein by SDS-PAGE analysis. While pAN909 seems to produce a 
functional Pi transporter, allowing the Pi auxotrophic strain AN3066 to grow on solid 
Pi media, the growth of these cells was noticeably impaired when compared to AN3066 
containing wild type pitB plasmids pAN656 or pANl 116 (plasmid diagrams - Figure 
5.5). When the pAN909/AN3066 transformants were grown on rich media, which 
eliminates any requirement for Pi transport, these also grew slowly and exhibited spotty 
uneven growth, even in the absence of IPTG (results not shown). IPTG induction of 
pAN909 transformed into strain JS5 did not produce an obvious protein band when 
analysed by Coomassie stained SDS-P AGE, and it was decided to leave the attempted 
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Figure 3.9 
Plasmid diagrams for pAN683 and pAN909. 
pitB without its putative promoter region was placed behind a glutathione-S-
transferase fusion gene (GST£30) to create pAN909. 
An EcoRl site was inserted 23 nucleotides upstream from the putative open 
reading frame of pitB (this mutagenesis was carried out by Di Webb), allowing 
pitB without its putative promoter region to be isolated on an EcoRl fragment. 
This was ligated into the EcoRl site of pAN683 behind the glutathione-S-
transferase fusion gene (GST£30). Restriction endonuclease analysis was used to 
isolate a plasmid with pitB in the same orientation as the GST£30 fusion gene 
(pAN909). 
pAN683 was created by Andrew Rodgers. 
Gstc30 
pAN909 
7kb 
\ 
\ 
EcoRI 
Gstc30 
pAN683 
5.2kb 
/ EcoRI 
/ 
pitB 
- EcoRI 
over-expression of PitB until a suitable method was developed for the tagged PitA 
protein. 
3.5 Identification of the translation starts of 
the pitA and pitB open reading frames using 
site-directed mutagenesis 
As over-expression of PitA and PitB protein was proving difficult, an alternative 
approach was used to identify the translation starts of these genes. Functional analysis 
of alleles carrying mutated start codons has previously been used to identify A TG 
translation start codons (233). This approach is only reasonable if the targeted ATG 
codon has a high probability of being the translation start of the gene. Both pitA and 
pitB have an ATG codon at the beginning of a 1500 nucleotide ORF, with the 
nucleotide sequence similarity between the two cosmid DNA fragments being strongest 
over this region. Thus, it is highly probable that these A TG codons may initiate 
translation of the pit genes. 
These putative A TG start codons were changed to GTG and CTG by site-directed 
mutagenesis, using oligonucleotides 93-107, 93-108 for pitA and 93-135, 93-136 (see 
Table 2.5 for sequence details) and single stranded pitA or pitB M13 DNA. Manual 
DNA sequencing of mutated alleles on single stranded Ml 3 DNA was carried out over 
the region of oligonucleotide binding to check that the correct mutation had been 
inserted, and that no unintended mutations had occurred. Double stranded RF M 13 
DNA was prepared for each mutated allele, which was then subcloned into the vector 
pBR322 using Salli BamHI digestion for pitA and by ligating the Ssp l / Hindlll fragment 
from pitBM13 RF into the EcoRV/HindIII sites of pBR322 (Figure 3.10). These 
plasmids were transformed into the Pi auxotroph AN3066 and these cells were cultured 
in the presence of cx-glycerol-3-phosphate (G3P), providing an alternative source of 
phosphate to remove any selection pressure for Pi transport. All strains were able to 
grow when plated onto minimal media containing 500µM Pi, indicating that all mutated 
alleles resulted in the synthesis of some protein. The initial rates of Pi uptake (where 
uptake was linear) were then measured for wild type pitA and pitB, and the associated 
alleles. The initial rates of Pi uptake were measured for several isolates for each allele, 
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Figure 3.10 
Plasmid diagrams for pAN1107, pAN1108, pAN1109 and 
pANlll0. 
The putative ATG start codons of pitA and pitB were altered to GTG or CTG by 
site-directed mutagenesis. 
The putative start codon of wild type pitA in M13mp18 was altered using 
oligonucleotides 93-107 (GTG) or 93-108 (CTG - see Table 2.5 for details). 
The pitA Sall/BamHl fragments were ligated into the Sall/BamHl sites of vector 
pBR322 to create pAN1107 (GTG) and pAN1108 (CTG). 
The putative start codon of wild type pitB in M13mp18 was altered using 
oligonucleotides 93-135 (GTG) or 93-136 (CTG - see Table 2.5 for details). 
The pitB Sspl/Hindlll fragments were ligated into the EcoRV/HindlII sites of 
vector pBR322 to create pANl 109 (GTG) and pANl 110 (CTG). 
pAN1107 
(GTG) 
pAN1108 
(CTG) 
6.3kb 
SaA 
Hindlll 
pAN1109 
(GTG) 
pANlllO 
(CTG) 
6kb 
BamHI 
pitA 
GTG/CTG 
Clall Acd 
pitB 
GTG/CTG 
EcoRV/Sspl 
as the full DNA sequence of each mutant had not been verified. For each mutated start 
codon the isolates gave similar rates of uptake ( data not shown) and repeat assays were 
subsequently performed on only one isolate for each allele. Examples of the initial 
rates of Pi uptake are given in Figure 3 .11, with a summary of the data ( a compilation 
of three experiments for pitB and 6 experiments for pitA) in Table 3 .2. These results 
show that for both pitA and pitB changing the putative ATG start codon to GTG and 
then CTG caused a progressive drop in the Pi uptake activity of these mutants. This is 
likely to occur when the mutated ATG codon forms the start of the translated protein, 
as the GTG and CTG changes progressively reduce affinity for the ribosomal initiation 
complex, effectively decreasing translation of the encoded proteins. 
pitA has several in frame ATG codons within this large open reading frame at 166, 235, 
286 and 298 nucleotides. To check if these are possible starts to the pitA gene site-
directed mutagenesis was used to place in frame termination codons before ( at 118 
nucleotides) and between ( at 208 and 268 nucleotides) these methionine codons (Figure 
3.12) using oligonucleotides 94-55, 94-56 and 94-57 (Table 2.5). The mutations were 
confirmed, subcloned into pBR322 and transformed into AN3066 by the methods 
previously described in this section. All mutated pitA strains failed to grow on Pi 
media, indicating all pitA Pi uptake activity has been abolished. In addition, two 
termination codons inserted in frame only 13 nucleotides after pitB 's putative A TG 
start completely abolished all Pi uptake activity by this gene (89). 
The combination of the above results indicates that translation of the pit genes 
commences at the beginning of the identified ORFs. 
3.6 Comparison of the deduced • amino acid 
sequences of PitA and PitB 
The open reading frames of pitA and pitB were translated into amino acid sequences 
and aligned, using the ClustalW program in Mac Vector 6.0 (Figure 3 .13). Both consist 
of 499 amino acids with 81 % identity in the deduced amino acid sequences. Sequence 
variability appears to occur in patches, with a large variable region between alanine 266 
and serine 373. 
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Figure 3.11 
Initial rates of phosphate uptake from pitA and pitB with 
altered putative start codons. 
The putative A TG start of each large open reading fraine on the DNA 
fragments containing either PitA or PitB activity were mutated to GTG or 
CTG by site-directed 1nutagenesis, then assayed for Pi transport. The initial 
rates shown below were used to formulate Table 3.2. These rates were 
calculated using six (pitA) or three (pitB) individual detenninations using 
linear regression in the Graphpad Prism prograin. Error bars represent the 
standard error of the 1nean (SEM). 
PitA 
30 
-1 o------r----------,,------, 
0 
30 
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0 
PitB 
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Time (secs) 
10 20 30 
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., GTG 
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TABLE 3.2: Phosphate uptake activity of PitA and PitB 
with altered putative start codons 
Putative start Comparison with wild type Pi uptake 
codon activity (%) 
PitAa PitBb 
vector 
ATG 
GTG 
CTG 
<0.5 
100 + 1.6 
32.4 + 0.6 
3.9+0.l 
a assayed at 6µM Pi, SEM, n = 6 
100% = 45nmol Pi min- 1 mg dry weighr 1 
b assayed at 50µM Pi, SEM, n = 3 
100% = 55nmol Pi min- 1 mg dry weighr 1 
<0.5 
100+2.7 
8.4 + 1.0 
4.4+ 0.5 
Figure 3.12 
Analysis of putative pitA ATG starts within the putative open 
reading frame by the insertion of stop codons. 
The largest open reading frame (ORF) on the DNA fragment containing pitA 
activity has an in frame stop codon just before the putative ATG start, and 
several in frame ATG codons at 166,235, 286 and 298 nucleotides within this 
ORF. In frame stop codons were inserted at 118, 208 and 268 nucleotides 
using the oligonucleotides 94-55, 94-56 and 94-57 (see Table 2.5 for details). 
l (ORF start) 
TAA CTG CCT ATG CTA CAT TTG TTT GCT GGC CTG 
25 
GAT TTG CAT ACC GGG CTG TTA TTA TTG CTT GCA 
58 
CTG GCT TTT GTG CTG TTC TAC GAA GCC ATC AAT 
91 118 
TAA 
GGT TTC CAT GAC ACA GCC AAC GCC GTG GCA ACC 
124 
GTT ATC TAT ACC CGC GCG ATG CGT TCT CAG CTC 
157 166 
GCC GTG GTT ATG GCG GCG GTA TTC AAC TTT TTG 
190 208 
TAG 
GGT GTT TTG CTG GGT GGT CTG AGT GTT GCC TAT 
223 235 
GCC ATT GTG CAT ATG CTG CCG ACG GAT CTG CTG 
256 2 68 286 
TAG 
CTT AAT ATG GGA TCG TCT CAT GGC CTT GCC ATG 
289 298 
GTG TTC TCT ATG TTG CTG GCG GCG ATT ATC TGG 
Figure 3.13 
Alignment of PitA and PitB deduced amino acid sequences. 
A 
a 
Represents amino acids identical between PitA and PitB. 
Represents amino acids unique to PitA. 
Represents amino acids unique to PitB. 
This alignment was carried out with ClustalW (Mac Vector 6.0) using a Blosum 30 
scoring matrix with an opening gap penalty of 10 and an extending gap penalty of 0.1. 
1 
PitA MLh LFa GLDl h TGLLLLLAL AFVLFYEAIN GFHDTANAVA t VIYTRAMrs 
PitB MLn LFv GLD i y TGLLLLLAL AFVLFYEAIN GFHDTANAVA ;:1_VIYTRAM 
50 
PitA QLAVVMAAv F NFLGVLLGGL SVAYAIVHML PTDLLLNMGS s HGLAMVFSM 
PitB QLAVVMAA::F NFFGVLLGGL SVAYAIVHML PTDLLLNMGS t HGLAMVFSM 
100 
PitA LLAAIIWNLG TWYFGLPASS SHTLIGAIIG IGLTNALMTG t SVv DALNip 
PitB LLAAIIWNLG TWFFGLPASS SHTLIGAIIG IGLTNALLTG SV7 'DALN 
150 
PitA kVl s IFg SLI VSPIVGLVf A GGLIFLLRRY WSGTKKRa RI HltPa ERe KK PitB ,vt~IF s SLI VSPIVGLVi A GGLIFLLRRY WSGTKKR }RI H~ p DR KK 
200 
PitA dGKkKPPFWT RIALi l SAi G VAFSHGANDG QKGIGLVMLV Li GvAPAGFV 
PitB ~GK ~KPPFWT RIALiv SAa G VAFSHGANDG QKGIGLVMLV L- G APAGFV 
250 
PitA VNMNAt GYEI TRTRDAinNv Ea YFe QHPa L lkqatgaDql v PApeagaTQ Pi tB VNMNAs GYEI TRTRDAV+- Nf E1- YL r-.-QHPF L .... r'- - . ·, EI PA -: TQ 
300 
PitA paEFHCHPs N TinAlnRl Kg MLttdVesyd klslDqrsqm r RIMLCVSDT PitB T t EFHCHPa.N T LdA~,,:,_ R K+- ML ~J 1I k r , • E - --·: RIMLCISDT 
350 
PitA idKvvKMPGV Sa DDQr LLKK Lk SDMLSTIE YAPVWIIMAV ALALGIGTMI Pi tB ,- ciK 1 .. KLPGV SkEDQ.,, LLKK L SDMLSTIE YAPVWIIMAV ALALGIGTMI 
400 
PitA GWRRVAt TIG EKIGKk GMTY AQGMs AQMTA AVSIGLASYt GMPVSTTHVL PitB GWRRVA:11TIG EKIGKr GMTY AQGM,_AQMTA AVSIGLASY _ GMPVSTTHVL 
450 
PitA SS s VAGTMW DGGGLQRKTV TSILMAWVFT LPAAVLLSGG LYWlsLQF l PitB ss -.VAGTMW DGGGLQRKTV TSILMAWVFT LPAAIFLSGG LY½' LQL 
Membrane proteins are predicted to contain hydrophobic regions capable of spanning the 
membrane as a-helices or ~-sheets. The deduced amino acid compositions of PitA and 
PitB indicate that these proteins are moderately hydrophobic, with nonpolar residues 
making up 53% and 54% of each protein, respectively. Hydropathy profiles were 
determined by the methods of Kyte and Doolittle (138), and Goldman, Engleman and 
Steitz (GES) (63). The average hydrophobicity of a moving window of 19 amino acids 
was calculated against every position in each sequence. These profiles produced similar 
results and suggest that both PitA and PitB contain 9 or 10 hydrophobic regions large 
enough to span the cytoplasmic membrane as an a-helix (Figure 3.14). 
von Heijne's TopPred IV program combines the GES analysis with the 'positive charge 
inside' rule (276) to determine the orientation of a protein in the cytoplasmic membrane 
and the positioning of the putative a-helices. von Heijne found that positively charged 
residues were four times more prevalent in the cytoplasmic loops of bacterial 
membrane proteins of known topology than in the periplasmic loops, while there 
appears to be no preference for negatively charged side chains on either side of the 
membrane (276). The MEMSAT program, which optimally 'threads' a polypeptide 
chain through a set of topology models, was also used (111). The putative models 
produced by these programs for PitA and PitB are very similar and a topological model 
based on the results for PitA is shown in Figure 3 .15, containing 10 transmembrane 
domains. The amino acid residues which differ between PitA and PitB are highlighted 
in this figure, showing that most variability occurs in the putative hydrophilic loops. 
The topology of PitA is explored in more detail in Chapter 6. 
3.7 Kinetic parameters of PitA ana PitB 
To characterise the kinetic properties of PitA and PitB with respect to Pi uptake, the 
relevant DNA fragments were subcloned into plasmid vector pBR322 to produce 
pAN656 and pAN686 (Figure 3.16). These plasmids were transformed into the Pi 
auxotrophic strain AN3066 (pitAJ t1pstC345), which does not grow in minimal media 
supplemented with 500µM Pi (Pi media), but will grow with the addition of G3P. Both 
pAN686 (pitA) and pAN656 (pitB) support the growth of this strain on Pi media (data 
not shown). These cells expressing pitA or pitB were then cultured, deprived of 
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Figure 3.14 
Hydropathy profiles for the deduced amino acid sequences of 
pitA and pitB. 
Each amino acid sequence was analysed by the methods of Goldman, Engleman 
and Steitz (GES) (63) and Kyte and Dolittle (KD) (138), using a moving 
window of 19 amino acids. This was done through the TopPred IV program. 
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Figure 3.14 
Hydropathy profiles for the deduced amino acid sequences of 
pitA and pitB. 
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Figure 3.15 
Topological model of PitA. 
This model was formulated by combining information from GES (63) and Kyte-Dolittle 
(138) hydropathy profiles (using a moving window of 19 amino acids) with the results 
of the prediction programs TopPred IV (276) and MEMSAT (111). 
The models proposed for PitA and PitB were identical in topology, so the PitA 
sequence is shown, highlighting the amino acids which show variability when 
compared with the PitB sequence. 
A Amino acids identical between PitA and PitB. 
A PitA amino acids which are different in the PitB sequence. 
* Highlights the peptide sequence used to create the polyclonal PitA antipeptide 
antibody. The equivalent region of PitB was used to create the polyclonal PitB 
antipeptide antibody. 
The boxes represent the putative transmembrane ex-helices, which have been drawn to 
contain 19 amino acids, the predicted minimum number needed to cross the 
cytoplasmic membrane. The single letter amino acid code has been used. 
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Figure 3.16 
Plasmid diagrams for pAN656 and pAN686. 
Wild type pitA or pitB on vector pBR322. 
pitA was isolated from pCE27 (Elvin et al (59)) on a Clal/Sphl fragment, which 
was then ligated into the Clal/Sphl sites of pBR322 to form pAN686. (This 
plasmid effectively represents genomic pitA DNA on a BamH l fragment cloned 
into the pBR322 BamHl site, as pCE27 consists of a pitA BamHl 
fragment within cosmid vector pHC79, which is a pBR322 derivative.) 
pitB was isolated on a cosmid Clal/BamHI fragment (Harris et al (89)) and 
ligated into the Clal/BamHI of pBR322, creating pAN656. 
Both the above plasmids were constructed by Dianne C. Webb. 
BamHI 
pAN656 
7kb 
/ Clal 
Sspl 
Clal 
I 
pAN686 
6.6kb 
\ 
Sphl BamHI 
pitB 
pitA 
phosphate, and assayed for the initial rates of Pi uptake as described in Section 2.11. 
Measurement of 33Pi uptake by cells was carried out under conditions in which Pi 
uptake was linear over time. Examples of the experiments used to determine Km app and 
V maxapp are given in Figure 3.17. Statistical analysis was used to combine the ~app 
and V maxapp parameters from individual experiments to produce the values listed in 
Table 3.3. 
The PitA protein has a Kmapp about 14 fold lower than PitB on pAN656 in whole cells. 
While the V maxapp for PitA was relatively stable, PitB V maxapp values were variable, as 
indicated by the large error values. Magnesium concentration and pH were altered to 
allow comparison with kinetic parameters measured by other researchers. While the 
Km app values remained similar under these conditions, the V maxapp was lower for both 
PitA and PitB when the magnesium concentration was increased from l .8mM to 1 0mM 
and the pH was increased from pH6.6 to pH7.0 (Table 3.3). 
3.8 Discussion 
pitA and pitB are individual genes which code for Pi transporters that function in the Pi 
auxotrophic strain AN3066 of Escherichia coli. They have differing kinetic 
parameters, with the plasmid-borne PitA Km app of 2µM being approximately 14 fold 
lower than the PitB Kmapp of 28µM. Plasmid-borne PitB also has a lower V maxapp in 
these whole cell assays, indicating that this protein maybe less active in Pi transport 
than PitA. Translation of both pit genes occurs from the beginning of each 1500 base 
ORF. Several topology prediction programs use the deduced amino acid sequences of 
PitA and PitB to propose that they both have a secondary structure of 10 
transmembrane a-helices connected by hydrophilic loops, with most amino acid 
variability occurring in a few putative hydrophilic loops. The differing Km app values 
and the 81 % identity in the deduced amino acid sequences means that PitA and PitB 
form a good comparative system where differences in mechanism, kinetic parameters 
and amino acid sequence may be systematically explored. 
The presence of a second Pit transporter reveals that Pi uptake activity previously 
attributed to a single Pit transporter may be a combination of distinct PitA and PitB 
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Figure 3.17 
Experiments used in the determination of Kmapp and V mapp for 
PitA and PitB. 
Shown below are the individual experi1nents used to detennine the kinetic 
parameters listed in Table 3.3, using the conditions ofpH6.6 and l.81nM 
1nagnesium. Error bars represent the standard error of the 1nean (SEM). The 
initial rates were calculated using one to three (usually three) individual 
detenninations, taken at 15 and 25 sec intervals. The kinetic parameters were 
calculated by nonlinear regression using the Graphpad Prism prograin. 
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TABLE 3.3: Kinetic parameters for PitA and PitB 
Plasmid a Phenotype Assay conditions Kmappb Vmaxappb 
pH [Mg] mM µM nmol Pi min-1 mg 
d wei hf 1 
pAN686 pitA+ 6.6 1.8 1.9+0. l (n=5) 58+4 (n=5) 
pAN686 pitA+ 7.0 10.0 1.9 39 
pAN656 pitB+ 6.6 1.8 28.6+ 1.4 (n=5) 33+9 (n=5) 
pAN656 pitB+ 7.0 10.0 28.1 + 1.0 (n=3) 17+3 (n=3) 
a host strain is AN3066 for all experiments 
b SEM 
activities, or may even be the result of a heteromeric transporter and this will be 
examined in the next two chapters. A screening of 34 completely sequenced genomes 
revealed that several other bacteria, including Pseudomonas aeruginosa, contain more 
than one pitA homologue (99), and multiple Pi transporters with overlapping activities 
have been reported in Saccharomyces cerevisiae (169) and Neurospora crassa (274). 
The nucleotide sequences and chromosomal locations of pitA and pitB were published 
for E. coli K-12 by the E. coli genome sequencing project during the course of this 
work. These nucleotide sequences proved to be identical to those determined in this 
laboratory (89), with the genomic locations being 78.51 min for pitA (245) and 67.44 
min for pitB (18). 
While the 6xHis affinity tag has been successfully used to isolate other membrane 
proteins ( 151) and is reported to rarely interfere with protein structure or function, the 
Pi auxotrophic phenotype of pAN9 l 8 in AN3066 was clearly attributable to the 6xHis 
tag. However other pitA::6xHis plasmid constructs procured Pi uptake. The reasons 
for this variability are unclear. The poor growth of some strains may be due to toxicity 
effects caused by the over-expression of a membrane protein. Harry Rosenberg's 
group, which produced a strain over-expressing wild type PitA (59), found these E. coli 
cells had highly invaginated cytoplasmic membranes, as shown by electron 
micrographs (personal communication, G. B. Cox). Attempted over-expression and 
purification of PitA6xHis protein from plasmid constructs which showed some Pi 
uptake activity produced no obvious band of protein by Coomassie stained SDS-PAGE 
analysis. This protein purification work, which was placed on hold until PitA6xHis 
could be specifically identified, was never resumed as the regulation of pitB became 
more central to this thesis (Chapter five). The production of the polyclonal PitA and 
PitB antipeptide antibodies (Sections 4.3.3, 5.4.2) and the commercial availability of 
Penta.His or Tetra.His antibodies (QIAGEN) now allows for identification of the PitA, 
PitA6xHis and PitB proteins. This, combined with subsequent refinements in the 6xHis 
technique (QIAGEN), means that growth conditions and protein isolation can now be 
optimised should protein purification become a goal in the future. 
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Identification of the E coli K-10 Pit 
mutation 
4.1 Introduction 
E. coli relies on the Pst and Pit systems for the uptake of inorganic phosphate (Pi). 
Another two transporters accept Pi as a low affinity analogue for either glycerol-3-
phosphate (glpT) (91) or glucose-6-phosphate (uhpl) (199, 295) but in the absence of 
Pit and Pst activity these latter two systems cannot support cell growth when cells are 
supplied with Pi alone (249). When the Pst system of E. coli strain K-10 is inactivated, 
cells cannot utilise Pi for cell growth (289), suggesting that K-10 has a mutation that 
affects Pit activity. Conjugational mapping placed this defect at about minute 77 on the 
E. coli genome (249). The E. coli genome sequencing project has located pitA at 
minute 78.51 (245), indicating this K-10 lesion is likely to be in the pitA gene. The 
mutation has yet to be defined. 
The discovery of pitB, a second Pit Pi transporter located at 67 .44 minutes on the E. 
coli genome (18) means that this gene should also be examined for mutations if the true 
nature of the K-10 Pit mutant is to be understood. 
It is important that the K-10 Pit mutant is fully defined as all assays to characterise pitA 
and pitB have been carried out in strain AN3066, a Pi auxotroph derived from K-10. 
While AN3 066 has negligible Pi transport, this does not guarantee that there is no 
expression of wild type pitA or pitB, or that the addition of plasmid-borne pit will not 
alter genomic pit expression. There are a variety of possible scenarios. Mutations within 
a post-transcriptional regulatory gene or protein may inhibit PitA and/or PitB protein. If 
only hetero-dimers are functional, expression of either pitA or pitB would not provide 
function. Mutations within regulators or regulatory regions of either genomic pit gene 
may be overcome by multicopy pit plasmids. Thus, pitA or pitB introduced on a plasmid 
has the potential to interact with the genomic pit system in a number of unintended ways. 
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This chapter identifies the mutation/s in the K-10 pit genes and analyses them with 
respect to Pi uptake activity and protein assembly. 
LJ..2 Identification of the £ coli K - 1 O pit 
mutationfs 
Strain AN3066 was the standard background strain used for measuring the kinetic 
parameters of plasmid-borne pitA or pitB as described in Chapter three. It is unable to 
grow on minimal media supplemented with Pi as the sole source of phosphate, 
therefore has no Pi transport. AN3066 is a derivative of strain K-10, which has been 
modified by a deletion in the pstC gene ('1pstC345), producing a nonfunctional Pst 
system, and the introduction of a recA mutation (srl::Tnl O recA) to hinder genetic 
recombination events (284). 
The pitA and pitB nucleotide sequences were amplified from the genomic DNA of 
strain AN3066 by PCR, using Pfu DNA polymerase in order to minimise the 
introduction of errors (156). Oligonucleotide primers complementary to the 5'- and 3'-
regions flanking the open reading frames (ORFs) of pitA and pitB, including 
approximately 40 upstream nucleotides and ending just after the translation termination 
codons, were used for this amplification. BamHl sites were included at the distal ends 
of each primer (Figure 4.1, Table 2.5). The 1.5kb pitA and pitB PCR products were 
confirmed by restriction analysis, purified, digested with BamHI and subcloned into the 
BamHl site of dephosphorylated Ml3mp18. RF DNA was screened for the correct size 
and orientation of the insert by restriction analysis. ssDNA was purified from several 
phage isolates, and one isolate was fully sequenced. Manual sequencing was carried 
out over regions where the cycle sequencing results were ambiguous. 
DNA sequencing revealed that the pitB ORF is wild type. To investigate whether 
regulatory sequences were mutated a longer pitB+ PCR product including 319 
nucleotides upstream of the ORF was also prepared by PCR (Figure 4.1 B, primers 
listed in Table 2.5). A DNA fragment of 1.95kb was amplified and verified as pitB 
DNA by restriction analysis. This DNA was purified and subcloned into Ml3mpl8, 
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Figure 4.1 
PCR amplification of the putative pitA and pitB open reading 
frames. 
A pitA PCR amplification. 
The largest open reading frame (ORF) on the DNA fragment containing pitA 
activity was amplified by PCR using the oligonucleotides 95-87 /95-88 (see 
Table 2.5 for details). The nucleotides amplified at the beginning and end of 
this open reading frame are shown below. 
CTG -- AGT PCR amplification product. 
AT G T AA Open reading frame. 
52 9 BamHI 
CTGAG GATCC 
AGTCACTGAT AATGCGCCGC GTTCATGTCC TCAAAATGGC 
573 
GTAACGTCCT ATGCTACATT 
20 72 BamHI 2098 
CCT AGGCAGT 
GTTCCTGTAA TCGTACGCAC CAAAACGAGC GGGTCAGCTG 
B pitB PCR amplification. 
The largest open reading frame (ORF) on the DNA fragment containing pitB 
activity was amplified by PCR using the oligonucleotides 95-89/95-90 (see 
Table 2.5 for details). The nucleotides amplified at the beginning and end of 
this open reading frame are shown below. The larger pitB PCR product 
containing 319 nucleotidesupstream of the ORF start, using oligonucleotides 
97-73/97-74 is also shown. The putative stem loop sequence is underlined. 
C TG -- AGT PCR amplification product for the pitB ORF. 
ATG -- TAA Open reading frame. 
AGA -- CAC PCR amplification product for the longer pitB fragment 
(ORF plus 319 upstream nucleotides). 
1075 BamHI 
AGAGGGATCC ----------------
AAGAGAGTGATATTGAACCGTTAATTGTGGTGAAAAAGTAATAC 
ATGTTGTAGCAACCCCGTACTGATTATGAAGAATAATCAGTACG 
GGGATTAATCAAAATATTCAATATTTATATATTCCAATATTTAT 
TCATTTCATATGTGAATATATTAACCAGTGGAATACCTGTGTTT 
TGATTATTTCTAAAGGTTTTGAATGAATGCTTATTGTCTGATAC 
ACAAGAAATAACACTCTTTTTATCGTTAAAAAATGATATTTCAC 
1354 BamHI 
GTCAGGATCC --------
TTTGCCCATGCCGTTAAAGTCACTGATAATGCGTCCGTTCGTAA 
1404 
ATTCAAAATGGCGTAATCTAATATATGCTAAAT -----
2903 BamHI 2930 
CCTAGGCCGC 
TTGATTTAACCTTCCTGAAAATGCCCGGTCCTGGCGATCGGGCA 
TTTCCATTTTTGACTAGTGATAACCACGCGCGGTCATAAAATCC 
BamHI 3022 
---------------- CCTAGGTCAC GTAATCGCTTTTTCTGCATCAACCAACACCTGTTCCAGTGGCTG 
screened for the correct orientation and insert size and the M 13-40 primer was used to 
cycle sequence three isolates over the upstream region of pitB and into the pitB ORF. 
These 319 upstream nucleotides were wild type in all isolates. Therefore pitB, 
including both the promoter region and ORF, appears to be wild type in AN3066 even 
though this strain exhibits no Pi transport activity. 
The pitA sequence contained a single point mutation of G to A at nucleotide 65 8 in the 
ORF of the published sequence. This was confirmed by sequencing three independent 
PCR isolates over this region, all of which contained the G to A mutation (Figure 4.2). 
The point mutation creates an amino acid change of glycine to aspartic acid (G220D) at 
residue 220 in the coding sequence of PitA (pitA 1), and this amino acid substitution is 
located within a putative transmembrane ex-helix of the PitA membrane protein, using 
the proposed topological model of PitA (Figure 3 .15). 
4.3 Functional analysis of pitAJ from K-10 
strain AN3066 
4.3.1 pitAI Pi transport 
The pitA 1 gene from AN3066, which contains the G to A point mutation, was then 
tested for its ability to produce a functional Pi transporter. The PCR isolate that had 
been fully sequenced was subcloned from the Ml3 RF into the BamHI site of pBR322 
(pAN1243) and then transformed into AN3066. The desired orientation was selected 
using restriction endonuclease analysis (Figure 4.3). This new strain, AN393 7, was 
unable to grow on Pi media, indicating that the amplified pitAJ gene from AN3066 was 
nonfunctional. 
4.3.2 Preparation of pitA(G220D) by site--directea 
mutagen es is 
The lack of Pit function in strain K-10 is quite stable. Point mutations are often 
unstable due to their ability to revert to wild type at a moderately high frequency when 
placed under selection pressures. Therefore it seemed reasonable to check that this 
single base change could fully account for the stable loss of Pit function found in K-10. 
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Figure 4.2 
Sequencing of K-10 plasmid-borne pitA mutation. 
Manual sequencing gel autoradiograph of PCR amplified pitA from Pi 
auxotrphic strain AN3066, which contains a G658A point mutation. This 
mutation was present in the three independent PCR isolates that were 
sequenced. 
GA TC 
G658A-. 
pitA mutant 
wild type pitA 
Sequence 
(reading from bottom to top) 
+ TCCTTTCCGCTATCGACGTGGCGT 
TCCTTTCCGCTATCGGCGTGGCGT 
Plasmid pAN686 has E. coli K-12 wild type pitA sequence over its full length, from 
573 nucleotides upstream of the ORF to 199 nucleotides downstream of the ORF (245). 
Double stranded site-directed mutagenesis was used to recreate the G to A point 
mutation in this wild type pitA gene, creating plasmid pAN1244 (Figure 4.3, 
oligonucleotide 95-101 in Table 2.5). The mutation was confirmed by sequencing and 
pAN 1244 was then transformed into strain AN3 066 so that Pi uptake could be assayed. 
This new strain, AN3938, did not grow on Pi media, indicating that this single point 
mutation can disrupt the function of the wild type pitA gene. As this gene is wild type 
for at least 573 nucleotides upstream of the pitA ORF, it is unlikely that another 
mutation in the regulatory region is needed to reproduce the K-10 pitA l phenotype. 
However, pitAI and pitA(G220D) will be further characterised by comparing their 
levels of protein expression by Western blot using PitA polyclonal antipeptide 
antibody. 
4.3.3 Analysis of PitA expression using po/yclonal PitA 
antipeptiae antisera 
The nonfunctional PitA protein has glycine 220, a small hydrophobic amino acid, 
replaced by aspartic acid which has a medium sized negatively charged side chain. 
Amino acid substitutions may affect the assen1bly of the protein, and/or its enzyme 
activity. To determine if this pitAl(G220D) mutation affected the assembly of PitA, 
the levels of PitA protein in the membrane fraction of whole cells containing either 
wild type or mutant PitA were compared by W estem blotting. 
Polyclonal antipeptide PitA antibody was used to visualise the PitA protein. This was 
prepared by immunising rabbits with a multiple antigen peptide system (MAP) 
conjugate consisting of the peptide ARIHL TP AEREKKD-C attached to a poly lysine 
core via a C-terminal cysteine (Section 2.13 .2). This PitA peptide forms part of an 
extramembranous loop in the putative folded structure (Figure 3 .15) and is in a region 
of variability between the PitA and PitB sequences. After initial testing of the sera by 
an ELISA assay against the PitA peptide, the specificity of the antipeptide PitA sera 
was investigated by W estem blot. Sera was applied to the membrane fractions of the 
AN3066 background strain, which has no Pi uptake, containing either a vector control 
or wild type pitA on a plasmid. Polyclonal antibodies in this sera bound strongly to a 
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Figure 4.3 
Plasmid diagrams for pAN1243 and pAN1244. 
pitA (PCR) or pitA(G220D) on vector pBR322. 
The pitA PCR amplification product from AN3066 (using primers 95-87 /95-88 , 
See Table 2.5 for details) was digested with BamH l and ligated into the BamH l 
site of pBR322. The desired orientation was selected by restriction 
endonuclease analysis , forming pAN1243. 
The pitA(G220D) mutation was created by using site-directed mutagenesis to 
make a G658A nucleotide change in the open reading frame of wild type pitA on 
plasmid pAN686, creating pAN1244. 
pAN1243 
5.9kb 
pAN1244 
6.6kb 
Sphl 
"' 
"" 
BamHI 
- pitA 7 (PCR) 
BamHI 
pitA (G220D) 
BamHI 
protein at approximately 48kDa (from a 10% manually poured polyacrylamide gel with 
a Tris buffer system) (Figure 4.4). There were no equivalent bands in Western blots 
exposed to pre-immune sera. The deduced molecular weight of the PitA protein is 
53kDa. The smaller than expected apparent molecular weight is not unusual for 
membrane proteins, which often undergo anomalously fast migration during 
electrophoresis. This may be due to the reformation of some of the a-helical structure 
during electrophoresis, or by the binding of excess molecules of SDS by the highly 
hydrophobic regions of the protein. No further purification of the sera was carried out 
as this W estem blot showed minimal binding of other membrane proteins by the 
polyclonal antibody. 
Possible cross-reactivity with the PitB protein was investigated by a W estem blot of the 
sera against the membrane fractions of AN3066 containing either vector (pBR322), 
wild type pitA (pAN920) or the long pitB plasmid (pAN656) (Figure 4.4). The 
membrane fraction of the pAN920/ AN3066 strain had a strongly labeled band at 
approximately 48kDa representing the PitA protein. The vector and long pitB 
membrane fractions had weakly labeled bands in the same position. While this does 
not completely rule out any cross reactivity of the PitA antipeptide antibody with PitB 
protein, it does indicate that under the experimental conditions used here cross 
reactivity is negligible. 
J/..3.1/- Comparison of PitA assembly in strains containing 
either wild type pitA or pitAl 
Plasmids containing wild type pitA, pitAJ or pitA(G220D) were transformed into the Pi 
transport negative background strain AN3066 (pitAJ pst) so the levels of PitA protein 
assembly conferred by each plasmid could be compared. As the cytoplasmic 
membrane of AN3066 may contain a nonfunctional PitA protein, an E. coli strain with 
wild type pitA on the genome plus the AN3066 background strain were also included in 
this comparison. 
The membrane fractions of whole cells were isolated from strains grown in rich media 
via an ammonium sulfate precipitation procedure (Section 2. 7 .6). The protein 
concentrations were determined and membrane fractions were diluted into 2mg/ml 
80 
Figure 4.4 
Western blot analysis of polyclonal PitA antipeptide antisera 
against PitA and PitB protein. 
The membrane fractions of the Pi auxotrophic strain AN3066 containing 
plasmids pBR322 (vector), pAN920 (PitA) or pAN656 (PitB) were 
solubilised and separated by PAGE on a 10% polyacrylamide gel (Tris 
buffer system) and transferred onto PVDF membrane. Protein was 
visualised by incubation with polyclonal PitA antipeptide antisera, 
followed by incubation with alkaline phosphatase conjugated goat anti-
rabbit secondary antibody and the application of Western blue alkaline 
phosphatase substrate. 
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aliquots and stored at -70°C. Western blots were carried out by denaturing samples 
diluted to 200µg/ml protein, separating these proteins by polyacrylamide gel 
electrophoresis (NUPAGE 4-12% gradient gel with MES buffer system), and carrying 
out semi-dry electroblotting and visualisation using an alkaline phosphatase coupled 
secondary antibody (Section 2.13.3). 
The membrane fraction of the control strain AN3066 plus vector pBR322 (AN3514) 
contained very little PitA protein (Figure 4.5), while the wild type pitA plasmid 
produces significant levels of PitA (AN3531 ). AN248, which has wild type PitA on the 
genome, produced an intermediate level of PitA protein. This level of protein 
expression was much greater than that produced by genomic pitAI from AN3066, but 
was less than that produced from the wild type pitA plasmid. Cells with the pitAI 
plasmid or the site-directed pitA(G220D) plasmid had low levels of protein similar to 
the AN3066 background strain (AN3937, AN3938). Therefore the G220D mutation 
seems to greatly reduce the insertion of PitA protein into the membrane, and protein 
levels between the site-directed mutant and the AN3066 pitAJ mutation appear similar. 
Although the membrane fractions of these mutant strains did contain a small amount of 
PitA protein, they have negligible Pi transport and it is unlikely that this mutated 
membrane protein is functional. 
4.4 Discussion 
Strain K-10 is defective in Pit transport, as outlined in the introduction to this chapter. 
Both the pitA and pitB genes were examined for potential mutations. While pitB had 
wild type sequence for the ORF and at least 319 upstream nucleotides, DNA 
sequencing of the pitA ORF from the K-10 strain, AN3066, identified a single point 
mutation of G to A at nucleotide 65 8 in the published sequence. This causes an amino 
acid change from glycine to aspartic acid at residue 220 in the PitA protein. 
W estem blots using polyclonal PitA antipeptide antisera showed that the mutated PitA 
protein is found in cell membranes at a much lower level than in an equivalent strain 
containing wild type pitA. This suggests that inhibiting the insertion of the PitA protein 
into the plasma membrane is a major effect of the pitAJ mutation. However, a small 
amount of PitA protein is visualised in the membrane fraction of AN3 93 7, which 
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Figure 4.5 
Western blot analysis of PitA protein expression by the 
plasmid-borne K-10 pit mutant and pitA(G220D) site-
directed mutant. 
Membrane protein fractions of the wild type strain AN248 and the Pi 
auxotrophic strain AN3066 containing the plasmids listed below were 
solubili sed and separated by PAGE on a 4-12% gradient polyacrylamide 
gel (MES buffer system) and transferred onto PVDF membrane. Protein 
was visualised by incubation with polyclonal PitA antipeptide antibody 
followed by incubation with alkaline phosphatase conjugated goat anti-
rabbit antibody and application of Western blue stabilised alkaline 
phosphatase substrate. 
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contains the pitAJ mutant plasmid in the pitAJ AN3066 background strain. This level 
of protein is only a little less than that found in the membrane fractions of AN248, a 
strain with wild type pitA on the genome, and normal Pit function. Therefore it is likely 
that the substitution of aspartic acid for glycine 220 affects both the assembly and 
function of the PitA protein. 
Putative topological models of PitA places glycine 220 within transmembrane (TM) a-
helix 6 (Figures 3.15, 6.2). Aspartic acid is a medium sized negatively charged amino 
acid, while glycine has a small and uncharged side chain. The insertion of charged 
residues into the hydrophobic environment of the membrane has a high energy cost 
(62). Thus, the substitution of a negatively charged aspartic acid for glycine 220 may 
prevent this section of a-helix from inserting into the membrane, or greatly reduce its 
stability or efficiency of insertion. The bulk and charge of the aspartic acid side chain 
may interfere with the a-helical packing of the TM a-helix and/or interhelix 
interactions within the mutant PitA protein. Thus, some PitA may insert in the 
membrane, but have a disrupted structure that creates a nonfunctional protein. This 
region of PitA may be very sensitive to change as the G220D substitution is located 
near several charged residues within putative TM a-helix 6 that have been found to be 
important in PitA structure/function (Figure 6.2). 
These postulations assume that the G220D point mutation is the only mutation inpitAI. 
The lack of Pit function in strain K-10 is quite stable. Point mutations are often 
unstable due to their ability to revert to wild type at a moderately high frequency when 
placed under selection pressures. As the ORF of only one isolate of pitAI was fully 
sequenced, there remained the possibility that other mutations may have been missed, 
either within the ORF or in the promoter region of the gene. Therefore it seemed 
prudent to determine if the G220D substitution alone could create the changes in 
function and protein expression observed in the pitAI mutant. A site-directed mutation 
changing nucleotide 0658 to A658 in wild type pitA , showed that this pitA(G220D) 
gene behaved identically to the pitAI mutant, being unable to support cell growth on Pi 
media, and having similarly low levels of protein inserted in the cell membranes. This 
gene had wild type sequence for at least 573 nucleotides upstream of the pitA(G220D) 
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ORF, so the need for additional mutations in the pitA regulatory region seems unlikely. 
Subsequently, another group of researchers have identified the same K-10 p itA point 
mutation (99). 
The pitB gene from AN3066 was sequenced and is identical to the functional pitB gene 
isolated by cosmid cloning, and to the pitB gene sequenced as part of the E. coli K-12 
genome sequencing project ( 18). The open reading frame and 3 19 upstream 
nucleotides were sequenced, which should include the promoter and most regions, 
which may potentially interact with regulatory proteins. However, this pitB gene does 
not function as a Pi transporter on AN3066. pitB was cloned due to the ability of the 
3kb fragment to complement for Pi uptake when located on vector pHC79 (pCE27) in 
strain AN3066 (89) and Pi uptake assays confirmed that a functional Pi transporter was 
encoded on this fragment. The only known differences between AN3066 and 
pCE27 / AN3066 are the location of the pitB gene on either a plasmid or the genome and 
the number of pitB copies. Therefore genomic pitB may be under regulation that is 
disrupted when the gene is placed on a plasmid. The gene copy number may be most 
important, as Hoffer et al (99) identified a pitA pst mutant able to transport Pi which 
had a DNA rearrangement creating multiple copies of the wild type pitB gene. 
Experiments to investigate the regulation of pitB are described in the next chapter. 
Defects in translation may also be responsible for this lack of PitB activity. These defects 
may occur as mutations in the either the mRNA or 16S rRNA sequence motifs to 
decrease complementarity, which reduce the efficiency of initiation of translation, or 
could occur as defects in peptide transfer, translocation of the protein through the 
ribosome, the stability of the mRNA or the mRNA/ribosome complex, or termination and 
removal of the ribosome. It is unlikely that the decrease in PitB Pi uptake activity is 
caused by the mRNA Shine Dalgarno rRNA binding site. Both pitA and pitB appear to 
have poor Shine Dalgarno (SD) sequences, consisting of GCGG (promoter sequences are 
in Figure 5.9) rather than the more favourable AGGAGG sequence that is found 4 to 7 
nucleotides 5' of the initiator AUG of many mRNAs. However, the identity between 
these pitA and pitB SD sequences shows that this aspect of translation is not the source of 
differential activity between the two pit genes. Possible post-transcriptional modification 
defects are discussed in "Section 7 .2 Regulation of the Pit system". Comparison of the 
levels of mRNA transcription (via northern blots) with translation (via western blots, the 
use of reporter genes or by testing Pi uptake activity) for various pitA and pitB constructs 
could be used to determine if the reduced PitB activity is caused by defects in translation. 
Chapter five 
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5.1 Introduction 
The Pit system was previously characterised as the product of a single locus which is 
constitutively expressed (59, 211, 212, 249, 289). However, evidence presented in the 
previous two chapters indicates that E. coli, has two pit genes, and at least one of these 
may be regulated. Therefore both pitB and pitA should be analysed for any potential 
interactions or regulation. Previously presented kinetic data which could represent a 
combination of PitA and PitB activities may, upon re-examination, provide clues as to 
what environmental or genetic conditions influence Pit regulation. 
This analysis should be open to the possible involvement of the Pst system and the 
genes that regulate it. The Pst operon is induced by the phoBR two component 
regulatory system when external Pi concentrations become limiting (0.1 to lmM) (291) 
(2, 254, 259). The phoB-phoR operon controls the pho regulon, activating over 100 
genes involved in phosphate metabolism and assimilation (271, 280). There is also 
evidence to suggest that several members of the pho regulon are repressed under these 
conditions (271, 291 ). The process of Pi-dependent activation of the pho regulon is 
described in Section 1.4. Inhibition of the pho regulon occurs when external Pi 
conditions rise above 0.1-lmM. The Pst system, which is thought to play a role in the 
detection of the external Pi concentration, interacts with PhoU and PhoR to cause the 
dephosphorylation of PhoB and subsequent inhibition of the pho regulon (Figure 1.2). 
The majority of mutations in PhoU or any of the four Pst proteins result in high 
constitutive pho regulon gene expression (181, 282). This may be relevant to the 
regulation of PitA or PitB as the Pst system needs to be inactivated to measure the 
kinetics of the E. coli Pit system. Pst activity can be inhibited by growing the cells in 
media containing high concentrations of Pi, using membrane vesicles which removes a 
binding protein that is essential for Pst activity, or by the mutation of Pst genes to create 
a nonfunctional Pst system. As any change to the Pst system has the potential to affect 
pho regulon activity, previous experiments isolating Pit activity may have 
unintentionally created environments with very different Pi regulatory conditions. 
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It is possible that pitB may be repressed by processes which activate most members of 
the pho regulon. Rhizobium meliloti contains a Pit-like Pi transporter that is repressed 
under conditions of Pi limitation. This repression is relieved in phoB mutants of R. 
meliloti (8). All Pi uptake assays to measure Pit activity undertaken in Chapter 3 have 
been carried out in the background strain AN3066, which contains the i1pstC345 Pst 
system deletion. This deletion prevents repression of the p ho regulon, so it is 
constitutively expressed at all Pi concentrations ( 44) rather than being expressed only 
when Pi concentrations are very low. If pitB is repressed when the E. coli pho regulon 
is activated, a constitutively expressed pho regulon could repress PitB activity under all 
the conditions we have used to assay Pit transport. This could explain the lack of 
activity from genomic pitB that is described in Chapter four. 
With this frame of reference the work of past researchers was examined for any 
evidence of pitB activity. In 1974 Willsky et al (292) described a pitAJ strain grown 
and assayed at lmM Pi which had a Km app of 0.4µM Pi, indicative of Pst system 
activity. When a pstS72 mutation was introduced the rate of uptake fell and the Kmapp 
increased to l 8µM, which is similar to the Km app values we have obtained for pitB. The 
pstS72 mutation in the above strain reduces the activity of the Pst system but does not 
eliminate all Pi uptake (211). If pstS72 has no effect on the pho regulon (which is 
certainly possible, as the regulatory and transport roles of the Pst system could be 
uncoupled by specific amino acid substitutions in pstC or pstA ( 43 , 44)) pitB could be 
expressed in lmM Pi, which is within the 0.1-lmM Pi concentration range where the 
pho regulon starts being repressed. In K-10, which has a wild type Pst system and the 
pitAJ mutation, a component of the Pi uptake attributed to the Pst system at high Pi 
concentrations could also represent PitB activity (211 ). phoBR controls the pho 
regulon, so its influence on pitB activity will be investigated. 
The presence of a wild type pitB gene in AN3 066, which has been the background 
strain used in all Pi assays reveals several potential complications. Pi transport from 
pitA plasmids has been measured in the presence of a genomic wild type pitB gene. 
Thus Pi uptake activity previously attributed to pitA could conceivably result from an 
interaction between the plasmid' s PitA protein and PitB protein expressed from the 
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genome. It is not known if genomic wild type pitA can function as a Pi transporter in 
the absence of the wild type pitB gene. AN3 066 is therefore not an appropriate 
background strain and a new background strain which lacks pst, pitA and pitB genes is 
required to replace AN3066. 
This chapter examines the ability of PitA and PitB to function as independent Pi 
transporters. The expression and regulation of pitB is analysed, and the possible 
involvement of the pho regulon is investigated. 
5.2 Preparation of a Pi transport triple mutant 
Previous experiments have shown that the pitB gene of AN3066 has wild type sequence 
(Section 4.2). Although no conditions have yet been found where the genomic wild 
type pitB gene on AN3066 is functional, insertional inactivation of the pitB gene 
removes all chances of ambiguity in future experiments. 
The pitB gene was insertionally inactivated by ligating the chloramphenicol resistance 
gene from pBR328 ( cut with restriction endonucleases Aatll and Saul, then endfilled 
with T4 DNA polymerase) into the Stul site of pAN656, creating pANl 193 (Figure 
5.1). This placed the chloramphenicol resistance gene 514 nucleotides into the open 
reading frame of the pitB gene (pitB::Catr). Recombination with genomic E. coli DNA 
was carried out by transforming pAN 1193 into competent JC7 623 cells. This strain 
contains recBC sbcBC mutations which allow double crossover events to occur 
between covalently closed circular plasmid DNA and the genome (Section 2.6.1) ( 189). 
Recombinant JC7623 cells were selected by plating the transformation mix onto rich 
media containing the antibiotics chloramphenicol ( selecting pit B: :Catr) and 
streptomycin (selecting the JC7623 background). The absence of plasmid pANl 193 
was verified by screening transformants for sensitivity to ampicillin, as pANl 193 . 
contains an ampicillin resistance gene. Those isolates which were Catr Strr Ap 5 were 
streaked to single colonies and the presence of the nonfunctional pitB: :Catr gene was 
confirmed by PCR analysis, using the primers for the pitB ORF (Table 2.5). The PCR 
reaction results for four isolates are shown in Figure 5 .2. All isolates amplified an 
approximately 2. 7kb DNA fragment, indicating that the pitB gene contained the Catr 
insert. No 1.5kb DNA band was amplified, which showed that the wild type pitB gene 
86 
Figure 5.1 
Plasmid diagram for pAN1193. 
Insertional inactivation of wild type pitB with a chloramphenicol resistance gene. 
The choramphenicol resistance gene from pBR328 was removed on an 
AatII/SauI fragment and then endfilled with T4 DNA polymerase. This was 
ligated into the Stul site located within pitB on pAN656. Restriction 
endonuclease analysis was used to choose the desired orientation, forming 
pANl 193. 
BamHI 
C/al lipitB 
pAN1193 
8.1 kb 
~pitB 
Stu1 /endfilled Saul 
Stu1 /endfilled Aatll 
Figure 5.2 
PCR and restriction endon uclease analysis of recombinant 
JC7623 (AN3901) to confirm the replacement of pitB by 
pitB::CatR. 
A PCR amplification of pitB and/or pitB::CatR 
0.8% agarose gel analysis of the PCR products from reactions using the 
primers for the pitB open reading frame (95-89/95-90, See Table 2.5 for 
details) with genomic DNA from JC76 23 and isolates of AN3901, to 
confirm that the pitB (1.5kb) of JC7623 has been replaced by pitB::CatR 
(2.7kb). 
Size 
kb 
4.1 
3.1 
2.0 
1.6 
\ 
pitB: :CatR 
pitB 
J 
Figure 5.2 
PCR and restriction endon uclease analysis of recombinant 
JC7623 (AN3901) to confirm the replacement of pitB by 
pitB::CatR. 
B Restriction endon uclease analysis of the PCR 
amplification products described in Figure 5.2A. 
0.8% agarose gel analysis of the pitB/pitB::CatR PCR amplification 
products from JC7623 and individual isolates of AN3901, which are 
described in Figure 5.2A. Stu! restriction endonuclease digestion of pitB 
(which is 1.5kb in size) produces 0.5 and 1.0kb fragments, but does not cut 
pitB::CatR, which is 2.7kb in size. 
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1.6 · ,, 
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isolates 
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JC7623 AN3901 
pitB::CatR 
pitB 
1.0kb 
0.5kb 
was completely replaced. These PCR products were verified by restriction 
endonuclease digestion. 
Plkc transduction was used to transfer the pitB::Catr gene into the pitA pstC strain 
AN3020, creating pitA pitB::Catr pstC (AN3902). Transformants were selected by 
resistance to 50µg/ml chloramphenicol on rich media containing lmM G3P. The 
absence of donor cells was verified by screening for the 11pstC345 gene of AN3020 
using the rapid spray alkaline phosphatase assay. phoA alkaline phosphatase is 
normally inhibited when phosphate concentrations are greater than 0.1-1 mM (291 ), but 
many mutations in the Pst system, including 11pstC345, cause constitutive synthesis of 
phoA. This alkaline phosphatase assay showed that phoA was active at high phosphate 
conditions, indicating the presence of 11pstC345 (Figure 5.3). Complete removal of 
wild type pitB was confirmed by PCR, as described above (Figure 5.4). 
This triple mutant was unable to grow on Pi media and subsequently replaced AN3066 
(pitA pstC recA) as the background strain for assaying plasmid-borne pit genes for Pi 
function. 
5.3 Expression of wild type pitA 
5.3.1 Expression of wild type pitA from the K-12 genome 
The Kl0 strain AN3066, which contains a mutant pitAJ and a wild type pitB on the 
genome, is unable to grow with Pi as the sole source of phosphate. Yet, pitB expresses 
a functional Pi transporter when located on a plasmid. Could pitA also prove 
nonfunctional when it is the sole pit gene on the genome? To explore this further, a 
pitA + pitB pstC mutant was created by insertional inactivation of the pitB gene in pstC 
strain AN25 3 7. 
Bacteriophage Plkc transduction was used to transfer the pitB::Catr gene (previously 
prepared in Section 5.2) into the pstC strain AN2537. Recipients were selected for the 
presence of pitB::Catr by their resistance to 50µg/ml chloramphenicol on rich media 
containing lmM G3P. They were also screened for the presence of !JpstC345 which 
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Figure 5.3 
Confirmation that Pl transduced strain AN3902 is not the 
donor strain AN3901 by analysis of alkaline phosphatase 
activity. 
Cells were grown on rich media and single colonies were patched onto filter 
paper for the rapid spray alkaline phosphatase assay (22). 
Colour Alkaline phosphatase activity 
-
+ 
Recipient strain 
AN3020 
Donor strain 
AN3901 
"-------) 
Transduced isolates 
AN3902 
Figure 5.4 
PCR amplification analysis of the Pl transduction of 
pitB::CatR into strains AN3020 and AN2537. 
0.8% agarose gel analysis of PCR products from reactions using primers 
for the pitB open reading frame (95-89/95-90, See Table 2.5 for details) 
with genomic DNA frompitB::CatR donor strain AN3901, the recipient 
strains AN3020 (pitAJ iJpstC345) and AN2537 (iJpstC345) and two 
isolates of each of the Pl transduction products AN3902 (pitB::CatR 
pitAJ iJpstC345) and AN3926 (pitB::CatR iJpstC345). pitB is 1.5kb in 
size while pitB: :CatR is 2. 7kb. 
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causes a positive response in the rapid spray alkaline phosphatase assay when it is 
performed on cells grown on rich media. Inactivation of wild type pitB was confirmed 
by PCR, as described in Section 5.2 (Figure 5.4). 
This new strain, AN3926, which contains wild type pitA and nonfunctional pitB and pst 
was able to grow on Pi media. This Pi uptake activity can be attributed to PitA, as the 
pitA pitB: :Catr pstC triple mutant, AN3902, cannot grow on Pi media. The ability of 
pitA+ strain AN3926 to transport Pi shows that genomic pitA is expressed in the 
presence of a mutated pitB gene and that the PitA protein can transport Pi in the 
absence of PitB. 
5.3.Z Expression of plasmid-borne pitA or pitB in a Pi 
transport triple mutant strain 
Wild type pitA or pitB plasmids transformed into the pitA pitB: :Catr pstC triple mutant 
AN3 902 could restore growth on Pi media, as they did in AN3 066, confirming that 
both PitA and PitB can transport Pi independent of each other. 
5.11 Expression and activity of wild type pitB 
5.'l-.1 Variability of pitB kinetic parameters Kmapp and 
V maxapp 
The lack of Pi transport from the genomic wild type pitB located on AN3 066 indicates 
that pitB may be repressed and/or inhibited under certain conditions. In addition, the 
maximum apparent velocity (V max arr) and the apparent Km (Km arr) of the PitB protein 
were unexpectedly altered by reducing the DNA upstream of the pitB ORF from 1403 
to 207 nucleotides. 
pitB was isolated on a ClaI/BamHI cosmid fragment and subcloned into vector pBR322 
with 1403 nucleotides of genomic DNA upstream of the open reading frame to form 
pAN656. pANl 116 was created by subcloning pitB on a SspI/ClaI fragment into the 
EcoRV!ClaI site of pBR322 (Figure 5.5). This reduced pitB 's upstream genomic DNA 
from 1403 to 207 nucleotides, removing restriction endonuclease sites, which would 
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Figure 5.5 
Plasmid diagrams for pAN656 and pAN1116. 
Wild type pitB with either 1403 (pAN656) or 207 (pANl 116) genomic 
nucleotides upstream of the putative pitB open reading frame. 
pitB was isolated on a cosmid Clal/BamHI fragment (Harris et al (89)) and 
ligated into the Clal!BamHI of pBR322, creating pAN656. This plasmid was 
constructed by Dianne C. Webb. 
The SspI/BamHl region of genomic DNA upstream of the pitB open reading 
frame was deleted by removing pitB from pAN656 on an Sspl/Clal fragment, 
and ligating it into pBR322 digested with EcoRV/ClaI, producing pANl 116. 
BamHI 
pAN656 
7kb 
Clal 
pitB 
Sspl 
pAN1116 
6kb 
\ 
/ Clal 
/ 
pitB 
EcoRV/Sspl 
interfere with the production of pitA/pitB chimeras (Section 6.4). Pi uptake assays on 
these plasmids showed that removal of these 1196 nucleotides increased the V max app by 
four-fold (Table 5 .1 ). The variability in V max app recorded from individual experiments 
was also reduced as shown by the decrease in error values between pANl 116 (pitB 
short) and pAN656 (pitB long). This reduction in V maxapp variability was greater than 
these error values suggest, as five experiments with pAN656 produced Pi transport 
activity too low to calculate a ~app' thus were not included in Table 5.1. pANl 116 
never produced very low Pi transport activity. 
This reduction in pitB 's upstream DNA also decreased the Kmapp of PitB 5-fold (Table 
5 .1 ), a significant change that cannot be ascribed to experimental variation. Km app is 
normally expected to remain constant even if the V max app is greatly altered as Km app 
effectively represents the characteristic mechanism of the transporter. This alteration in 
Km app indicates that the transport mechanism of PitB has changed. 
Different plasmid constructs may change the copy number of a gene or the amount of 
transcription, thus altering the levels of protein expression and the maximum apparent 
velocity (V maxapp) of a transporter in whole cell assays. Alternatively, modifications 
may occur at the protein level, such as oligomerisation or the interaction with 
activators, which alters both the PitB V maxapp and Kmapp, or a combination of the above 
may take place. To determine if the increase in V maxapp and the reduction in Kmapp 
correlated with an increase in protein expression, the levels of PitB protein inserted in 
the cell membranes of strains containing either pAN656 or pANl 116 were compared. 
5.1/-.2 PitB antipeptiae antibody production 
Polyclonal antipeptide PitB antibody was prepared to visualise the PitB protein. The 
peptide used is in the equivalent position to the PitA peptide, and forms part of an 
extramembranous loop in the putative folded structure (Figure 3 .15). Initially, antibody 
preparation was attempted by immunising rabbits with a multiple antigen peptide 
system (MAP) conjugate consisting of the peptide DRIHRIPEDRKKKKC attached to a 
polylysine core via a C-terminal cysteine, as prepared for PitA. However, this MAP 
conjugate failed to produce an antigenic response in several rabbits , whose sera was 
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TABLE 5.1: Kinetic parameters for PitB with either the long or short upstream 
nucleotide sequence. 
Plasmid a Phenotype Assay conditions 
pH [Mg] mM 
pAN656 pitB+ longc 6.6 1.8 
pAN656 pitB+ longc 7.0 10.0 
pANl 116 pitB+ shortd 7.0 10.0 
· a host strain is AN3 066 for all experiments 
b SEM 
c 1403 upstream nucleotides 
d 207 upstream nucleotides 
K appb 
m 
µM 
28.6+ 1.4 (n=5) 
28. 1 + 1.0 (n=3) 
Vmaxappb 
nmol Pi min-1 
mg dry weighf 1 
33+9 (n=S) 
17+3 (n=3) 
6.0+0.5 (n=3) 67+2 (n=3) 
screened by ELISA and by Western blot against cell membrane fractions. The PitB 
peptide was then attached to maleimide activated keyhole limpet hemocyanin and this 
conjugate was used for immunisation as described in Section 2.13.2. Detection of sera 
antibodies to PitB was carried out by a W estem blot against the membrane fractions of 
AN3066 containing either vector (AN3514), wild type pitA (AN3531) or the long pitB 
plasmid (AN3135) (Figure 5.6). A protein of approximately 45kDa was detected in 
AN3135 (long pitB plasmid) exposed to post-immune sera which was not present in 
either the pitA plasmid strain or the background strain. No protein at an equivalent 
position was visible in the AN3135 membrane fractions exposed to pre-immune sera. 
While PitB protein has a deduced molecular weight of 53.5kDa, in vitro 
transcription/translation carried out on wild type pitB plasmid pAN909 also produced a 
protein at approximately 45kDa which was negligible in its control (Figure 3.6) and 
many membrane proteins undergo anomalously fast migration during electrophoresis. 
The western blots of most sera samples revealed several other strong bands of protein. 
These were approximately uniform in intensity for each strain, and were also present in 
the pre-immune sera, indicating that nonspecific binding by other polyclonal antibodies 
was occurring. Therefore PitB antipeptide polyclonal antibody was purified from 
pooled sera by immuno-affinity purification following selective ammonium sulfate 
precipitation, as described in Section 2.13 .4, greatly decreasing the presence of 
nonspecific bands. There was no cross-reactivity of this purified antibody with the 
PitA protein, as shown in lane 5 of Figure 5.7. 
5.4.3 Investigation of PitB protein expression 
Strains with no Pi uptake containing vector pBR322 and either genomic pitB::Catr 
(AN3903) or genomic wild type pitB (AN3514) in the pitAJ 11pstC345 background 
were analysed by western blot for the presence of PitB protein (lanes 1 and 2 - Figure 
5. 7). Only negligible levels of PitB protein could be detected by polyclonal antipeptide 
PitB antibody in the membrane fractions of these strains. Therefore genomic wild type 
pitB does not express PitB protein in a pitAJ iJ.pstC345 background, and the lack of Pi 
uptake is due to the absence of protein rather than the presence of an inactive protein. 
In these circumstances the presence of genomic wild type pitB gene is indistinguishable 
from pitB: :Catr for both PitB function and PitB protein expression. A strain with wild 
type pitA on a plasmid was also included in this western blot, to show that the PitB 
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Figure 5.6 
Western blot analysis of polyclonal PitB antipeptide antisera 
against PitA and PitB protein. 
The membrane fractions of the Pi auxotrophic strain AN3066 containing 
the plasmids pBR322 (vector), pAN920 (PitA) or pAN656 (PitB) were 
solubilised and separated by PAGE on a 10% polyacrylamide gel and 
transferred onto PVDF membrane. Protein was visualised by incubation 
with either preimmune sera or sera taken after immunisation with 
conjugated PitB peptide/keyhole limpet haemocyanin, followed by 
incubation with alkaline phosphatase conjugated goat anti-rabbit secondary 
antibody and the application of Western blue alkaline phosphatase 
substrate. 
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Figure 5.7 
Western blot analysis of PitB protein expression from 
various strains using purified polyclonal PitB antipeptide 
antibody. 
The membrane fractions of the strains listed below wer solubilised and 
separated by PAGE on a 10% polyacrylamide gel and transferred onto 
PVD F membrane. Protein was visualised by incubation with pol yclonal 
PitA antipeptide antibody, followed by incubation with alkaline 
phosphatase conjugated goat anti-rabbit secondary antibody and the 
application of Western blue alkaline phosphatase substrate. Plasmid 
containing pitB (long) has genomic DNA for 1403 nucleotides upstream of 
the open reading frame while pitB (short) has 207 nucleotides. 
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antipeptide polyclonal antibody had no cross reactivity with PitA protein. The absence 
of a band at approximately 48kDa indicates that genomic pitB does not express PitB 
protein in a tdpstC345 background, as well as the pitAJ tdpstC345 background. 
Western blots were also used to visualise the PitB protein in the membrane fractions of 
the above background strains containing either pAN656 (1403 upstream nucleotides) or 
pANl 116 (207 upstream nucleotides) (lanes 3 and 4 - Figure 5.7). The presence of 
plasmid pAN656 (wild type pitB plus 1403 upstream nucleotides) resulted in low levels 
of PitB protein in the cell membranes, while large amounts of PitB were produced 
when the upstream pitB DNA was decreased to 207 nucleotides in pANl 116. When 
the length of upstream DNA of pitB was decreased by 1196 nucleotides the V max app 
increased 4-fold (Table 5 .1 ). Therefore this western blot showed that the higher Pi 
uptake activity from pANl 116 correlated with increased PitB protein expression. 
However, the increase in PitB protein expression was much greater than the 4-fold 
elevation in V max app noted in uptake experiments (Section 5 .4.1 ). 
5.5 Regulation of pitB 
5.5.1 Deletion of the phoB-phoR operon from pitAJ 
i1pstC345 strains with/without genomic pitB 
The pho regulon consists of many genes involved in phosphate assimilation that are 
induced via activation of the phoB-phoR two component regulatory system when 
external Pi concentrations are limiting. This regulon may also include genes that are 
repressed under these conditions (271, 291) such as the Pit-like Pi transporter of 
Rhizobium meliloti (8). The potential regulation of pitB by the phoB-phoR operon was 
investigated by mutating the phoB-phoR operon of AN3020, which contains a wild type 
pitB and the pitAJ tdpstC345 Pi transport mutations. AN3020 is unable to grow on Pi 
media. The phoB-phoR operon was also deleted from AN3902, the pitB::Catr pitAJ 
11pstC345 triple mutant, which was used as a pitB control. This strain is also unable to 
grow on Pi media. 
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Strain ANCHl contains a phoB-phoR operon deletion which replaces these genes with 
a kanamycin resistance gene (304). This phoB-phoR deletion was transduced into 
AN3020 and AN3902 with bacteriophage Plkc· Transductants were selected by their 
resistance to kanamycin on rich media containing lmM G3P (which prevents selection 
pressure for Pi transport). Inactivation of the pho regulon was determined by testing 
single colonies grown on rich media for phoA activity using the rapid spray alkaline 
phosphatase assay. A negative result indicated that the phoBR operon had been deleted, 
as both AN3020 and AN3902 contain the JJ.pstC345 mutation that causes constitutive 
induction of phoA. These new strains were AN408 l (pitAJ JJ.pstC345 JJ.(phoB-phoR) 
Kanr) and AN4085 (pitB: :Catr pitAJ JJ.pstC345 JJ.(phoB-phoR) Kanr). 
5.5.2 Effect of the pho regulon on pitB activity 
AN3020 and AN3902 have negligible Pi transport and do not grow on Pi media. The 
introduction of the phoB-phoR deletion into AN3020, which contains wild type pitB, 
enabled the new strain to grow on Pi media. Therefore the presence of phoB-phoR does 
repress Pi transport in AN3020 (pitAI JJ.pstC345). However deleting phoB-phoR from 
AN3902, which has a mutated pitB gene, also enabled this new strain to grow on Pi 
media. Thus the inactivation of the pho regulon allowed one or more systems to 
transport Pi in both these strains. No conclusions can be made about the possible 
regulation of pitB through the pho regulon as AN408 I(phoB-phoR pitA pstC) and 
AN4085 (pitB phoB-phoR pitA pstC) cannot be differentiated by a Pi complementation 
test. 
Pi uptake assays revealed that AN4085, which contains no Pit or Pst transporters, had 
Pi uptake that was not significantly above background levels (Table 5 .2, Figure 5. 8). 
However the pitB+ strain, AN4081, had a significant rate of Pi transport. The fact that 
the control strain was able to grow on Pi media but had no measurable Pi uptake may 
be attributed to the difference in Pi concentrations used in these experiments. Growth 
was assessed at 500µM Pi, while Pi uptake was measured at 20µM Pi. Thus, the 
growth of the control strain may be due to the presence of a transport system which has 
a lower affinity for Pi than either PitA or PitB. As the pho regulon contains a large 
number of genes involved in Pi assimilation more than one system may be involved. 
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TABLE 5.2: Effect of the phoBR operon on PitB inorganic phosphate uptake activity 
Strain Relevant Alkaline Growth on minimal media Phosphate 
genotype phosphatase with the following source uptake ct 
activity a of phosphate nmol Pi min-1 
Pi and G3P b Pi c mg dry weighf 1 
AN3066 pitB+ phoB+ 
phoR+ 
pitB+ 
+ + 0.6 + 0.1 
AN4081 + + 
AN4085 + + 
a rapid spray assay on cells grown on Luria Bertani media (22). 
b 500µM Pi and lmM glycerol-3-phosphate. 
c 500µM Pi. 
d assayed at 20µM Pi, SEM, n=4. 
4.4 + 0.3 
0.9 + 0.2 
Figure 5.8 
Effect of the phoB-phoR operon on PitB Pi uptake activity. 
Strains containing mutations in pitA and pstC were analysed for the effect of 
the phoB-phoR operon on pitB activity , by deleting the phoB-phoR operon 
and/or pitB and measuring the initial rates of Pi uptake, using 20µM Pi. 
Shown below are the assays used to determine the initial rates listed in Table 
5.2. These were calculated using four experiments (each having two to three 
individual determinations per time point) by nonlinear regression in the 
Graphpad Prism program. Error bars represent the standard error of the mean 
(SEM). 
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pitB+ strain AN4081 exhibited Pi transport of 4.4nmol Pi min- 1 mg dry weighr 1 at 
20µM Pi. By comparison, Pi uptake by PitB expressed from pAN656 was 5-25nmol Pi 
min-I mg dry weighr 1 at 20µM Pi, and PitB on pANl 116, which produced greater 
protein expression and a lower Km app, had Pi uptake rates of 46-59nmol Pi min- 1 mg dry 
weight-I at 20µM Pi (assay results isolated from Kmapp experiments, data not shown). 
Thus, these experiments show that chromosome-encoded pitB is active in the absence 
of the phoBR operon. 
5.6 Discussion 
Results described here indicate that genomic pitB is regulated. The lack of Pi uptake in 
strains with pitB+ pitAJ ,1pstC345 correlates with negligible levels of PitB protein, 
suggesting regulation is at the level of transcription or translation. This regulation is 
likely to be mediated through the pho regulon, since a deletion which inactivates the 
phoB-phoR operon allows Pi uptake activity that is attributable to the presence of a pitB 
gene. pitB may be directly repressed by PhoB, or repressed/inhibited . by a pho regulon 
intermediate. Alternatively, pitB mRNA may be stabilised. 
Construction of a new background strain, AN3902, which has mutations in all three E. 
coli Pi transporters (pitAJ pitB::Catr t1pstC345) allows independent expression of PitA 
and PitB on plasmids, confirming that both proteins can function independently as Pi 
transporters. In addition, genomic pitA was shown to be free of the regulatory control 
that represses/inhibits pitB in the ,1pstC345 background, as strain AN3926 (pitA + 
pitB: :Catr ,1pstC345) is able to transport Pi. 
PitB activity may be modulated by more than one form of regulation, as deletion of 
DNA 207 nucleotides upstream of pitB 's ORF on plasmid pAN656 unexpectedly 
increased the substrate affinity of PitB for Pi, as well as increasing the maximum 
velocity of the transporter and the level of PitB protein expression. This change in 
Km app indicates that the Pi transporter's mechanism has been altered. 
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While most studies on the pho regulon in E. coli have focussed on the activation of 
genes involved in phosphate assimilation, there is mounting evidence that some genes 
within the pho regulon are repressed. 2D protein experiments have shown that 
conditions of Pi limitation induce about 118 proteins of the pho regulon and repress 
around 19 proteins (all with pl's less than seven) (271). This does not include all 
potentially regulated proteins as many proteins have pl' s greater than seven, such as 
PitA and PitB, which have estimated pls of 9.5 and 9.9 respectively. More specifically, 
Willsky and Mallamy (291) have shown that two proteins which are repressed under Pi 
limiting conditions are not repressed in phoB or phoR strains under the same 
conditions. Smith and Payne (244) propose that these are the periplasmic peptide 
binding proteins OppA and DppA. Putative pho box sequences have been identified 
within the promoter regions of the E.coli opp and dpp operons and the R. meliloti orfA-
pit operon (9, 244). These pho boxes were found in atypical locations when compared 
with genes activated by PhoB. Genes activated within the pho regulon often lack an 
efficient -3 5 promoter region and have a pho box located 10 bases upstream from the -
10 promoter region. A dimer of phosphorylated PhoB interacts with the pho box and 
with the CJ 70 subunit of the RNA polymerase holoenzyme, and seems to create a 
bending of the DNA which may assist in initiation of transcription (159, 191). The 
presence of multiple upstream pho boxes can increase the induction by Pi limitation 
(236). These pho boxes may be placed at regular intervals so that PhoB dimers always 
bind on the same face of the DNA. This has been shown to be the case for the 
formation of efficient catabolite repressor cAMP-CRP binding sites, which occur at 
different locations in a number of promoters ( e.g. -41 gal locus, -65 lac operon ( 145)). 
Those operons which may be repressed within the pho regulon have putative pho boxes 
upstream of the promoter, or overlapping the proposed -35 region, -10 region or within 
the transcribed region. It has been suggested that this atypical positioning may reflect 
the negative regulation by PhoB, but there is no experimental evidence in support of 
this proposition so far (9, 244). Most E. coli transcription repressors are homo-dimers 
which bind to an inverted repeat located betweeen + 30 to -50bp relative to the 
transcriptional start of + 1 ( 152). The position of a transcription factor binding site 
relative to the transcriptional start site of a gene can be critical for the precise effect 
created by this binding. The CreBC two component regulatory system has been shown 
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to activate and repress different genes. Its consensus "ere-tag" binding sequence, 
which is similar in organisation to the pho box, having a highly conserved TTCAC 
repeat separated by six nucleotides, occurs between -40 and -80 in Aeromonas genes 
which are activated by this regulon when expressed in E. coli. However the putative 
ere-tag binding site of malE, which is repressed by the ere regulon, is downstream (i.e. 
within the transcript) of the transcription start site (7). Atypical binding sites can also 
cause repression by activating a divergent promoter (87, 134, 148, 285). While most 
members of the TyrR regulon have two adjacent TyrR boxes overlapping the putative 
RNA polymerase binding site of the principal promoter P 1, the amino acid transporter 
aroP has two adjacent TyrR boxes that are downstream from and outside this binding 
site. This allows TyrR-mediated activation of a divergent promoter, P3, located on the 
opposite DNA strand, which directs the RNA polymerase away from promoter Pl 
(279). Dual activation/repression functions are also carried out by the cl repressor 
protein of lambda phage. Dimers bind to the PRM, PR/OR regulatory region, repressing 
the PR promoter which controls transcription along one strand, while activating the PRM 
promoter to transcribe the cl mRNA in the other direction (145). Thus, atypical 
positioning of pho boxes in pho regulon repressed genes is a feasible mechanism of 
. 
repression. 
It is useful to examine the promoter regions of pitA as well as pitB for putative pho 
boxes, as pitA is reported to be constitutive (211, 212, 249, 289) and seems unaffected 
by changes in the pho regulon. Therefore potential inhibitory pho boxes should be 
unique to pitB 's regulatory region. The identification of the RNA polymerase 
promoters for pitA and pitB is necessary to determine if these potential pho boxes have 
an atypical location. The E. coli cr 70 RNA polymerase promoter consists of two 
consensus hexamers separated by a spacer of 1 7 nucleotides centred at -10 and -3 5 
nucleotides from the site of transcription initiation. Other nucleotides around these 
hexamers are also conserved, giving a consensus E. coli promoter of 
AAATAATTCTTGACAT(l lbp spacer)TTTGGTATAATACA, where the-10 and-35 
consensus hexamers are underlined. A search for potential RNA polymerase promoters 
in pitA and pitB was carried out with the computer program MacTargSearch. Several 
of the highest matching possible promoters for pitA and pitB are listed in Table 5.3. 
The underlined sequences are identical between pitA and pitB, or contain only a GI A 
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TABLE 5.3: Comparison of putative RNA polymerase promoter sequences 
Sequence Location a E. coli promoter sequenced 
(bp) 
consensus 
pitA 
pitB 
34c 
34c 
84 
85 
-35 Regionb 
AAATAATTCTTGACAT 
ATATTTCACTTTGCCC 
TATTTCACTTTGCCCG 
AATTATTTTTTGAGTG 
AATTATTTTTTGAGTG 
ATATTTCACTTTGCCC 
TATTTCACTTTGCCCA 
AAATGATATTTCACTT 
ATAACACTCTTTTTAT 
ATTGTCTGATACACAA 
Spacer -10 Regionb 
11 bp TTTGGTATAATACA 
12 bp 
11 bp 
11 bp 
10 bp 
12 bp 
11 bp 
11 bp 
11 bp 
11 bp 
TCACTGATAATGCG 
TCACTGATAATGCG 
GGGGGCAAATCAAA 
AGGGGGCAAATCAA 
TCACTGATAATGCG 
TCACTGATAATGCG 
TTAAAGTCACTGAT 
GATATTTCACTTTG 
CTTTTTATCGTTAA 
a number of nucleotides from the 3' end of the -10 region to the ORF start 
b italised nucleotides represent the -3 5 and -10 consensus hexamers 
Simila 
. e 
-nty 
(%) 
100.0 
48.5 
50.3 
50.3 
47.3 
48.5 
51.5 
43.8 
46.2 
47.9 
c underlined sequences are the putative pitA and pitB promoters that are identical or very similar 
d from Mulligan et al (179) and Goodrich et al (76) 
e calculated by MacTargsearch from consensus sequence information 
difference in the last nucleotide of the -35 region. These two matches form virtually 
the same promoter, as the only difference is the -35 region being displaced sideways by 
one nucleotide. When the regulatory regions of pitA and pitB are aligned, the 
underlined putative promoters have high sequence identity while being surrounded by 
sequence with lower homology (Figure 5.9). This homology decreases drastically 
upstream of these putative promoters. Whilst these promoters are speculative, they will 
be considered in the search for a unique pitB pho box. 
The 18 nucleotide p ho box consensus sequence consists of 5 ' -
CTGTCA TA(A/T)A(T / A)CTGTCA(C/T)-3 ', where the nucleotides in bold form the 
direct binding sites for phosphorylated PhoB (159). Further details on the pho regulon 
can be found in Section 1.4. The computer program MacTargsearch was used to look 
for putative pho box sequences in the regulatory regions of pitA and pitB. Several 
possible pho box sequences with atypical positioning in relation to the putative RNA 
polymerase promoters on either DNA strand were revealed (Table 5.4). However, there 
is no obvious pho box unique to pitB. Either pitA and pitB have similar pho box 
sequences in the equivalent locations, or there are several pho box sequences with 
similar degrees of identity within the immediate vicinity. Any potential pho box 
involved in negative regulation should be unique to pitB, as pitA is not repressed by the 
pho regulon. Therefore a simple analysis of the regulatory regions of pitA and pitB 
does not reveal a putative pho box sequence unique to pitB that could be involved in its 
repression. It should be emphasised that the binding sites for PhoB repression have not 
been characterized for any gene, so other DNA motifs may be involved. Analysis of 
the ere regulon has revealed that some activated genes contain only half of a "ere-tag" 
(7). While the active form of PhoB is a phosphorylated dimer, the presence of 
inhibitory "half sites" cannot be ruled out. Thus, DNA binding studies will be needed 
to locate any PhoB interactions with the pitA and pitB genes. 
Increasing the copy number of pitB by placing it on a plasmid may titrate out pho 
regulon mediated repression, allowing the Pi uptake we have observed with plasmids 
pAN656 and pANl 116. This titration effect has been recently observed by Hoffer et al 
(99), who analysed a pseudorevertant of a Pi auxotrophic pitA pstS strain that conferred 
the ability to grow with Pi as the sole source of phosphate. They demonstrated that Pi 
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Figure 5.9 
Alignment of pitA and pitB putative RNA polymerase 
promoter sequences. 
Highlighted in red is the putative RNA polymerase promoter sequence 
that is identical between pitA and pitB. The open reading frame of each 
gene is highlighted in green. A second putative RNA polymerase 
promoter alters the -35 region by one base, so there is a G/ A difference 
between pitA and pitB, highlighted in blue, and the spacer region is one 
base shorter. (The -10 region is identical - see Table 5.3 for details.) 
-35 region 
PitA 473 -----ACAGGGGGCAAATCAAAAAAAGTCTATATTTCACTTTGCCCGCGC 
PitB 1297 AAATAACACTCTTTTTATCGTTAAAAAATGATATTTCACTTTGCCCATGC 
*** *** **** *************** * ** 
-10 region 
PitA 518 CGCGAAAGTCACTGATAATGCGCCGCGTTCATGTCCTAAAATGGCGTAAC 
PitB 1347 CGTTAAAGTCACTGATAATGCGTCCGTTCGTAAATTCAAAATGGCGTAAT 
** **** ************** * * ************ 
open reading frame 
PitA 568 GT--CCT~\TG\ Tt\{~ATTI't..;T"_,_'l'__;r <7 ,,_:rc_: 1 'J\TT' r7 r_ l'''r: ~c 
PitB 1397 CTAATAT · _::ic,;TA!\l\.' 'Tll"T'f lc' r ,G 'I'I ·,,_r\r,; .l1 'i.CAC' _,I- 1 1 
* 
TABLE 5.4: Comparison of putative pitA and pitB pho box sequences 
Sequence Location a pho box sequence b Similarity Identity 
(bp) C 
(%) (binding site) all 
a CTGTCATAPATCTGTCAC 100.0 Q_Q_) 18 consensus 
TA T 
pitA-1 pe 2 CTATGCTACATTTGTT'IG 25.4 ill 10 
pitB-1 F 9 CTCTAATATATGCTAAAT 22.4 ill 10 
pitA-2 F 80 TCTATATTTCACTTTGCC <10 ill 8 
pitB-2 F 77 ATGATATTTCACTTTGCC 20.9 ill 10 
pitA-3 R 97 CTTTTTTTGATTTGCCCC 25.4 ill 10 
pitB-3 R 105 CGATAAAAAGAGTGTTAT 22.4 ® 1 1 
pitA-4 F 122 TTATTTTTTGAGTGAAAT 19.4 ill 9 
pitB-4 F 121 GTCTGATACACAAGAAAT 20.9 ill 9 
pitA-5 R 140 TTATCTTATATAATTCAG 31.3 .(fil 10 
pitA-6 R 144 CTTATATAATTCAGGCAA 29.8 ill 1 1 
pitB-5 R 134 CAGACAATAAGCATTCAT 26.9 .(fil 1 1 
a number of nucleotides from the upstream side of the putative pho box to the ORF 
start (i.e. 5' end of+ strand sequences, 3' end of - strand sequences) 
b italised nucleotides represent the PhoB direct binding sites 
C calculated by MacTargsearch from consensus sequence information 
d from Wanner, B.L. (280) 
e located on the Forward ( + strand) or Reverse (- strand) of the DNA 
transport was linked to the presence of multiple genomic copies of pitB, caused by an 
IS5 mediated DNA rearrangement. (The number of pitB repeats was not identified.) 
Transcriptional repression by PhoB has already been observed for a pitB-like pit gene 
in Rhizobium meliloti, using a pit. :lacZ fusion. The R. meliloti pit gene was repressed 
under conditions of Pi limitation but this repression was relieved in a phoB mutant (8). 
As in E. coli, mutating a Pst transport system equivalent (phoCDET) caused 
constitutive expression of the pho regulon, repressing pit at all Pi concentrations. This 
mechanism of repression may also explain the Pi uptake observed from pitB located on 
various plasmids and cosmids. Transforming a phoC R. meliloti strain with plasmid-
borne pit increases cell growth on high Pi media to normal levels, suggesting that the 
repression can be overcome by supplying multiple copies of the gene. Repression was 
also overcome by a single thymidine deletion 54 nucleotides upstream of the or/A-pit 
operon transcription start site which increased the level of or/A-pit transcription (9). 
Only a two- to three-fold increase in pit expression was needed to suppress the phoC 
phenotype, overcoming the effects of constitutive expression of the pho regulon. 
Further investigation of pitB transcription, using Northern Blots or by replacing 
genomic pitB with a reporter gene such as lacZ is required. 
pho boxes in activated proteins can overlap the binding sites for other transcription 
factors such as cAMP-CRP (120). The putative pho box in R. meliloti, which may 
repress pit, overlaps a hepta-thymidine repeat. Deletion of a thymidine from this repeat 
was shown to increase the transcription of pit, allowing Pi uptake to occur in a phoC 
strain (9). A search for an equivalent regulatory region to this hepta-thymidine repeat 
revealed that pitA has a 6 thymidine repeat 117 nucleotides upstream of the ORF, while 
pitB has a 5 thymidine repeat 94 nucleotides upstream of the ORF. As pitB undergoes 
some form of repression and the presence of a 5 thymidine repeat was associated with 
an increase in the transcription of R. meliloti pit, there is no obvious connection 
between these sequences and the expression of pitA or pitB. 
Post-transcriptional regulation enhancing mRNA stability is a less common, but viable 
alternative to increasing protein expression through transcriptional activation. 
Increased stability of mRNA has been shown to occur for the Pi transporter PiT-2 in 
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human cell lines, as a response to Pi depletion (3 5). Thus, this mechanism cannot be 
ruled out for pitB. 
PitB may also undergo further regulation. Decreasing the length of pitB 's upstream 
DNA from 1403 to 207 nucleotides unexpectedly decreased the Kmapp five-fold, from 
28µM to 6µM, making PitB Pi transport more efficient at lower concentrations of Pi. 
This DNA deletion also raised the V maxapp four-fold, showing the overall level of PitB 
activity had also increased. Kmapp effectively represents the characteristic mechanism 
of a transporter, and is expected to remain constant even when the protein's level of 
expression changes. PitB' s decrease in Km app indicates a different mode of enzyme 
activity is occurring in the protein expressed from the shortened plasmid pANl 116. 
There are a variety of ways that a protein's mechanism can be altered, and these usually 
involve post-translational modification. The increase in PitB protein expression may 
dilute out an inhibitor, which interacts with the PitB protein, or may allow the transport 
protein to form a homo-oligomeric complex with a more effective mechanism. 
Although most secondary transporters are thought to function as monomers, this is not 
always the case. The sodium proton antiporter from E. coli has been crystallised as a 
dimer (288), and exists in the cytoplasmic membrane as a homo-oligomer (73). 
Glutamate transporters from the human brain have been shown to form dimers and 
trimers (90). While lactose permease has been shown to function as a monomer ( 40), 
mutants with large deletions are able to complement each other, allowing the possibility 
that the wild type permease may form oligomers ( 16). There are also several examples 
of transporters that have dual-affinity for their substrate and/ or two mechanisms (71, 
123, 147,241,309). Further investigation is needed to determine if this applies to PitB. 
There are already clear examples of multiple levels of regulation in other members of 
the PiT family. The expression of mammalian Pi transporter PiT-2 (which is also a 
receptor for amphotropic murine leukemia virus) is increased by phosphate starvation, 
but this is not its only form of regulation. Only a fraction of PiT-2 molecules at the cell 
surface are capable of processing virus entry, suggesting that the receptor may have 
active and inactive forms (10). Rodrigues et al (207) propose the PiT-2 monomer may 
be inactive. As Pi concentrations decrease PiT-2 molecules associate with the actin 
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cytoskeleton network and form high molecular weight complexes. Salaun et al (229) 
suggest that these may be post-translational changes important for receptor activity. 
Modulation of Pit activity by a second protein is a distinct possibility. The pit gene of 
Rhizobium meliloti forms part of the or/A-pit operon. OrfA, also known as the Pit 
accessory protein, is transcribed at around three times the levels of pit, by lacZ reporter 
gene studies (8). Currently its function is unknown, but a Blastp search (NCBI) shows 
that similar proteins are found in a number of prokaryotes and archaea, including 
Pseudomonas aeruginosa, several Listeria and Pyrococcus species, Agrobacterium 
tumefaciens, Haemophilus influenzae, Clostriduim acetobutyli, Vibrio cholerae and 
Archaeoglobus fulgidus, as well as one human example. The prokaryotic genes are all 
closely associated with putative pit genes whose proteins have some identity to PitA 
and PitB. Most pit genes start within 20 bases of the associated protein's ORF, 
suggesting they are part of the same operon. Slight variations occur in Mesorhizobium 
loti, which has two "Pit accessory protein" genes preceding a pit gene and Bacillus 
subtilis where the pit gene occurs before the accessory protein gene. While the "Pit 
accessory proteins" are linked to a pit gene, not all pit genes are associated with 
"accessory protein" genes. Blastp and tBlastn searches (NCBI) produced no matches 
for "Pit accessory protein" in E. coli and neither pitA nor pitB are closely linked to any 
other gene. This "accessory protein" could potentially regulate transcription or cause 
post-translational changes to Pit, or may be involved in another aspect of Pi 
metabolism. 
Western blots using PitB polyclonal antipeptide antibody showed that the four-fold 
increase in V max app' from 1 7-67nmol Pi min-1 mg dry weighr1, correlated with 
increased PitB protein expression in the cell membranes. This increase in expression is 
not unusual. Different plasmid constructs may change the copy number of a gene or 
the amount of transcription, altering the levels of protein expression and the V max app of 
a transporter in whole cell assays. For example, moving pitA from a single copy to a 
multicopy plasmid increased Pi uptake activity at S0µM Pi by 10-fold (59), and genes 
can be inserted behind strong promoters such as the tac promoter, to increase 
transcription. However, the increase in PitB protein expression was much greater than 
the four-fold elevation in V max app noted in Pi uptake experiments. This variation may 
99 
be due to the different growth conditions used. Pi uptake assays were carried out on 
cells grown in minimal media while the cells used in western blotting were cultured in 
Luria Bertani media. The difference in Pi concentrations and other nutrients may have 
had unintended effects on the regulation of Pi transport. For example, many members 
of the pho regulon, which is constitutively activated in these cells, are also regulated by 
the cell's carbon and energy sources and the state of the cells metabolism. Analysis of 
phoR mutants also indicates that regulation of the pho regulon may sometimes be 
influenced by these factors (120, 125, 255, 280). 
The increase in PitB V max app was also accompanied by a noticeable reduction in the 
variability of V maxapp between individual experiments. This stabilisation in V maxapp 
was greater than suggested by the standard errors of the mean (SEM) listed in Table 
5.1, as pAN656 (pitB long) often produced Pi uptake activities too low to allow the 
calculation of Kmapp or V maxapp_ These assays on pAN656 may have been carried out 
under conditions where the regulation of pitB was finely balanced, and small changes in 
growth conditions may have lead to big changes in protein expression. The altered 
DNA sequence on pANl 116 may have allowed pitB to overcome the finely balanced 
repression which often left PitB activities from pAN656 too low to measure accurately. 
Research on the pit equivalent in Rhizobium meliloti noted that only a two- to three-fold 
increase in pit expression was needed to overcome suppression (9). Unfortunately, the 
levels of PitB protein expression in whole cells was not measured for each 
V maxappfKm app determination. 
Thus, the deletion of DNA 207 nucleotides upstream of the pitB ORF altered both the 
expression levels and the mechanism of PitB activity, possibly by increasing the levels 
of pitB transcription. While it is unlikely that this deletion affected the pitB promoter 
and any regulatory sequences immediately surrounding it, the excised 1196 nucleotides 
does contain a putative mRNA transcription terminator (294). This consists of a large 
stem loop followed by a sequence rich in T and A nucleotides that is appropriately 
positioned after a large ORF which has the same orientation as the pitB ORF (Figure 
5.10). Removing this stem loop sequence from pAN656 could increase pitB 
transcription by allowing continuation of any mRNA initiated at the plasmid's 
ampicillin resistance gene. There is previous evidence for plasmid-borne gene 
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Figure 5.10 
Structure of the putative stem loop sequence that is 
present in the upstream DNA of pitB on plasmid pAN656, 
but which is removed on plasmid pAN1116. 
The AT rich region continues after the stem loop structure shown below. (See Figure 4. IB for more sequence details.) 
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expression from non-specified promoters within a vector. The F 0F 1-ATPase uncF gene 
lacks its own promoter, as it forms part of the F0F 1-ATPase operon. This uncF gene 
could restore the ability of an uncF mutant strain to grow on succinate as the sole 
carbon source when it was placed in plasmid pUC 18 in the opposite orientation to the 
lac promoter on this vector (206). While the increase in PitB activity and substrate 
affinity is an interesting result it is also the response to an artificially induced situation 
that may have little relevance to PitB regulation in a wild type cell. As such, the 
mechanism causing increased PitB protein expression from pANl 116 was not 
investigated further. 
While pitA is not modulated by the pho regulon, it is possible that PitA undergoes some 
form of regulation. PitA's substrate affinity may change when protein expression is 
increased, as is the case for PitB. Western blots indicate PitA protein expression was 
greatly elevated by placing it on plasmid pBR322 (AN248 and AN353 l, Figure 4.5), 
and Elvin et al (59) showed that initial rates of Pi uptake increased ten-fold when pitA 
was transferred from a single copy to a multicopy plasmid. The Kmapp obtained from 
plasmid-borne PitA was around 2 µM, significantly lower than the l l.9-38µM range 
recorded by researchers using genomic pit genes (211, 290, 268). Further 
experimentation is needed before any conclusions can be made, as these Km app values 
for genomic pit have been measured under a variety of conditions that make it 
impossible to attribute activity to pitA and/or pitB. 
While our results indicate that PitA is likely to be active under a greater variety of 
conditions than PitB, and that both transporters can function independently, these do 
not rule out the possibility that a population of PitA and PitB proteins may interact to 
form a Pi transporter complex in wild type cells. 
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Chapter six 
Investigations into the Structure 
and Function of PitA 
Chapter • SIX 
Investigations into 
Function of PitA 
6.1 Introduction 
the Structure and 
When studying the mechanism of a transporter it is helpful to know the protein 
structure, so that side chains likely to be involved in the mechanism can be identified 
and examined. However only a few membrane protein structures have been resolved to 
atomic resolution and currently none is an ion-coupled transporter. Therefore other 
methods of analysis must be used. Topology prediction programs utilise the unique 
features of membrane proteins to propose a basic secondary structure from the amino 
acid sequence. Further analysis of the protein can then be explored through 
experimentation. 
At the time that PitA and PitB were being analysed, site-directed mutagenesis was 
·being used to elucidate the important amino acids involved in lactose/H+ symport by 
lactose permease. The possibility that PitA, which imports a neutral MeHPO4 complex 
with a proton (268), may have a similar proton translocation/coupling mechanism to 
lactose permease was worth exploring. Below is a summary of the work carried out on 
lactose permease that led to the proposed topological and functional models for PitA 
and PitB. Current models for the mechanism of lactose permease are described in 
Section 1.9.2 of the general introduction. 
Chemical modification studies showed that histidine residues may be important in 
coupling proton and lactose translocation. Replacement of His-322 with neutral or 
positively charged amino acids caused severe loss of activity. H322R carried out 
facilitated diffusion without proton translocation (117). Glu-325 is located one turn 
away on the same face of the putative ex-helix and was mutated to neutral side chains 
which gave mutants exhibiting no active transport or efflux but that were able to 
undergo wild type levels of exchange and counter flow (29, 30). Therefore these 
mutants have no proton translocation and are probably unable to release protons. 
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Kaback proposed that His-322 probably undergoes protonation/deprotonation during 
symport, and that His-322 and Glu-325 may be components of a charge relay system 
coupling lactose and proton transport (117). 
Mutagenesis of Arg-302, which is located on putative a-helix 9, showed that mutants 
with various amino acid substitutions for Arg-302 behaved similarly to the equivalent 
His-322 mutants. Thus Arg-302 may also be involved in the putative charge relay 
pathway (171). Lys-319 was analysed as it is located one tum away from His-322 on 
a-helix 10, in the opposite direction to Glu-325. Neutral substitutions for Lys-319 
produced mutants with no active transport or efflux that exhibited wild type exchange 
and counterflow. The similarity of these mutants to those produced by neutral 
substitutions for Glu-325 indicates that Lys-319 may also be involved with proton 
translocation, either directly or by modulating proton transfer capabilities of nearby 
residues (209). 
Second site suppressor experiments have identified complementary mutations for 
detrimental mutants, such as the neutral substitution K319L. This approach identified 
potential interactions between Lys-319 and Asp-240 or Glu-269 (142, 143). 
Mutagenesis studies showed that the neutral combination of K319C/D240C had activity 
and normal protein assembly. Therefore this pair may interact as a salt bridge, and 
these results imply that K-319 is not directly involved in proton translocation. 
However, the polarity of the interaction could not be interchanged, so the local charges 
on Lys-319 and Asp-240 are important for normal functioning, possibly by affecting 
the proton transfer characteristics of nearby side chains (222). 
Second site suppressor experiments also discovered a putative Asp-237/Lys-358 salt 
bridge when neutral suppressor mutations for the detrimental mutant K3 5 8T formed at 
Asp-237 (127). Neutral substitutions at both residues produced an active transporter 
with low levels of protein insertion in the membrane, indicating that Lys-358 and Asp-
23 7 may form a salt bridge. The Asp and Lys residues could be interchanged, 
suggesting that the charge of neither residue of the salt bridge is important (52, 127). 
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These experiments suggest that amino acids involved in the mechanism of lactose 
permease may include Glu-325, His-322 and Lys-319 on ex-helix 10, plus associated 
groups Glu-269 on ex-helix 8, Arg-302 on a-helix 9 and Asp-240 on ex-helix 7. 
Interactions have been proposed between His-322/Glu-325, His-322/Arg-302, Lys-
319/ Asp-240, Lys-319/Glu-269 and possibly Lys-319/His-322. These amino acids are 
highlighted in Figure 6.1. No sulfhydryl/disulfide interconversions are needed for the 
symport mechanism, and no proline residues were found to be essential for activity 
(209). 
This chapter aims to formulate putative topological models for PitA and PitB using the 
available tools for secondary structure prediction from amino acid sequence. Residues 
similar to amino acids involved in the mechanism of the model transporter lactose 
permease will also be taken into consideration. The functional importance of various 
amino acids which these models identify as significant will then be examined in PitA. 
PitA/PitB chimeric proteins will be used to analyse the effects of amino acid 
differences between these two Pi transporters. Conserved residues and domains within 
the recently compiled PiT transporter family will then be considered in the light of 
these findings. 
6.2 Putative topological models for PitA and 
PitB 
A topological model has been formed for PitA based on the GES hydrophobicity profile 
and predictions from the programs TopPre:d IV and MEMSAT (Figure 3.15). These 
programs try to reduce the number of charged or polar residues inserted into the 
hydrophobic environment of the membrane. However, charged or polar residues often 
play an important mechanistic role in membrane protein transporters. These side 
chains may insert into the membrane as uncharged, polar groups or interact with each 
other to reduce the degree of charge within the hydrophobic environment, by forming 
salt bridges ((305) and references therein). Therefore polar and charged residues may 
be under-represented in the membrane regions of the suggested models. Studies on 
lactose permease, a model protein for symporters energised by the proton-motive force, 
show that it has three residues on ex-helix 10 which may play a role in the active uptake 
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Figure 6.1 
Important charged residues in the lactose permease model. 
The secondary structure of lactose permease, based mainly on hydropathy analysis. 
The single letter amino acid code is used. Hydrophobic transmembrane helices are 
shown in boxes. The charge pairs between Asp-237 and Lys-358 and Asp-240 and 
Lys-319 are highlighted in green. Other key amino acids are highlighted in red, 
including Glu-269, Arg-302, His-322 and Glu-325. (Lys-319 is also part of this 
group.) 
This diagram is modified from Jung et al (114). 
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of lactose/ H+ (116). These residues, Lys- 319, His-322 and Glu-325, may be next to 
each other on the same face of this ex-helix (KxxHxxE). PitA has three similar 
residues, His-225, Asp-229 and Lys-232, which are located in the periplasm of the 
TopPred IV models. When placed within an ex-helix, these residues would also line up 
on the same face of the ex-helix (HxxxDxxK). Equivalent residues are found in PitB 
and for simplicity, only PitA will be considered here. 
Thus, two alternative topological models for PitA have been formulated by modifying 
the model produced by von Heijne's TopPred IV program to insert these three charged 
and polar residues within the membrane as part of a-helix 6 (Figure 6.2). These 
models are very similar for the first half of PitA and follow the topology predicted by 
TopPred IV for the first 5 transmembrane (TM) segments and the first four hydrophilic 
loops (Table 6.1). TopPred IV predicts that His-225, Asp-229, Lys-232 are in loop 6 
between TM 6 and TM 7, and moving these residues into the membrane makes the new 
TM 6 a composite of this putative loop plus the adjacent sections of putative TM 6 and 
TM 7. Two alternative arrangements have been proposed for the last half of the 
protein. Model A leaves the remainder of putative TM 7 in the periplasm, so there are 
9 transmembrane regions, one large periplasmic loop and a cytoplasmic C-terminus. 
Model B draws the remainder of putative TM 7 into the membrane so there are 10 
transmembrane a-helices with a medium sized and a large cytoplasmic loop and a 
periplasmic C-terminus (Figure 6.2). The last three putative ex-helices for each model 
are similar, but are reversed in orientation within the membrane. The charge ratios (i.e. 
the number of lysines and arginines within cytoplasmic loops of 60 residues or less 
subtracted from the number of positively charged residues in similarly sized 
periplasmic loops) for PitA and PitB in Model A are -14 and -18 respectively, and are 
-11 and -12 for PitA and PitB in Model B. The TopPred IV charge ratios for PitA and 
PitB are -1 0 and -11, respectively. Therefore the new models have more favourable 
charge ratios. 
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Figure 6.2 
Topological models of PitA. 
These two models were formulated by combining information from site-directed 
mutagenesis studies on lactose permease with the information used to determine the 
topological model illustrated in Figure 3.15 - GES (63) and Kyte-Dolittle (138) 
hydropathy profiles plus the results of the prediction programs TopPred IV (276) and 
MEMSAT (111). 
The models proposed for PitA and PitB were identical in topology, so the PitA 
sequence is shown, highlighting the amino acids which show variability when 
compared with the PitB sequence. 
A Amino acids identical between PitA and PitB. 
A PitA amino acids which are different in the PitB sequence. 
A The amino acids in PitA which may be equivalent to the lactose permease 
residues R-319, H-322, and E-325, which have been shown to be important for 
lactose permease function. 
The boxes represent the putative transmembrane (TM) a-helices, which have been 
drawn to contain 19 amino acids , the predicted minimum number needed to cross the 
cytoplasmic membrane. The single letter amino acid code has been used. 
Model A 
Contains 9 TM domains. This leaves the large variable loop in the periplasm. 
Model B 
Contains 10 TM domains. An extra TM domain is inserted after the sixth TM domain, 
so most of the large variable loop is now in the cytoplasm. The remaining three TM 
a-helices are identical to model A, but in the opposite orientation 
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Table 6.1: Predicted transmembrane re ions of PitA all startin lasmic N-terminus 
Transmembrane TopPred IVa MEMSAT Model Be 
region 
1 D9 - 129 Tl 2 - F32 Tl2 - N30 Tl2- N30 
2 L52 - V72 L52 - 176 L52-L70 L52- L70 
3 S91-T111 G93 - Ll 16 A95-Yll3 A95 - Yl 13 
4 Hl23-Vl43 T124 - V144 L125 - S142 Ll25-S142 
5 G 157 - Ll 77 Ll53 - Ll 77 S158-L176 S158-Ll76 
6 F208 - N228 F208 - G226 
7 G233 - M253 G233 - V25 J V384-W402 G243 -T261 
8 A382 - W402 V384 - W402 M428-T447 V384- W402 
9 Q427 - T447 M428 - L450 M475-W493 M428-T447 
10 T469 - G489 V470 - W493 
- M475 - W493 
a Prediction program co1nbining GES profile with 'positive inside' rule, (276). 
b Prediction progran1 using 'dynamic programming' to optimally thread a polypeptide chain through a set of topology models, 
(111). 
c Models formulated by co1nbining the predictions of TopPred IV and MEMSAT with lactose permease mutagenesis data. 
6.3 Identification of important amino acids in 
PitA 
6.3.1 Investigation of charged or polar amino acids 
located within the putative transmembrane helices of 
PitA 
The putative topological Model A for PitA places three charged amino acids - lysine, 
aspartic acid and glutamic acid - and two polar histidines within the putative membrane 
spanning sections of the protein. Three of these amino acids have been specifically 
placed within putative a-helix 6 (HxxxDxxK) as they form a similar arrangement to 
key residues in lactose permease a-helix 10 (KxxHxxE). Therefore these three PitA 
residues, His-225, Asp-229 and Lys-232, were targeted for mutagenesis to see if they 
were important for Pi uptake. 
The charged PitA residues His-225, Asp-229 and Lys-232 were individually altered by 
site-directed mutagenesis to polar amino acid side chains of similar dimensions. His 
was mutated to Gln (H225Q), Asp was mutated to Asn (D229N) and Lys was changed 
to Gln (K232Q). This was carried out by single stranded site-directed mutagenesis on 
wild type pitA inserted into M13 DNA ( oligonucleotides are listed in Table 2.5). The 
individual mutations were sequenced and subcloned into the Sall/BamHI sites of 
pBR322 and transformed into AN3066. 
pitAH225Q, pitAD229N and pitAK232Q produced cell growth equivalent to wild type 
pitA on Pi media (minimal media plus 500µM Pi), showing these strains can transport 
enough Pi for cell growth under these conditions (Figure 6.3). (Intracellular 
concentrations of Pi in E. coli are often around 3-9mM. Cells started to excrete Pi 
when levels rise to approximately 13mM, with a maximum intracellular Pi 
concentration of about 3 0mM, as measured by 31 Pnuclear magnetic resonance 
spectroscopy (262, 302)). Pi uptake assays for each mutated PitA show that initial rates 
of activity are reduced to less than 3% of plasmid-borne wild type PitA when cells are 
supplied with 6µM Pi (Table 6.2). However, western blots using polyclonal antipeptide 
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Figure 6.3 
Growth of the PitA single mutations H225Q, D229N and K232Q 
on Pi media. 
Plasmids containing PitAH225Q, PitAD229N and PitAK232Q were transformed 
into the Pi auxotrophic strain AN3066. Single colonies were then streaked onto 
minimal medial containing 500µM Pi , and grown overnight at 37°C. The 
positive control is AN3531, which has wild type PitA on pBR322 within 
AN3066, and the negative control is AN3514, which is vector pBR322 within 
AN3066. 
TABLE 6.2: Analysis of charged residues within/near putative a-helix 6 
of PitA using site-directed mutagenesis 
Strain Plasmid Pi uptake 
AN353 l 
AN351 l 
AN3512 
AN3513 
AN3514 
genotype 
(pitA) 
wild type pitA 
pitA H225Q 
pitA D229N 
pitA K232Q 
vector only 
AN3776 pitA A213D 
AN3938 pitA G220D 
Growth on 
Pi mediaa 
+ 
+ 
+ 
+ 
Initial rate of Pi 
uptake 
nmol Pi. min- 1 mg 
d wt·1 
35.0 + 1.5 
0.82 + 0.07 
0.63 + 0.08 
0.81 + 0.05 
% 
wild type 
(AN3531) 
100.0 
2.3 
1.8 
2.3 
0.15+0.07 0.4 
nd 
nd 
nd 
nd 
a Growth on Pi media - minimal media containing 500µM Pi. 
b Assayed at 6µM Pi, SEM, n = 5. 
Presence of 
PitA in 
cytoplasmic 
membranec 
++ 
++ 
++ 
+ 
c Determined by western blot of cytoplasmic membrane fractions using PitA 
polyclonal antipeptide antibody. ++ indicates the presence of more protein than+ 
(see Figure 6.4). 
PitA antibody against the membrane fractions of these strains show that the levels of 
protein expression are similar to that of the wild type pitA gene on plasmid pAN 686 for 
H225Q and D229N, with K232Q protein expression being less (Figure 6.4). Therefore 
the drop in Pi uptake activity for PitA H225Q and PitA D229N cannot be attributed to 
lack of protein insertion in the membrane. While the amount of K232Q PitA 
membrane insertion is lower than that of the plasmid-borne PitA protein, it cannot 
account for the greater than 97% drop in initial velocity for Pi uptake. The PitA protein 
expression from plasmid-borne K232Q PitA is also higher than that found in AN248, 
which has wild type pitA on the genome. The ability of these strains to grow on Pi 
media while having very low Pi uptake activity may be due to a number of factors . 
These plasmid-borne proteins are all expressed at high levels when compared to the 
amount of PitA protein produced by wild type strain AN248 (Figure 6.4). Thus low 
levels of Pi transport may be compensated for by high levels of protein expression. 
Transporters impaired in active Pi uptake, but able to undergo facilitated diffusion, may 
also be able transport enough phosphate from the 500µM Pi media to allow cell growth 
while exhibiting low initial rates of uptake in assays using 6µM Pi. 
6.3.2 Investigation of the role of other PitA amino acids 
In the course of placing Bg!II restriction endonuclease sites within the pitA gene, 
various residues towards the end of the putative hydrophilic loops were replaced with 
aspartic acid, leucine and a number of other amino acid substitutions (Figure 6.5). 
(This was done in preparation for making phoA sandwich fusions to determine the PitA 
topology - an approach that was left when the investigation of PitB regulation became 
paramount.) These mutations effectively serve as a limited form of random 
mutagenesis. While most of these altered proteins (including eight with aspartic acid 
substitutions) could grow on minimal media containing 500µM Pi , two PitA constructs 
had negligible growth on this Pi media (Table 6.3) . 
Changing Ala-213 to Asp (A213D) completely disrupts Pi transport by PitA. This 
mutation is near the beginning of putative a-helix 6 in Models A and B (but within the 
transmembrane region of a-helix 6 in the TopPred IV model). Very little PitA(A213D) 
protein is inserted in the cytoplasmic membrane, as is shown by Western blot using 
polyclonal antipeptide PitA antibody against the cytoplasmic membrane fraction of 
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Figure 6.4 
Western blot analysis of PitA expression from mutants 
PitA(H225Q), PitA(D229N) and PitA(K232Q). 
Membrane fractions of wild type strain AN248 and Pi auxotrophic strain 
AN3066 containing plasmids with the PitA mutations listed below were 
solubilised and separated by PAGE on a 10% polyacrylamide gel (Tris 
buffer system) and transferred onto PVDF membrane. Protein was 
visualised by incubation with polyclonal PitA antipeptide antibody, followed 
by incubation with alkaline phosphatase conjugated goat anti-rabbit 
secondary antibody and the application of Western blue alkaline 
phosphatase substrate. 
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Figure 6.5 
Topological model of PitA showing site-directed mutagenesis changes. 
These site-directed mutagenesis changes, shown in black, were the consequence of 
inserting BgllI sites into PitA, with the exception of G220D (within TM 6), which is the 
pitAJ mutation. Therefore each group of mutations occurs in a separate constn1ct (e.g. 
PitA(S50D, Q51L), PitA(S91D, H92L). Different colours have been used to show the 
effect of these mutations on Pi uptake, and this is covered in more detail in Table 6.3. 
A Amino acid which is identical between PitA and PitB. 
A PitA amino acid which is different in the PitB sequence. 
A The amino acids in PitA which may be equivalent to the lactose permease 
residues R-319, H-322, and E-325, which have been shown to be important for 
lactose permease function. 
A The amino acid changed by site-directed mutagenesis. These changes 
allowed growth on 500µM Pi media. 
A The amino acid changed by site-directed mutagenesis. These changes 
did not allow growth on 500µM Pi media, therefore were detrimental to PitA. 
A The amino acid substitution created by site-directed mutagenesis. 
The boxes represent the putative transmembrane a-helices, which have been drawn to 
contain 19 amino acids, the predicted minimum number needed to cross the 
cytoplasmic membrane. The single letter amino acid code has been used. 
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TABLE 6.3: Presence of Pi uptake activity for various 
PitA mutations 
Putative PitA amino acid Pi uptakea 
locationb substitutions 
Loop 1 S50D + Q51L 
Loop2 S91D + 
H92L 
Loop 3 Hl22Q + 
Tl23D 
Loop 4 Fl56D + 
Gl57L 
Loop 5 early Sl82R + 
Gl83D 
Tl84L 
Loop 5 late A213D 
Loop 6/7 M375L + 
Loop 7/8 1413D 
G414L 
a-Helix 8/9 S438D + 
Y439L 
Loop 8/9 S472D + 
I473L 
C-terminus F498D + 
a Growth on minimal media containing 500µM Pi. 
b From the putative topological models: Model A and Model B 
(underlined where different). 
strain AN3776 (Figure 6.6). While some membrane protein is assembled, it is at a 
similar level to that of the pitA 1 G220D mutation identified in K-10, and it is unlikely 
that this protein is functional. 
A second mutated PitA protein, which contains Ile-413 changed to Asp and Gly-414 
altered to Leu (1413D G414L), also displays no growth on Pi media. These residues are 
located within cytoplasmic loop 7 in Model A and periplasmic loop 8 of Model B 
(Figures 6.5, 6.2B). Membrane protein assembly of this PitA protein approaches that of 
wild type PitA expressed from a plasmid (Figure 6.6), so these changes cause a 
nonfunctional protein to be produced, without significantly altering assembly of the 
membrane protein. 
6.11 Investigation of substrate binding by PitA 
and PitB through the construction and analysis 
of chimeras 
6.1/-.l Preparation of pitA and pitB with silent restriction 
endonuclease sites 
Chimeric PitA and PitB proteins were prepared for analysis of their kinetic parameters 
to see if specific regions of variable amino acid sequence between the two proteins 
could be linked with changes in Pi transport. PitA and PitB share 81 % identity in 
deduced amino acid sequence, with most of this variability occurring within the 
putative hydrophilic loops. At the time that this experiment was designed the Kmapp of 
PitA appeared to be 14 fold lower than that of PitB (2µM versus 28µM, Table 3.3). 
Four silent restriction endonuclease sites were inserted into the pitA and pitB genes at 
Gly-110 (BbrPI), Arg-178 (S/ul), Val-251 (Hpal) and Leu-394 (Saul) by site-directed 
mutagenesis, to allow the variable regions of PitA and PitB to be exchanged between 
the proteins (Figure 6. 7, plasmid constructs - Figure 6.8). A Hpa I site and a Sfu l site 
were also removed from the PitB coding region by site-directed mutagenesis. (See 
Table 2.5 for the oligonucleotide sequences.) 
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Figure 6.6 
Western blot analysis of the expression levels of various 
PitA mutants, using polyclonal PitA antipeptide antibody. 
The membrane fractions of the wild type strain AN248 and the Pi 
auxotrophic strain AN3066 containing the plasmids listed below were 
solubilised and separated by PAGE on a 4-12% gradient polyacrylamide 
gel (MES buffer system) and transferred onto PVDF membrane. Protein 
was visualised by incubation with polyclonal PitA antipeptide antibody 
followed by incubation with alkaline phosphatase conjugated goat anti-
rabbit antibody and application of Western blue stabilised alkaline 
phosphatase substrate. 
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Figure 6.7 
Topological models of PitA showing the silent restriction endonuclease 
sites used for PitA/PitB chimera construction. 
These restriction endonuclease sites were inserted by site-directed mutagenesis, but 
cause no changes to the amino acid sequence of either PitA or PitB. The colours 
highlight the sequence between each unique restriction endonuclease site that could 
potentially be exchanged between PitA and PitB. 
The chimeras tested in this study were: 
- loop 5/helix 6 (Model A) exchanged between PitA and PitB . 
- loop 6 (Model A) exchanged between PitA and PitB. 
loops 3/4 of PitA placed into PitB. 
(See Table 6.4 for details.) 
The boxes represent the putative transmembrane a-helices, which have been drawn to 
contain 19 amino acids, the predicted minimum number needed to cross the 
cytoplasmic membrane. The single letter amino acid code is used. 
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Figure 6.8 
Plasmid diagrams for pitA and pitB containing silent restriction 
endonuclease sites. 
Four unique silent restriction endonuclease sites were placed in equivalent 
positions in the wild type pitA and pitB genes, to allow the construction of 
pitA/pitB chimeras. 
Site-directed mutagenesis was carried out on pitA in M13mp18 to insert the 
unique restriction endonuclease sites BbrPl, Sful, Hpal and Saul (using 
oligonucleotides 93-77, 93-79, 92-150 and 92-151 respectively, See Table 2.5 
for details). The Sall/BamHl fragment from the replicative form of this con-
struct was then ligated into the Sall/BamHl sites of pBR322, creating pANl 117. 
Similar mutagenesis experiments were carried out on pitB in M13mp18 to insert 
the unique restriction endonuclease sites BbrPl, Sful, Hpal and Saul (using 
oligonucleotides 93-78, 93-80, 93-18 and 92-153 respectively, See Table 2.5 for 
details) and to remove an Sful site (94-29) and a Hpal site (93-76). The 
Sspl/Hindlll fragment from the replicative form of this construct was then 
ligated into the EcoRV/Hindlll sites of pBR322, removing a Hpal site from the 
genomic DNA upstream of pitB, to create pANl 119. 
pAN1117 
6.3kb 
/ BamHI 
/ 
\ 
SaA 
SaLA 
Hpal 
SfLA 
pitA 
Hindlll 
Clal/ Acd 
pAN1119 
6kb 
/ 
pitB 
Saul 
11SfLA 
Hpal 
Sful 
11Hpal 
BbrPI 
EcoRV/Sspl 
6.4.2 Production and analysis of chimeras 
Most variability between PitA and PitB proteins occurs in putative hydrophilic loops 5 
and 6 (Model A), which lie either side of a-helix 6, containing the polar and charged 
residues which have been shown to play a role in Pit function. Putative loop 4 also 
contains a moderate number of variable residues. Therefore chimera production 
concentrated on exchanging these regions of the protein (Figure 6. 7). Chimeras were 
prepared by exchanging equivalent sequences between the PitA plasmid pANl 117 and 
the PitB plasmid pANl 119. Thus pitA containing a pitB sequence will have a pitA 
promoter, and pitB containing an internal pitA sequence will be surrounded by pitB 
DNA control regions. These chimeras were then transformed into the Pi auxotrophic 
strain AN3066, checked for growth on Pi media and then analysed as previously 
described for Km app and V maxapp (Table 6.4 ). All chimeric proteins were functional 
and had V maxapp which were at least 50% of the PitA and PitB values. 
This experiment was designed when the Km app values for PitA and PitB appeared 
significantly different (2µM and 28µM respectively - Table 3.3). However, all 
chimeras produced Km app values that were very low, with all except one being well 
under I0µM. This is an unexpected result. As the two plasmid constructs used for the 
preparation of pitA and pitB chimeras were slightly different from those used to 
determine the kinetic parameters for wild type PitA and PitB, new control plasmids 
were prepared and analysed for each gene. The orientation of pitA in vector pBR322 
was reversed to form plasmid pAN920 by subcloning a SalI/BamHI wild type pitA 
fragment from pAN686 into the Sall/BamHI sites of pBR322 (Figure 6.9A). This had 
no effect on Km app and V maxapp (results not shown). The upstream DNA of the pitB 
gene was reduced from 1403 to 207 nucleotides (pANI 116 - Figure 6.9B), as this DNA 
had been deleted in the preparation of the pitB gene containing unique silent restriction 
endonuclease sites to remove a Hpal site. Unexpectedly this plasmid had a Kmapp 
change for PitB from 28µM to 6µM, explaining why all Km app determined for the 
chimeras were under 12µM. This Kmapp change is discussed in detail in Sections 5.4 
and 5.6. Therefore the difference between the PitA and PitB Kmapp is only 3-fold, 
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TABLE 6.4: Kinetic arameters for PitA/PitB chimeras. 
Chimeraa d Kmapp b c V app b c max 
PitA 
PitB 
(short 
upstream)e 
PitA loop 
5/helix 6 
into PitB 
PitB loop 
5/helix 6 
into PitA 
PitA loop 6 
into PitB 
PitB loop 6 
into PitA 
PitA loops 
3+4 into 
PitB 
a All chimeras are on plasmid pBR322 in host strain AN3066 
b Pi uptakes with 1 OmM magnesium, pH7. 0 
cSEM 
d From topology Model A, Figure 6.2 
µM 
1.9 
nmol Pi min-1 mg 
dry wei hr 1 
39 
6.0±0.5 (n=3) 67±2 (n=3) 
3.0±0.06 (n=3) 46±11 (n=3) 
5.7±1.6 (n=5) 40±5 (n=5) 
12±3.6 (n=3) 24±11 (n=3) 
2.3±0.4 (n=4) 54.5±0.3 (n=4) 
4.7 58 
e Has a similar upstream nucleotide composition to the pitB chimeras 
Figure 6.9 
A Plasmid diagrams for pitA plasmids pAN920 and pAN686. 
Creation of a control plasmid for pANl 117 (pitA containing silent restriction 
endonuclease sites) which was used for the construction of pitA chimeras 
containing sections of pitB. Wild type pitA from pAN686 was reversed in 
orientation (pAN920), effectively creating the same construct as pANl 117. 
pitA was isolated from pCE27 (59) on a Clal/Sphl fragment, which was then 
ligated into the Clal/Sphl sites of pBR322 to form pAN686. (This plasmid 
effectively represents genomic pitA DNA on a BamHl fragment cloned into the 
pBR322 BamHI site, as pCE27 consists of a pitA BamHI fragment within 
cosmid vector pHC79, which is a pBR322 derivative.) This plasmid was 
constructed by Dianne C. Webb. 
pitA was removed from pAN686 on a SalI/BamHI fragment and ligated into the 
SalI/BamHI sites of pBR322, reversing the direction of wild type pitA 
AmpR 
I 
Clal 
I 
pAN686 
6.6kb 
\ 
Sphl 
pAN920 
6.3kb 
BamHI 
/ BamHI 
\ 
SaA 
pitA 
pitA 
Figure 6.9 
B Plasmid diagrams for pAN656 and pAN1116. 
Creation of a control plasmid for pAN 1118 (pitB containing the silent restriction 
endonuclease sites) which was used for the construction of pitB chimeras 
containing sections of pitA. 1196 nucleotides of genomic DNA upstream of wild 
type pitB (between BamH 1 and Sspl) was removed, effectively creating an 
identical construct to pANl 118, which has 207 rather than 1403 genomic 
nucleotides upstream of the putative pitB open reading frame. 
pitB was isolated on a cosmid Clal!BamHI fragment (89) and ligated into the 
Clal/BamHI of pBR322, creating pAN656. This plasmid was constructed by 
Dianne C. Webb. 
The Sspl/BamHl region of genomic DNA upstream of the pitB open reading 
frame was deleted by removing pitB from pAN656 on an Sspl/Clal fragment, 
and ligating it into pBR322 digested with EcoRV/Clal, producing pANl 116. 
BamHI 
pAN656 
7kb 
Clal 
pitB 
Sspl 
pAN1116 
6kb 
\ 
/ Clal 
pitB 
EcoRV/Sspt 
making it much more difficult to extract information from the chimeric protein Km app 
values, as changes are much smaller and meaningful differences are more likely to be 
obscured by the variability inherent in these whole cell experiments. 
The variable residues in 'loop 5' may influence the different Kmapp of PitA and PitB. 
Replacing PitB's 'loop 5/helix 6' (Figure 6.7) with the equivalent region from PitA 
reduces the Kmapp from 6µM to 3µM (approaching the PitA value of 2µM) (Table 6.4). 
Creating the complementary chimera by placing 'loop 5/helix 6' from PitB into PitA 
increases the Kmapp from 2µM to 5.7µM (similar to the PitB value of 6µM). Thus the 
characteristic Kmapp of each protein was transferred with the 'loop 5/helix 6' region, 
which contains 12 amino acid changes (9 within the putative loop 5, one within helix 6 
and 2 conservative changes within the first part of loop 6 - see Figure 6.10). Placing 
PitB 'loop 6' into PitA has little effect on the KmaPP, while placing 'loop 6' from PitA 
into PitB increased the Kmapp and decreased the V maxapp in comparison to wild type 
PitB. This decrease in transporter efficiency and activity is characteristic of some 
chimeric constructs and can represent a general incompatibility between different 
regions of the chimeric protein, rather than indicating the transfer of a specific region of 
structure/function. 
While further chimeras were prepared, they were not analysed in detail once the 
lowered Km app for PitB became apparent. An initial experiment for the insertion of 
'loops 3 and 4' from PitA into PitB showed this change has little effect or may decrease 
the Kmapp slightly by comparison to wild type PitB (Table 6.4), but further experiments 
will be needed to confirm this. 
6.5 Sequence comparison and domain analysis 
of PitA and PitB with other members of the PiT 
family 
While the Pho-4 phosphate transporter from Neurospora crassa was the only known 
protein which exhibited any sequence similarity to PitA and PitB when this project was 
started (21 ), the PiT family has grown to include more than 71 members (ProDom 
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Figure 6.10 
Topological models of the 'loop 5/helix 6' region of PitA, showing the 
PitB amino acid side chains for the variable residues. 
The 12 amino acid differences found between PitA and PitB in the 'loop 5/helix 6' 
region which may be involved in determining the substrate affinity of each Pi 
transporter. The topology is shown for Model A and Model B. 
A 
A 
A 
PitA 
PitB 
PitA 
PitB 
'loop 5/helix 6' region exchanged between PitA and PitB. 
PitA amino acids which differ from the PitB sequence. 
PitB amino acids which differ from the PitA sequence. 
RRY WSGTKKRa RI Hlt PaeRe KK d GKk KPPFWT RIALi l SAi G 
RRY WSGTKKRdRI Hri PedRk KK k GKr KPPFWT RIALI~ SArl G 
VAFSHGANDG QKGIGLVMLV Li Gv APAGFV 
VAFSHGANDG QKGIGLVMLV LvGi APAGFV 
The boxes represent the putative transmembrane a-helices, which have been drawn to 
contain 19 amino acids, the predicted minimum number needed to cross the 
cytoplasmic membrane. The single letter amino acid code is used. 
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database). It is defined by homology to the PD 1131 domain, which is duplicated in 
most of these proteins (229), Transport Commission classification (226). Figure 6.11 
shows two multiple sequence alignments using representative sequences from 
evolutionarily distant organisms over the N- and C-terminal regions, which demonstrate 
a high similarity across all kingdoms. The intervening central regions between these 
repeated domains have poor similarity and large insertions/deletions. Members of the 
PiT family originating from animals, worms, yeast and fungi contain an additional 
domain, PD7717, in this central region (ProDom database - (229)) and many plant 
proteins also have an extended N-terminus (47). 
It is interesting to note that the C-terminal PD 1131 domain of PitA and PitB has been 
split by a sequence (Figure 6.11B) which forms the large variable hydrophilic loop in 
the PitA and PitB topological models (Figure 6.12). The multiple sequence alignment 
in Figure 6.13 shows that this region is present in the putative Pit sequences of closely 
related Gram-negative bacteria, forming domain PD040191 (ProDom database), but is 
lacking in the Pit proteins of Gram-positive bacteria and other more distantly related 
species. Many members of the PiT family exhibit diversity in this location. The 
mammalian PiT-1 and PiT-2 transporters have a variable 13 amino acid recognition 
sequence for retroviral glycoprotein (Region A) in this position (51). Sections of the 
variable loop 5 of PitA and PitB are also lacking in the Gram-positive bacteria (Figure 
6.13). Rhizobium loti, which contains at least two Pit genes, has proteins with and 
without these loops. (NCBI Blast analysis performed at SIB - (1)). 
Salaun et al (229) have compiled 68 of these PD 1131 domains ( combining the N- and 
C-terminal domains) to identify four blocks of highly conserved amino acids. These 
have been numbered and highlighted on the multiple sequence alignments of Figure 
6.11. Figure 6.12 relates the N- and C-terminal PDl 131 domains to the proposed 
topology of PitA, and also locates the four highly conserved blocks of amino acids 
identified by Salaun et al, and the 'signature sequence' highlighted by Saier et al (226). 
The PitA residues His-225, Asp-229 and Lys-232, which greatly reduced PitA Pi 
uptake when mutated, are within the first highly conserved sequence of the C-terminal 
domain. These three residues are conserved in Pit proteins from closely related species 
(see mauve boxes in Figure 6.13), although Lys-232 becomes an Asn in more distantly 
1 1 1 
Figure 6.11 
Multiple sequence alignment of the N-PD1131 and C-PD1131 PiT 
domains from distant species. 
protein taxonomy N-terminal region C-terminal region 
PitA I£. coli bacteria 20-180 221-499 
PitB I £. coli bacteria 20-180 221-499 
Pit I R. meliloti bacteria 14-160 187-334 
Pht2;1 I A. thaliana plant 162-316 432-587 
PiT-1 I H. sapiens human/mammals 14-168 499-652 
Pho4 I N. crassa fungus 14-173 432-590 
YBR29C I S. cerevisiae yeast 14-169 415-574 
A N-terminal PD1131 domain alignment 
- Highlights the PDl 131 domain. 
Highlights the conserved sequences identified by Salaun et al (229). 
- Highlights the strongly conserved residues within these sequences. 
- Highlights mutated amino acids ref erred to in Chapter 7. 
The multiple sequence alignment was carried out using ClustalW with the 
following parameters. The Blosum scoring matrix was used, with Open and end 
gap penalties of 10, and extending and separating gap penalties of 0.05. 
B C-terminal PD1131 domain alignment 
- Highlights the PD 1131 domain (which has been split in PitA and PitB). 
Highlights the conserved sequences identified by Salaun et al (229). 
- Highlights the strongly conserved residues within these sequences. 
- Highlights mutated amino acids referred to in Chapter 6. 
The ClustalW alignment (Mac Vector 6.0) was carried out as described above, 
except the extending and separating gap penalties were dropped to 0.03. 
A - N terminal PD1131 domain alignment 
PitAIE . coli 
PitBIE . coli 
Pit!R . meliloti 
Pht2;1!A . thaliana 
PiT-l!H. sapiens 
Pho4 IN . crassa 
YBR29CIS . cerevisiae 
PitAIE . coli 
PitBIE . coli 
PitlR . meliloti 
Pht2 ; 1IA . thaliana 
PiT - llH . sapiens 
Pho4!N . crassa 
TANAVATVI YT RM-1RS QLJW\flvIAA VFNFLGVLLGG'.L Y Vl-il'-1 
TANAVAAVIYTPAMQPQLA.VVM .. l--..AFFNFFGVLLGGL lV,AYA'I VHM 
IAVALFFDFLN $:QAANSIATIVSTP..VLRPQYAVFvJA....A.FFNFIAFLFFG:LHVAE GTG 
LLFGFYMAWNI G'ANINANA...MG TSVGSGl\LTIRQAVMI'A....A.VLEFS G~LLMGl'HVTSTMQKG 
FIIAFILAFSVGANDVANSFG TAVGSGV\JTLRQACILASIFETTG VLL GEfl'J REG 
TI FAAL DAWN I GANfJVAN Sv-.JATS VAARS VTYLQP,.MILG S IMEFl'i.GpVGVGARVADIT'il RTK 
MLFAFLDAFNI GANDVANSFASSISSRSLKYWQAl'-f\lLAGLCEFLGA"./LA _ RVSGTI I--:NN 
* . * ** . * * * 
. . . . . . . . . 
PTDLLLNMGSSHGL.AMVFSMLLAAI IWNLGT1iJ'r.""FGL P: SSHTL IGP.I IGIGLTNALI'-IT 
!LPTDLLLNMGSTHGL.AMVFSMLLA...AIIWNLGTWFFGL P SSHTLIGAIIGIGLTNALLT 
IDPGIVT P- - - -- - QVI FA....A.LMG.AITWNIVTvNFGI PSS S SHA..L IGGLVG}\GLAKTGFS 
ILMA.NVFQGKDMLLFAGLLSSLJI_A..AGTWLQVA.SYYGWPN'S TTHCIVGSMVGFGLVYGG.AG 
I IDVNL YNETVETLMA.GEVSA...MVGSAVWQL IA.SFLRL B S GTHC IVG ST IGFSLVA.IGTI< 
\lVDTTLFADDP.ALLMLGMVCAWASSIYLTMATRFGL PWSTTHSIMGGVIGMGIAJWGlill 
YBR2 9C IS . cerevisiae IIDSSIFTNDPAVLMLTMTSALIGSSCWLTF.ATJI_IGMPW:S TTHSIVGGTIG.AGIJl~i'I._GGl\J-.J 
PitAIE . coli 
PitBIE . coli 
PitlR . meliloti 
Pht2 ; 11A . thaliana 
. . 
. . .. * * . * 
GTSVVDALNIPKVLS I,FGs,LIVSPIVGLVF.AGGLIFLLRRY 
GSSVMDALNLREVTKIFSSLIVSPIVGLVIAGGLIFLLRRY 
S I\lWQG - - - - - - LL KTAGAIVMS PG I GFVLALLL VL IVS- -
VFWSS ------ LAKVASSWV ISPILGALVSFLVYKCIRRF 
PiT-11 H . sapiens GVQvJME -- -- -- LVKIVAS:WF ISPLLSGFMSGLLFVLIRIF 
Pho41N . crassa GVQWVGSSINDGWS VFLAWVIAPGLAGAFASIIFLVTKYG 
YBR29C IS . cerevisiae GVVVJGWS ---- GVS, II.AS F IAPILAGAIAA.IVFSISRF-
.. * . . .. 
.. * . * 
B - C terminal PD1131 domain alignment 
PitAIE . coli 
PitBIE . coli 
Pit!R . meliloti 
Pht2 ; l jA. thaliana 
PiT-l!H. sapiens 
Pho4 IN . crassa 
YBR29C!S . cerevisiae 
PitAIE . coli 
PitB IE . coli 
Pit !R. meliloti 
Pht2 ; 1IA . thaliana 
PiT- l ! H. sapiens 
Pho4 IN . crassa 
YBR29CIS . cerevisiae 
PitA ! E . coli 
PitB I E . coli 
Pit!R . meliloti 
Pht2 ; l !A. thaliana 
DGQKGIGLVMLVLIGVAPAGFVVNMN"ATGYEITRTRDAINNVEAYFEQHPALL 
AFS G DGQKGIGLVMLVLVGIAPAGFVVNMNASGYEITRTRDAVTNFEHYLQQHPELP 
SLG~G DAQKTMGIIAVLL--FSQGYLG- ------------------------------
SFA.BlGGNDVSNAIGPLAAALSILQNGA.AAG - - ------ - ---------------------
SFA.ti;GfNDVSNAIGPLVALWLIYKQGGVT--- ------ - --- -- - ---------------
SFTHGf-~D IANAIGPYATVFQLWKDGALPE- -----------------------------
S G DVANATGPLSAVYVIWKTNTIG- - -----------------------------
** ** * 
KQATGADQLVPAPEAGATQPAEFHCHPSNTINALNRLKGMLTTDVESYDKLSLDQRSQMR 
QKLIAMEPPLPAASTDGTQVTEFHCHPANTFDAIARVKTMLPGNMESYEPLSVSQRSQLR 
RIMLCVSDTIDKVVKMPGVSADDQRLLKKLKSDMBSTIEYAPVWIIMAVALALGIGTMI G 
RIMLCISDTSAKLAKLPGVSKEDQNLLKKLRSDMLSTIEYAPVWIIMAVALALGI TMIG 
- -- - -- - ------ ---- - -- - ----- - -------- -SEFYVPFWVVITCQAAIAL TLFG 
- -- - -- - - -- ------ - ---------- ---- - ---GAEIVIPMDVLAWGGFGIVAG TMW 
PiT- l!H . sapiens --- ------- - --------- - ---- -- ----- - -- -QE_AATPVTtJLLFYGGVGICTG WVW 
Pho4 ! N. crassa - - ------------------ - ---- - ----- - ---KGKADVPVWILVFGASCLVI WTY 
YBR29CjS . cerevisiae --- - ---------- - ---------------- - --- -AI<SEVPVWVLAYGGVALVI CWTY 
PitA ! E . coli 
PitB ! E . coli 
Pit!R . meliloti 
Pht2 ; l !A. thaliana 
PiT - l !H. sapiens 
Pho4 IN. crassa 
YBR29C ! S . cerevisiae 
* * 
IWRRVA 'IIJ: GEKIGKKGMTYAQGMSAQMTAAVSIGLASYTGMEMSTTHVLSSSVAGTl'WvD 
R AMTlGEKIGKRGMTYAQGMAAQMTAAVSIGLASYIGMPM TTHVLSSAVAGTMVVD 
G ~IVHT~G SKITKL--NPMQGFCAETGGAITLFAATWLGI EmSTTHTITGAIIGVG_.l\AR 
GYRVIA :IG KKITEL - -TPTRGFAAEFAAASVVLFASKLGLB lATHTLVGAVMGVGFAR 
G!R VIQ MG KDLTPI -- TPSSGFTIELASAFTVVIASNIGL E TTHCKVGSVVAVGWIR 
G~ NIMHNLGNRITLQ- - SPSRGFS1"1ELGSAVTVILATRLKLEMSTTQCITGATVGVGLCS 
G NlI~~GNKMILQ--SPSRGFSIELAVAITTVMATQLGI E S TTQIAVGGIVAVGLCN 
. * * · * * . . . . 
PitA I E . coli G--GGLQRKTVTSILMAWVFT FAAVLLSGGLYWLSLQFL---- - -- - -
PitB IE. coli G--GGLQRKTVTSILMAWVFTl ~AAIFLSGGLYWIALQLI---------
Pit ! R. meliloti R-VSAVRWGLAGNIVVAWVITMP ISALCYFAADLVA-------- -
Ph t2 ; l !A. thaliana G-LNSVRAETVREIVASWBVTlFVG- ATLAVIYTWIFTKILSFVL--- -
PiT- llH. sapiens S-RKAVDWRLFRNIFVAWFVTVPVAGLFSAAVMALLMYGILPYV- --- -
Pho4 1N. crassa GTWRTINWRLVAWIYMGWBITThFVAGIISGCLMGIIINAPRWGYSG---
YBR29C j S . cerevisiae KDLKSVNWRMVAWCYSGW LT PIAGLIAGIINGIILNAPRFGVEYQMT 
* * · * . . . . 
Figure 6.12 
Topological model A of PitA, highlighting the N- and C-terminal 
PD1131 domains, and the highly conserved PiT family sequences. 
The C-terminal PD 1131 domain is split by a large variable region. Salaun et al (229) 
combined 68 N- and C-terminal domains of various PiT family transporters, to propose 
the presence of four highly conserved domains. Saier et al (226) proposed a signature 
sequence that is located in the first PD1131 domain. Russ et al (2 16) have identified a 
glycine sequence which seems to be important in helix packing. These sequences are 
highlighted on the topology model , with the proposed conserved sequences listed 
below. The boxes represent the putative transmembrane (TM) a-helices, which have 
been drawn to contain 19 amino acids, the predicted minimum number needed to cross 
the cytoplasmic membrane. The single letter amino acid code has been used. 
The models proposed for PitA and PitB were identical in topology, so only the PitA 
sequence is shown. 
A PD1131 domains. 
A Highly conserved amino acids within the conserved regions (see below). 
A Variable amino acids within the conserved regions (see below). 
A PitA sequence between domains. 
* "Signature sequence" for PiT family proposed by Saier et al (226) (see 
below). 
G Helix packing motif. 
Conserved regions 
1 
Consensus 
Pi tA N -PD 1131 
PitA C-PD l 131 
G<pND<p 
GFHDT 
GANDG 
2 
GxxxxGxxVxxT 
GxxxxGxxVxxA 
GxxxxWxxVxxT 
3 
P<pS 
PAS 
PVS 
4 
IxxxW¢ 
IxxxLI 
IxxxWF 
PitB is identical to PitA in the highly conserved amino acids for each region. 
Signature sequence 
Consensus GFNDLGNSLAA 
AHNIADAIGT 
G VS MS 
T F 
A W 
PitA GFHDTANAVAT 
PitB GFHDTANAVAA 
Helix packing motif 
Consensus 
PitA TM 4 
PitA TM 6 
GXXXG 
GXXXG 
GXXXG 
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Figure 6.13 
Multiple sequence alignment of Pit proteins from species closely 
related to E. coli. 
A Protein details 
This table includes information on the proteins and their organisms, such as 
accession details and basic taxonomic information . 
B C-terminal PD1131 domain alignment 
- Highlights the repeated PD 1131 domains. (The C-terminal PD 1131 
domain has been split into two parts.) 
- This identifies the PD040191 domain, found in the first 8 sequences. 
Highlights the conserved His (H), Asp (D) and Lys (K) residues that were 
changed by site-directed mutagenesis in PitA. 
The multiple sequence alignment was carried out using ClustalW with the follow-
ing parameters. The Blosum scoring matrix was used, with Open and end gap 
penalties of 10, and extending and separating gap penalties of 0.05. The single 
letter amino acid code has been used. 
A 
Database /access ion no. Name/description Organism Taxonomy 
PitA - Low- affinity spiP373081PITA ECOLI Escherichia coli Gram - ve bacteria 
-inorganic phosphate y-subdivision 
transporter 1 Enterobacteriaceae 
PitA - Low-affinity tnlAAL22449 Salmonella Gram - ve bacteria phosphate typhimurium - LT2 y- subdi vision transporter Enterobacteriaceae 
PitB - Low- affinity splP43676IPITB ECOLI Escherichia coli Gram - ve bacteria 
-inorganic phosphate y- subdivis i on 
transporter 2 Enterobacteriaceae 
PIT? - Phosphate tnlCAC93429 Yersinia pestis Gram - ve bacteria 
transport protein (plague) y- subdivision 
Enterobacteriaceae 
PIT? - Low affinity spiP576471PIT BUCAI Buchnera aphidicola Gram - ve bacteria 
-inorganic phosphate (subsp . y-s ubd i v i s i on 
transporter Acyrthosiphon pi sum) Buchnera 
PA4292 - Probable trlQ9HWA8 Pseudomonas Gram - ve b act e r i a phosphate aeruginosa y- subdivision 
transporter Pseudomonadace a e 
PA0450 - Probable trlQ9I668 Pseudomonas Gram - ve bacte ri a 
phosphate aerugino s a y-subdivision 
transporter Ps e udomonadace ae 
MLL3637 - Phosphate trlQ98FS6 Rhizobium loti Gr a m - ve b a cteri a 
transporter (Mesorhizobium loti) a-subdi vi s ion 
Rh i zob i aceae 
SA0619 protein trlQ99VV7 Staphylococcus Gram +ve bacteria 
aureus (strain N315) Fi r micutes 
Bacil l u s /C l os t ridium 
Lmo0405 protein tnlCAC98484 Liste r ia Gram +ve bacteri a 
monocytogenes Fi r micutes 
Bacillu s / Clostridium 
PITH - phosphat e tr lQ9KZW3 St r eptomyce s Gram +ve bacter ia 
t r an s po r t prote i n coelicolor Fi r micutes 
Actinobac t e r ia 
PIT? - Probable tnlCAD00327 Listeria i nnocua Gram +ve bacter ia 
phosphate Fi r micute s 
tran s po r ter Bac i llus/Clostr i d i um 
PIT? - Probable low- splO34436IPIT BACSU Bacillus subtili s Gram +ve bacteria 
-
affinity inorgan i c Fi r micute s 
phosphate Bacillus/Clostridium 
transporter 
PITH protein PI trlQ9EUSl Streptomyces griseus Gram +ve bact e ria 
subsp . griseus Firmicutes 
Actinobacteria 
trlQ97 EL7 Clo s t r idium Gram +ve bacteria 
Phosphate pe r mease - acetobutylicum Firmicu t es 
CAC3093 Bacillus/Clostridium 
PI T? - Probable low- tnlCAD15015 Burkholderia Gram - ve bacteria 
affinity phosphate solanacea r um ~-s ubdivision 
t r anspo r ter (Pseudomonas Ral s tonia 
solanacearum) 
PIT? - Probable low- splO304991PIT 
-
RHIME Rhizobium meliloti Gram - ve bacteria 
affinity inorganic (Sinorhizobium a - subdivision 
phosphate meliloti) Rhizobiaceae 
transporter 
PIT? Phosphate trlQ983D8 Rhizobium l o ti Gram - ve bacteria 
transporter (Mesorhizobium loti) a - subdivision 
Rhizobiaceae 
B 
PITA - E. coli 
PITA - S . typhimurium 
PITB - E. coli 
PIT? - Y. pestis 
PIT? - B. aphidicola 
PA4292 - P. aeruginosa 
------------------------------------------------MLHLFAGLDLHT 
------------------------------------------------MLHLFAGLDLHT 
------------------------------------------------MLNLFVGLDIYT 
------------------------------------------------MLHLFAGLDFHT 
------------------------------------------------MLHLFSYSDLNH 
------------------------------------------------MFDLFSGLDAWV 
PA0450 - P. aeruginosa MTSDVLPADAVASAAGNARKPHLEQRPG--RLTALVFFAVLATGLLFSAYSLMQDVDDVG 
MLL367 - R. loti ------MVDVVSSEAGIPRPDHPLHSSGSAKWFLPAFGVLVLVGVVYVGYALSQDLAEAK 
SA0619 - S . aureus ---------------------------- --- ------------ ------------MSYI-
Lmo0405 - L. n1onocytogenes-------------------------------------------------------MDTV-
PITH - S. coelicolor ---------- -------------- ---------------------- ---------MDTF-
PIT? - L. innocua -------------------------------------------------------MEGM-
PIT? - B. subtillus -------------------------------------------------------MDIL-
PITH - S . griseus -------------------------------------------------------MDTF-
CAC3093 - C.acetobutylicum-------------------------------------------------------MLNS-
PIT? - B. solanacearum -------------------------------------------------------MHTLQ 
splO304991PIT RHIME -------------------------------------------------------MDAT-
trlQ983D8 -------------------------------------------------------MEAT-
PITA - E. coli 
PITA - s. typhimurium 
PITB - E. coli 
PIT? - Y. pestis 
PIT? - B. aphidicola 
PA4292 - P. aeruginosa 
PA0450 - P. aeruginosa 
MLL367 - R. loti 
SA0619 - S . aureus 
G--------LLLLLALAFVLFYEA[ NGFHDTANAVATVIYTRA.MRSQLAV\TMJI...AVFNFLG 
G--------LLLLLALAFVLFYEA NGFHDTANAVATVIYTRAMRSQLAVWiAAVFNFFG 
G--------LLLLLALAFVLFYEA NGFHDTl'illAVAAVIYTP~~QPQLAVVMAAFFNFFG 
G--------LMLVLALLFVLFYEAINGFHDTANAVATVIYTR..i\MRSQIAV\IMAGVFNFLG 
S- -------LLVFLALFFVLFYEA NGFHDTANAVSTLIYTRAMSAHVAVIMSGIFNFLG 
G--- -----I SLVLALAFVLTFEF NGFHDTANAVATVIYTKAMSPYRAVMLSGVFNFLG 
STITTWTPFLLLGVALLIALGFE FVNGFHDTANAVATVIYSHSLPPHFAVVTtJSGCFNFLG 
T-----VPWILLGIALLIALGFEFVNGFHDTANAVATVIYTRSMPAEFAVMWSGAFNFLG 
--------IIVTIAVVIFSLIFDF NGFHDTANAVATAVSTRALTPKTAILMAAVMNFIG 
Lmo0405 - L. monocytogenes--------ILITVIIVIVGLAFDF NGFHDIANAVATSISTRALKPRVAIGIAAVMNFLG 
PITH - S. coelicolor ----------ALVVTIGVALFFTYr NGFHDSANAIATSVSTRALTPRAALAMAAVMNLAG 
PIT? - L. innocua --------FLITLVIVLAALAFDL ~NGFHDTA..~AIATSVSTKALKPRHAIILAAVMNFVG 
PIT? - B. subtillus --------LILTILIVICALAFDF NGFHDTANAIATSVSTKA.LKPRHAIILAA,~1NFVG 
PITH - S. griseus ----------ALIVTIGVALGFTYTNGFHDSAQRIATSVSTRALTPR..AALAMAAVMNLAG 
CAC3093 - C.acetobutylicum-------AVLITIIIVILAISFDFLNGFHDSANAIATSVSTRVLSMKSAVIMSAILNFLG 
PIT? - B. solanacearum I------SLWVVVLLVALAILFDFMNGFHDAANSIATVVSTGVLKPQQAVAMA..AAC}~JIA 
PIT? - R. meliloti L------AFPLLVGLIAVALFFDFLNGLHDAANSIATIVSTRVLRPQYAVFWAAFFNFI 
PIT? - R. loti I------AFPVLIALVAVALFFDFLNGLHDAA..NSIATIVSTRVLRPQYAVLWAAFFNFIA 
PITA - E. coli 
PITA - S. typhimurium 
PITB - E. coli 
PIT? - Y. pestis 
PIT? - B. aphidicola 
PA4292 - P. aeruginosa 
PA0450 - P. aeruginosa 
MLL367 - R. loti 
* . * 
VLLGGLSVAYAIVHMLPTDLLLNMGSSHGLAMVFSMLLAAIIWNLGTWYFGLPASSSHTL 
VLLGGLSVAYAIVHMLPTDLLLNMGSAHGLAMVFSMLLAAIIWNLGTWYFGLPASSSHTL 
VLLGGLSVAYAIVHMLPTDLLLNMGSTHGLAMVFSMLLAAIIWNLGTWFFGLPASSSHTL 
VMLGGLSVAYAIVHLLPTDLLLNVSSTHGLAMVFSMLLAAIIWNLGTWYFGIPASSSHTL 
VLLGGLTVAYTIVHLLPNDLLLNATSKNALAMVFSMLLAAIIWNLSTWYFCLPASSSHSL 
VLLGGVGVAYAIVHLLPVELLINVNTGHGLAMVFSLLAA.A.IAWNLGTWYFGIPltSSSHTL 
VLLS S GAVAFG I IALLPVEL I LQVGS SAGFAMVFP..LLIAAI LWNLGTWWLGLPASS SHTL 
VLTSSGAVAFGILSLLPVELILQVGSSSGFAMVF_A.LLVAAILWNLGTWFLGLPASSSHTM 
SAO 619 - S. a ureus ALTF-TGVAGTIT-- --KDIVDPFKLENGLV\TVL}VULAAI IWNLATWFYGIPSSSSHAL 
Lrno0405 - L. monocytogene AISF-TGVAESLT----KSIVDPFSLNNGEFVVLCGLIAAVIWNLMTWLVGMPSSSSHAL 
PITH - S. coelicolor AFMG-SGVAI'CTVS----EGVIETPEGSI.ZGMGILFP...ALVGAIVWNLITWYFGLPSSSSHAL 
PIT? - L. innocua AISF-TGVAKTIT----I<:DIVNPFDLDHGELVILAALLSAIAWNLITWYFGIPSSSSHAL 
PIT? - B. subtillus AfITF-TGVAKTIT----IWIVDPYTLENGSVVILAALLAAIAWNLITWYYGIPSSSSH..A.I 
PITH - S . griseus AFLG-QGVAKTVS----EGLIATPVGQKGMGILF.l\A.LVGAIIWNLITWYYGLPSSSSHAL 
CAC3093 - C.acetobutylicumAFMS-DKVAKTVG----DGIIDP--SKIVPSVIIVALIAAIIWNLITWYLGIPSSSSHAL 
PIT? - B. solanacearum IFIFHLKVATTVG----RDTIDP--SIVDHYVIFGALVGAIAWNIVTWYYGIPSSSSHAL 
PIT? - R. meliloti FLFFGLHVAETLG----TGIIDP--GIVTPQVIFAALMGAITWNIVTWVFGIPSSSSHAL 
PIT? - R . loti FMFFGLtNAETVG----KGIVDV--SIVTPAVIFSALVGAIVWNIVTWIAGIPSSSSHAL 
** *· **· ** 
• ·k•****•. . . . 
PITA - E. coli IGAIIGIGLTNALMTGT-SVVDALNIPKVL-SIFGSLIVSP VGLVFAGGLIFLLRRYWS 
PITA - S. typhimurium IGAIIGIGLTNAMMTGT-SWDALNIPKVI-NIFGSLIISP VGLVFAGGLIFLLRRYWS 
PITB - E. coli IGAIIGIGLTNALLTGS-SVMDALNLREVT-KIFSSLIVSP VGLVIAGGLIFLLRRYWS 
PIT? - Y. pestis IGAIIGIGLTNALMTST-SWDALNVPKMI-QIFLSLILSP VGLVIAGLMVFLLRRYWS 
PIT? - B. aphidicola IGAIIGIGLTNAFVTDS-SLVDAFNIPKMT-SVFLSLVFSP IGLIIAGSLIFLLRYYLN 
PA4292 - P. aeruginosa IGSILGVGLANALITDV-PLAEGINWQKAI - DIGLSLIFSP LAGFMVA-ALVLLGLKWWR 
PA0450 - P. aeruginosa IGSIIGVGVANALMHGR-DGTSGVDWGQAT-KVGYSLLLSPLI GFACAALLLLALRLLVK 
MLL367 - R. loti VGSIIGVGLANQFMAPAGSATSGVDWSQAT-NVGITLLVSP IGFFAAAILLYAMKLLVR 
SA06 19 - S. aureus IGSIAGAAIASE------GSFGVLHYQGFT-KIIIVLIVSP~ IAFCVGFLMYSIFKVIFK 
Lmo0405 - L. monocytogenes IGAIAGASIASA- - --- - SSFSVLNWSGFT-TIIIALIISP~ IGFTVGYLIYSLFKHLFH 
PITH - S. coelicolor FGGMVGAALA- --- --- -- GSTTVYWHGWDKIVIPMFVSPVIGLLAGYLV:MTAIMWIFR 
PIT? - L. innocua IGSIAGAAIASA- -- ---G-FAAIEYSGFT-KIIIGLLVSPVLAFWGYTI YSLFKVFLK 
PIT? - B. subtillus IGAIAGAAIAAA- - --- - G-FAALNYKGFI-KIIEALILSP~ IAFVLGFILYSIVKLIFK 
PITH - S. griseus FGGMVGAALA-- -- - - - -- GGTDVIWSGVLKKVVIPMFISPFVGL IAGYLVMVGIMWIFR 
CAC3093 - C.acetobutylicumIGGLIGAAVMYK--- - --TSFGWNWIGFFNKIVLWLFLSPVIGFWGYIFMILIEWL FH 
PIT? - B. solanacearum IGGLVGAAVA-K- - - - - - SGTGSLVASGLL-KTVAFILISP LLGFILGSCLMIAVSWLFF 
PIT? - R. meliloti IGGLVGAGLA- K- -- -- - TGFSSIVWQGLL- KTAGAIVMSPGIGFVLALLLVLIVSWLFV 
PIT? - R. loti IGGLVGAGVA- K-- - -- -SGFGAIVWTGLG - KTVAAIIVSPJ TGFLLALVLILV:VSWLFV 
. * . 
-~ . 
PITA - E. 
PITA - s. 
PITB - E. 
PIT? - Y. 
PIT? - B. 
PA4292 -
coli 
typhimurium 
coli 
pest is 
aphidicola 
P. aeruginosa 
GTKKRARIHLTPAEREKKDGKKKPPFWTRIALILSAIGVAFS GANDGQKGIGLVMLVLI 
GTKKRARIHLTPAEREKKDGKKKPPFWTRIALILSAIGVi FS HGANbGQRGIGLVJvILVLI 
GTKKRDRIHRIPEDRKKKKGKRKPPFWTRIALIVSAAGVAFSHGANOGQKGIGLVI~LVLV 
STKKQQRIHLTPAEREKKDGKRKPPFWTRTALILSAIGVSFSHGANDGQKGIGLIMLVLI 
NNKIFYRIHMTPLERKEKDGKKIPPFLIRMALILSSIGVSYAHGANDGQKGIGLIMLVLI 
---PLSKMHKTPETRRELDEKKHPPFWNRLVLVLSAMAVSFVHG SNDGQKGIGLIMLVLI 
PA0450 - P. aeruginosa N----RALYKAP------KGKAPPPWWIRGLLILTCTG~ SFAHG SNDGQKGMGLIMLILV 
MLL367 - R. loti N----PALYEAP------KGNTPPPWWIRGLLIFTCTGVSFAHG SNDGQKGMGLIMLILI 
SA06 19 - S. aureus N--------ANL---------TRANRNFRFFQIFTAALQSFSHGTNDAQKSMGIITLA.LI 
Lmo0405 - L. monocytogenesD--------KKL---------GKMNRRFRFIQIGTAAAQAYS HGTNDAQKTMGIITLALV 
PITH - S. coelicolor R--------ANP---------HKAKRGFRIAQTVSAAGMA.LGHGLQDAQK~MGIVVMALV 
PIT? - L. innocua N--------LNL---------ATTNRRFRMIQVGTAALQSYTBGTNDAQKSMGIITMALI 
PIT? - B. subtillus D--------SNL---------AKTNKQFRRVQIVTAALQSYTHGTNDAQ~AMGIITMA.LI 
PITH - S. griseus K--------SNP---------HKAKRGFRIAQTVSAAGMA.LGHGLQDAQKTMGIVVMALV 
CAC3093 - C.acetobuty1icumR--------SKP---------AFVSRVFSKAQIVSAMLM.11,LNHGGNDAQKSMGVITJv1ALM 
PIT? - B. solanacearum R--------TPP---- ----- SKVDRWFRRLQLLSASLYSLGHGGNDAQKTIGIIWMLLI 
PIT? - R. meliloti R--- ----- QTP---------FAVDSTFRVLQFVSASLYSLGI-IGGNDAQK'TMGIIAVLLF 
PIT? - R. loti R--------QTP---------FAVDSTFRVMQFFSASLYSLGBGGNDAQKTMGIIAVLLY 
** ·* ** · * ·· . * 
PITA - E. coli GVAPAGFWNMNATGYEITRTRDAINNVEAYFEQHPALLKQATGADQLVPAPEAGATQPA 
PITA - S. typhimurium GVAPAGFWNMNASSYEITRTRDAINNVETYFEQRPDLLKAVTGVDQLIPSPEPGATEPT 
PITB - E. coli GIAPAGFWNMNASGYEITRTRDAVTNFEHYLQQHPELPQKLIAMEPPLPAASTDGTQVT 
PIT? - Y. pestis GVAPAGFWNMNATGYDIARTRDAVTHVQLYYQQHAEALPHAIALKPLVPAPETLP GTPA 
PIT? - B. aphidicola GIVPSSFLVNLNTNKYEINCTKHTLNHLEKYFLEKNIKKSNIIKNKEEINN--------L 
PA4292 - P. aeruginosa GIVPAKFVLDLNSTTYQIERTRDAALHLSQFYQRHTDTLGDMLALGKSNGSE-----MPQ 
PA0450 - P. aeruginosa GTLPMAYALNRTMPADQAVQFAAVADVTQQALVKSAP----QPAPADPRQVLSDYVRSKQ 
MLL3 67 - R. loti GWPTAFALNRTPDINYLEAYKAASVNVETALGKYVKPGVTVTDAKDAKAAVQDAVRTRT 
SA0619 - 5. aureus VANVQ-------------------------------------------------------
Lmo0405 - L . monocytogenesASGLL-------------------------------------------------------
PITH - S . coelicolor IADVE-------------------------------------------------------
PIT? - L. innocua ASGFQ-------------------------------------------------------
PIT? - B. subtillus TANLH-------------------------------------------------------
PITH - S. griseus IADVE-------------------------------------------------------
CAC30 93 - C.acetobutylicumSSGLL------------- ------------ ------------------------------
PIT? - B. solanacearum AGGYA-------------------------------------------------------
PIT? - R. meliloti SQGYL----------- ---- ------------- ---------------------------
PIT? - R. loti SQGML-------- ---- -------------------------------------------
PITA - E. coli EFHCHPSNTINALNRLKGMLTTDVESYDKLSLDQRSQMRRIMLCVSDTIDKVVK--MPGV 
PITA - 5. typhinmrium EFHCHPANTINALNRAKGMLAN-VESYDKLSVEQRSQLRRIMLCISDTTDKVVK--LPGV 
PITB - E. coli EFHCHPANTFDAIARVKTMLPGNMESYEPLSVSQRSQLRRIMLCISDTSAKLAK--LPGV 
PIT? - Y. pestis QFHCDTSRAMVAINHAQALLTD-LKSYDDLTVDQRSQMRRLLMCVAETAGAVAK--LPET 
PIT? - B. aphidicola VVRSQSYNSIKNIKNTKLLLKN-ISNYNDLSIKKRFQLRHYLLCISDSIDKKVN--SSDI 
PA4292 - P. aeruginosa FYRCDPKQTEPTINALLRDLRG-VPSYNDLDADERVQVRRYLLCLDDTAKKVGK--LSDL 
PA0450 - P. aeruginosa ASPELIPALAALTGSIGQEVKG-YGAFSRVPAEAMGNVRNDMYLTSEAIRLMDKDGVGRF 
MLL367 - R. loti WNDQTTAALQTYIHNTTAGLQP-YATVDNVPTDLVSNARNDIYLIGEALKLIDKKKLLPM 
SA0619 - 5. aureus --------------------------------------------------------N---
Lmo0405 - L. n10nocytogenes--------------------------------------------------------K---
PITH - 5. coelicolor --------------------------------------------------------D---
PIT? - L. innocua --------------------------------------------------------T---
PIT? - B. subtillus --------------------------------------------------------T---
PITH - 5. griseus --------------------------------------------------------G---
CAC3093 - C.acetobutylicum--------------------------------------------------------s---
PIT? - B. solanacearwn --------------------------------------------------------S---
PIT? - R. meliloti --------------------------------------------------------G---
PIT? - R. loti --------------------------------------------------------G---
PITA - E. coli 
PITA - 5. typhinmrium 
PITB - E. coli 
PIT? - Y. pestis 
PIT? - B. aphidicola 
PA4292 - P. aeruginosa 
SADDQRLLKKLKSDMLSTIEYAP-VWIIMAVALALGIGTMIGWRRVATTIGEKIGKI<:GMT 
SSDDQRLLKKLKTDMLSTIEYAP-VWIIMAVALALGIGTMIGWRRVATTIGEEIGKI<:GMT 
SI<:EDQNLLKKLRSDMLSTIEYAP-VWI IMAVALALGIGTMIGWRRVAMTIGEKIGKRGMT 
SAENRRFLNNLRTDLLDTVEYA1 -TWIIVAVALALSLGTMVGWRRVAVTIGEKIGKEGMT 
CSKDKRFLIHSKKVILKTIEYAP-MWIILIVALSLSIGTMIGWKRIVVTIGEKIGEKRMT 
PAREKADLEKLRKDLTATTEYAP-FWVIIAVALALGIGTMVGWKRWLTVGEKIGKQGMT 
PA0450 - P. aeruginosa DADTRGKLQAFKQKIDDATI<FI P-LWVKIAVAIALGLGTJVNGWKRIVVTVGEKIGKTHLT 
MLL3 67 - R. loti EAADLKAVTDYHKAVDNATKFI P- HNKVAVALALGLGTMVGWKRIVVTVGEKIGKSHLT 
SA0619 - 5. aureus -----------------DGSVE PQLWVKFACATAMGLGTAIGGWKIIKTVGGNIMK--IR 
Lmo04 05 - L. monocytogenes------------------ESAG PFvNQVSCJIASMAIGSSVGGYRIIKTVGTKIMK-- IT 
PITH - 5. coelicolor -----------------YGDPI P-VWVKLACALMLSLGTYAGGWRIMRTLGRKIIE--LD 
PIT? - L. innocua ---------- ----- -- --TDD~QLvNQVSCAIAl"lAIGTS IGGWKIIKTVGGFIMK-- II{ 
PIT? - B. subtillus -----------------S-AND[PTWVQFACATAMGLGTSIGGWKIIKTVGGKIMK--IR 
PITH - 5. griseus -----------------PNDEI P-VWVKIACl\LMLSLGTYAGGWRIMRTLGRKIIE--LD 
CAC30 93 - C. acetobuty licum--- ----- -- --- -----S-FTVIJ?-Jl,WVKA.l>..CAIAMAFGTSFGGYRI IKTMGMNM .. l>..K-- LA 
PIT? - B. solanacearu1n -----------------ATAST PIWVIVCCYVAIGMGTLLGGWRIVRTMGQKITK--LK 
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related species (Figure 6.11 B - conserved region 1 ). It is interesting to note that these 
amino acids are in the small section of the C-terminal PD 113 1 domain which is 
immediately followed by a region of high variability between many PiT family 
members (Figures 6.12, 6.1 lB). 
6.6 Discussion 
Single polar amino acid substitutions of residues His-225, Asp-229 or Lys-232 in PitA 
produced assembled proteins with greatly decreased rates of Pi uptake, indicating the 
importance of these charged residues in Pit structure/function. PitA/PitB chimeras 
show that the adjacent putative loop 5 region plays a role in determining the affinity of 
these transporters for Pi. Therefore this putative 'loop 5/helix 6' section of the protein 
is important for function and is probably involved in the mechanism of Pi transport. 
However, where these regions are in relation to the membrane is not known because the 
topology of PitA and PitB is uncertain. 
The individual PitA mutations of H225Q, D229N and K232Q reduce initial rates of Pi 
transport to less than 3% of wild type activity. This triad has a resemblance to the 
arrangement of functionally important residues on lactose permease a-helix 10 (Figure 
6.1) consistent with placement of these residues within TM 6 of the putative topological 
model (Figure 6.2). While secondary structure prediction programs did not place this 
triad of amino acids within the membrane, this modification was made to our models 
because the unfavourable insertion of charged residues into a hydrophobic environment 
can be mediated by interactions with other charged residues, and such interactions 
cannot be predicted by these programs. 
There is some evidence suggesting that Lys-232 may play a different role in Pit 
structure or function to His-225 or Asp-229. The PitA K232Q mutation has decreased 
levels of membrane protein assembly when compared with PitA mutants H225Q and 
D229N, or PitA expressed on plasmids (Figure 6.4). It is interesting to note that 
Kaback's most recent model for lactose permease predicts that Lys-319 forms a salt 
bridge with Asp-240, while His-322 and Glu-325 play more direct roles in 
lactose/proton transport (Section 1. 9 .2). Evidence indicating the possibility of a Lys-
319/ Asp-240 salt bridge came from the double neutral mutation of K3 l 9C/D240C 
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producing activity and a normal amount of protein assembly (222). Lys-319 may still 
be important for modulating the proton transfer capabilities of nearby residues ( e.g. 
influencing pKa) (209). Thus it is possible that Lys-232 in PitA may form part of a salt 
bridge that is disrupted by the K232Q mutation. While the Pit HxxxDxxK triad is 
conserved in the Pit proteins of species closely related to E. coli (mauve boxes -Figure 
6.13) more distantly related organisms, such as eukaryotes, have the sequence 
HxxxDxxN (conserved region 1 - Figure 6.1 lB), where Lys has been replaced by the 
polar amino acid Asn. This does not necessarily mean that the role of this residue has 
changed. Recent experiments on models of inter-helical interactions show that Asn 
residues can form strong hydrogen bonds within membranes, and that these interactions 
are strong enough to form dimers that can be isolated by SDS gel analysis (20, 36, 308). 
Perhaps organisms containing an Asn in this strongly conserved sequence have 
replaced a salt bridge with a hydrogen bond. Further experimentation is required 
before any conclusions can be made. 
It is also possible that His-225, Asp-229 and Lys-232 may be functionally important, 
but located within the periplasm. Topology prediction programs and hydropathy 
profiles place these amino acids at the periplasmic surface of PitA/PitB (Figure 3 .15), 
and predictive methods also place the equivalent residues of other members of the PiT 
family, such as mammalian transporter PiT-2, in a similar location (229). Pit models A 
and B (Figure 6.2) can easily be adjusted place these residues in the periplasm by 
pulling the last third of putative loop 5 into the membrane. If so, the last part of 
putative loop 5 would be a transmembrane helix. This is predicted by the hydropathy 
profile, which shows that the first two thirds of putative loop 5 is highly charged, ( with 
a lot of amino acid variability between PitA and PitB), while the last third is 
hydrophobic, ( and has a more highly conserved sequence). Located within this putative 
transmembrane region is Ala-213. Replacement of this residue by Asp prevents 
assembly of the PitA protein, indicating it may be located in an area sensitive to charge. 
The pitA 1 mutation G220D, predicted to be within TM helix 6 in all models, also 
prevents assembly and functioning of the PitA protein. Eight other Asp substitutions in 
the putative hydrophilic loops of PitA allow the growth of these strains on Pi Media 
(Table 6.3), showing that Asp amino acid substitutions are rarely so detrimental in the 
loop regions of this protein. 
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PitA/PitB chimeras which have exchanged a region containing the putative 'loop 
5/helix 6' show that this sequence influences the Km app of each protein. The PitA 
'loop 5/helix 6' region placed within PitB gives this chimera a more efficient PitA-like 
Kmapp while the complementary chimera (PitB 'loop 5/helix 6' in PitA) has a higher 
Kmapp similar to that of PitB (Table 6.4). Thus this region seems to be important for 
substrate affinity. The exchanged region referred to as 'loop 5/helix 6' contains all the 
amino acid changes within the putative loop 5 (including L216V in the hydrophobic 
section), 1219A at the 'loop 5/helix 6' interface plus two other conservative changes 
(1242V, V244I) that reside at either the beginning of the large loop 6 (Model A) or the 
interface between the small loop 6/helix 7 (Model B) (See Figure 6.10). Most amino 
acid variation occurs within putative loop 5, which is highly positively charged and 
placed in the cytoplasm of all topological models. PitA contains 13 positive and 3 
negatively charged amino acids and PitB contains 16 positive and 4 negatively charged 
amino acids in the 42 residue loop. However, this variable region of 'loop 5' is only 
present in PiT family members which are closely related to E. coli (Figure 6.13), so it is 
unlikely to contain particular residues that are essential to a conserved Pi transport 
mechanism. Possibly amino acid residues in this loop interact with a-helix 6 and 
participate indirectly in the transport mechanism. Mutagenesis of individual amino 
acids that differ between PitA and PitB is required to determine the role of this region. 
These results do imply that putative TM helix 6 and its surrounding sequences are 
involved in the transport pathway of MePO4/H+. Determining the topology of this 
region will be an important step in defining the mechanism of Pit. 
The small 3-fold difference in Kmapp between PitA and PitB makes it difficult to 
interpret results for the remaining chimeric proteins, as variations between whole cell 
assays could obscure small to moderate alterations in kinetic parameters. PitB chimera 
containing PitA 'loop 6 'may slightly decrease the affinity for substrate and lower the 
activity of the transporter, but this may be due to nonspecific unfavourable interactions 
between the variable regions of the chimera. The complementary chimera (PitB 'loop 
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6' in PitA) has kinetic parameters almost identical to wild type PitA protein, suggesting 
that this highly variable region has little effect on the mechanism of Pi transport in Pit. 
Multiple sequence alignments of 68 PiT family PD 1131 domains identify eight highly 
conserved sequences that will also be useful targets for mutagenesis as these are 
conserved amongst distant species, suggesting that these regions may be important for 
transporter function (229). The His-225, Asp-229, Lys-232 triad forms part of one of 
these sequences, and there is evidence that other conserved sequences may be essential. 
For example the mutated PitA(I413D G414L) protein produces an assembled 
membrane protein that is nonfunctional, thus these mutations are more disruptive than 
the H225Q, D229N, or K232Q substitutions. Ile-413 and Gly-414 are predicted to be 
in either a cytoplasmic (Model A) or periplasmic (Model B) loop containing several 
charged side chains, and this region is also predicted to be within a cytoplasmic loop in 
PiT-2 (229). This degree of disruption is unexpected in a hydrophilic loop, as shown 
by the eight other Asp substitutions in the putative hydrophilic loops of PitA allow the 
growth of these strains on Pi Media (Table 6.3 ). However, Ile-413 and Gly-414 are at 
the end of one of the highly conserved PiT family sequences, and Gly-414 is strongly 
conserved within many of these proteins. Thus this region may play an important 
structural or functional role in Pi transport. 
The predicted topologies of other PiT family transporters such as PiT-2, Pht2; 1 and 
Pho89 bear some similarities to PitA and PitB models ( 4 7, 196, 197, 229). The 
mammalian type III NaPi transporter PiT-2 is predicted to have a similar topology to 
PitA for the first five transmembrane helices, three of which form the conserved N-
terminal PD 1131 domain. This topology has been confirmed experimentally by 
antibody tagging, identification . of glycosylation sites, and C-terminal truncation 
tagging, showing that the N-terminus plus loops 2 and 4 are extracellular. However 
experimental evidence indicates that the predicted topology for the remainder of the 
PiT-2 protein is incorrect. While there is less experimental support for the topology of 
the latter half of the protein, tagging experiments indicated that the C-terminus and loop 
8 are extracellular, while functional evidence places loop 7 intracellular and loop 8 
extracellular (229). This model then implies that the C-terminal PD 1131 domain of 3 
transmembrane helices has an inverted topology. This inverted topology has also been 
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predicted for the yeast Pho89 protein and the Arabidopsis Pht2; 1 protein ( 4 7, 196, 197). 
The presence of internal repeats with opposite membrane topologies has also been 
shown for the E. coli YrbG protein. PhoA fusions were used to confirm that this 
putative Na+ /Ca2+ exchanger consists of two sets of five transmembrane segments in 
opposite orientations (219). 
The predicted topology for the first 5 transmembrane helices of PitA and PitB is 
consistent with experimental data from PiT-2. However the topology is less clear for 
the C-terminal half of the proteins. The PiT-2 cytoplasmic loop 8, which coincides 
with the retroviral Region A binding site, is located where the large variable loop of 
PitA/PitB interrupts the C-terminal PD 1131 domain (See multiple sequence alignment, 
Figure 6.1 lB). This should unambiguously locate this area of PitA/PitB at the 
periplasm. However this large variable region, which is only found in the Gram-
negative bacteria that are closely related to E. coli, contains an extra hydrophobic 
region which has the potential to form a transmembrane helix. If this potential a-helix 
(between G23 3 and T261) is inserted in the membrane then the remainder of the C-
terminal PDl 131 domain is in the same orientation as the N-terminal domain (Table 6.1 
- transmembrane region 7, Figure 6.2 - Model B), while ignoring this potential a-helix 
causes the remainder of the C-terminal PD 1131 domain to be inverted (Figure 6.2 -
Model A). 
A number of topology prediction programs have been developed since the initial 
analyses used to form models for PitA and PitB. As more information on membrane 
proteins has become available new methods using neural networks (PHD - (215)) or 
Hidden Markov Models (TMHMM - (135), HMMTOP - (261)) have been formulated. 
von Heijne's group (185) have determined that if four or five methods ( out of five) 
agree on their topology predictions for a particular protein then experimental results 
show that these predictions are over 90% correct, (by analysis of 60 proteins of known 
topology). However this agreement between programs applies to only half the potential 
inner membrane proteins of E. coli, and PitA and PitB do not form part of this group 
(web site http: //www.sbc.su.se/,--johan/Very_Reliable_Topol_Pred.html, PitA -
EG12230, PitB - EG12883, (185)). Application of the TMHMM program to PitA and 
PitB produced topologies of 10 transmembrane helices quite similar to those of the 
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TopPred IV and GES profiles, but with a-helix 9 moved towards the N-terminus by at 
least 11 residues (G4 l 8 to T440). 
Locating the environment of amino acids His-225, Asp-229 and Lys-232, either within 
a transmembrane helix or within the periplasm, is important for determining the 
strategy of future mutagenesis studies. Therefore defining the topology of PitA, 
particularly around TM helix 6 and the latter half of the protein, will be very helpful. 
Sandwich fusions with bacterial alkaline phosphatase, which is active only when 
located in the periplasm, could be used to refine this topology (55). 
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7.1 Introduction 
PitA and PitB have been characterised as individual genes of E. coli with open reading 
frames of 1500 bases starting at the predicted A TG start codons. Each protein was 
shown to function as a Pi transporter, providing the first evidence of two E. coli Pit 
transport systems. Kinetic parameters were defined for the plasmid-borne Pit genes, 
showing PitA to have a Kmapp of about 2µM and PitB to have Km app of around 28µM. 
However, subsequent experiments indicated that the PitB gene undergoes some form of 
repression and/or activity modulation that affects these parameters, so at this point the 
kinetic determinations are relevant only to the specific assay conditions. Kinetic 
parameters that accurately reflect the characteristics of PitA and PitB in wild type cells 
can only be defined once these issues of regulation and/or modulation have been 
addressed. Therefore this thesis has evolved into two projects - the regulation of pitB 
and the characterisation of PitA/PitB structure and function. 
7.Z Regulation of the Pit system 
The pit lesion of strain K-10 was identified. K-10, which has no pit activity when its 
Pst system is mutated, contains a point mutation of G to A at nucleotide 658 in pitA 
causing a G220D substitution in the PitA protein, and a wild type pitB. (The pitA point 
mutation is discussed later.) PCR amplification of AN3066 genomic DNA showed that 
the pitB protein coding sequence and putative promoter region (for at least 319 
upstream nucleotides) were wild type. pitB was originally isolated by its ability to 
transport Pi, and can function as an independent Pi transporter on plasmid pBR322. 
This suggested that genomic pitB may undergo repression that is disrupted by placing it 
on a plasmid, and is the first evidence for regulation of the E. coli Pit system. The use 
of a PitB polyclonal antipeptide antibody clearly demonstrated that PitB activity was 
linked to the levels of PitB protein in cell membranes, so this regulation may occur at 
the level of transcription. The Pi auxotrophic background strains AN3066 and AN3902 
contain a pstC345 deletion that causes constitutive expression of the pho regulon. 
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While most genes of this regulon are activated there is also some evidence for gene 
repression (9, 244, 271, 291). The possibility that the phoB-phoR two component 
regulatory system may mediate this repression was explored by deleting this operon 
from Pi auxotrophic strains that contained either genomic pitB+ (pitA pstC) or no Pi 
transporters (pitB pitA pstC). Unexpectedly, the phoB-phoR deletion allowed both 
strains to grow on media containing 500µM Pi. However, assays of Pi uptake using 
6µM Pi showed that the pitB+ strain, AN408 l, had a significant initial rate of Pi 
transport while the control strain AN4085 had Pi uptake that was not significantly 
above background levels (Table 5.2). Thus, the presence of an active phoB-phoR 
operon mediates the repression of genomic pitB. This finding is significant, as it 
provides the first definitive evidence of PitB regulation. This regulation of pitB may 
explain why, despite extensive characterisation of Pit, previous research identified only 
one pit lesion (pitA) whose gene appeared to be constitutive in expression/activity (59, 
211,212,249,289). 
Transcriptional regulation of pitB by PhoB is the most likely mechanism of regulation. 
The above strains could be analysed by Northern blot to determine if an increase in pitB 
mRNA correlates with the presence of Pi uptake mediated by deleting phoB-phoR. 
Reporter genes may also be used to measure levels of transcription. A reporter gene 
such as ~-galactosidase (lacZ) could replace part of the open reading frame of pitB, or 
be fused near the C-terminus of this gene (activity requiring a cytoplasmic location). It 
would be important to place this pitB::lacZ fusion on the genome, as plasmid-borne 
pitB is not repressed by the pho regulon. The ~-galactosidase activity of wild type 
cells and the mutants described above could then be assayed under a variety of Pi 
concentrations. Rhizobium meliloti contains a pit equivalent that is repressed under 
conditions of Pi limitation. A chromosomal R. meliloti orfA-pit::lacZ fusion was used 
to show that expression of this operon becomes constitutive in a phoB mutant (8} It is 
likely that regulation of pitB in E. coli is similar. 
Repression of pitB may occur directly through the binding of PhoB, or may be 
mediated by another product of the pho regulon. It has been proposed that PhoB can 
cause repression by binding in atypical locations on the promoter. Genes repressed by 
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an active phoBR operon contain putative pho boxes in atypical locations (9, 244). 
Similarly, activation of the CreBC two component regulatory system causes repression 
of malE transcription. This gene has an atypically positioned "ere-tag" binding site 
within the transcript, rather than between -40 and -80 within the promoter (see Chapter 
five discussion, Section 5.6, for details) (7). However, there is no direct experimental 
evidence to support this theory. 
pitA and pitB form a good comparative system for analysis of putative PhoB binding or 
regulation, as pitA appears constitutive while pitB undergoes regulation. A preliminary 
analysis of the promoter sequences of these genes did not reveal any obvious pho boxes 
that are unique to pitB (Table 5.4). Thus, experimental analysis of these regions is 
needed. The putative transcriptional start sites should be confirmed for pitA and pitB 
by primer extension analysis, to define the promoters for each gene. The DNA of these 
promoter regions could be tested for PhoB binding in vitro by the use of electrophoretic 
mobility shift assays. Alternatively, DNase 1 footprinting could be used. This would 
also identify the region of PhoB binding, if it occurred. As proposed atypical binding 
sites occur before the -35 promoter region and after the transcriptional start (7, 9, 244) 
the analysed pitA/pitB DNA sequences should extend past these regions. Potential 
mechanisms of repression include the presence of divergent promoters, so binding to 
either DNA strand is a possibility (279). 
Profiling pitB expression and activity with a normal pho regulon under a variety of Pi 
concentrations will be important for gaining an understanding of pitB regulation. While 
the identification of genomic pitB activity in the presence of a phoB-phoR deletion is an 
important first step, mutations in the phoBR two component regulatory system can have 
wide ranging effects that may interfere with a detailed analysis of pitB regulation. For 
example, experiments on phoR mutants suggest that histidine kinases from other two 
component regulators 'cross talk' with PhoB in the absence of the PhoR protein. This 
activation may not be physiologically significant in wild type cells (7, 66, 125, 283). 
Mutations in over 14 genes have also been shown to dramatically alter alkaline 
phosphatase synthesis (which acts as a reporter of pho regulon activity) in phoR 
mutants via unknown mechanisms which may involve other two component regulatory 
systems (125). Whether 'cross talk' can also occur at the transcriptional activator level 
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in phoB mutants has not been investigated. Deletion of the phoB-phoR operon alters 
the expression of over 100 genes within the pho regulon (271). This may have many 
unexpected consequences, such as was shown by the induction of low level Pi transport 
when phoB-phoR was deleted from the Pi auxotrophic pitA pitB pstC triple mutant 
(Section 5 .5.2). Thus, a clear picture of normal pitB expression may be obtainable only 
in the presence of wild type phoBR and its associated regulators. 
All work described in this study used the pstC345 deletion to prevent Pi uptake by the 
Pst system. This mutation causes constitutive derepression of the pho regulon. Cox et 
al ( 43, 44) have described several PstA and PstC mutations which prevent Pi transport 
without causing constitutive derepression of the pho regulon ( as measured by alkaline 
phosphatase activity, a protein that is activated by the pho regulon). These Pst 
mutations may provide a better background strain for analysis of pitB regulation. 
However, as we do not fully understand the role of the Pst system in the control of the 
pho regulon, we cannot be sure that this regulon remains unaffected by these Pst 
mutations. Thus the pstSCAB U operon may also need to be wild type for unambiguous 
results. 
Analysis of pitB transcription through the use of northern blots or reporter genes allows 
the detection of pitB mRNA or transcription in the presence of wild type Pst, PitA and 
phoBR systems. These methods may be used to compare pitB expression between wild 
type cells and those containing the mutations i1(phoB-phoR) (no pho regulon activation) 
or i1pstC345 ( constitutive pho regulon activity) under different Pi concentrations. The 
levels of pitB mRNA or transcription may also be determined for previously 
constructed strains with varying levels of PitB protein expression. In particular, 
analysis of strains containing plasmids pAN656 and pANl 116 could determine if an 
increase in transcription is involved in the higher levels of Pi uptake and protein 
expression which occur upon deletion of 1196 nucleotides upstream of the pitB open 
reading frame (See Chapter 5, Section 5.4). 
It is probable that increased PitB Pi uptake and protein expression involves an increase 
in pitB transcription. Placing wild type pitB on a plasmid allowed a formerly Pi 
auxotrophic pitA pstC strain to transport Pi, while Hoffer et al (99) demonstrated that 
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the presence of multiple genomic copies of wild type pitB had a similar effect on a Pi 
auxotrophic pitA ps tS strain, consistent with titrating out a repressor protein. An 
increase in Rhizobium. meliloti pit transcription, caused by either placing this gene on a 
plasmid or by the presence of a single thymidine deletion 54 nucleotides upstream of 
the or/A-pit operon transcription start site, has been shown to overcome the effects of 
constitutive expression of the pho regulon (9). This required only a two- to three-fold 
increase in pit expression, as measured by an or/A-pit: :lacZ fusion. 
However, a viable alternative to transcriptional activation is the enhancement of mRNA 
stability. This post-transcriptional mechanism has been shown to occur for the Pi 
transporter PiT-2 in human cell lines, as a response to Pi depletion (35). Thus, this 
mechanism cannot be ruled out for pitB. Any increase in pitB mRNA found by 
northern blot analysis could then be checked by the reporter gene system to determine 
if pitB promoter activity has also increased. Timed quantitative Northern blot 
experiments could also be carried out to detect changes in mRNA stability, or real time 
PCR could be used. 
However, increasing the levels of pitB mRNA by transcription and/or enhanced mRNA 
stability, does not explain all of the regulatory effects observed in this transport system. 
The decrease in Km app noted for PitB expressed with only 207 upstream nucleotides 
(pANl 116) indicates a different mechanism of activity is occurring. This change in 
substrate affinity may be due to post-translational modifications stimulated by the 
increased PitB protein expression. Post-translational activation involving the 
aggregation of mammalian Pit-2 transporter has already been observed (207, 229). 
Cross-linking or the use of native polyacrylamide gel electrophoresis may be used to 
determine if PitB forms a homo-oligomer. An alternative explanation for the altered 
mechanism of PitB could be that an inhibitor which interacts with the PitB protein may 
be diluted out by the increased PitB expression. The presence of a second conserved 
gene, called the 'Pit accessory protein', which is found in the same operon as the pit 
gene in many bacterial species could indicate the involvement of another protein in Pit 
function or regulation. This situation has recently been demonstrated for the high 
affinity ammonium transporter, AmtB, of E. coli. Most prokaryotes and archaea 
encode at least one Amt protein, which is almost always found in an operon together 
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with a second gene (glnK) that encodes a small signal transduction protein involved in 
sensing the cellular nitrogen status (3, 257). Coutts et al ( 41) have demonstrated that 
GlnK acts as a negative regulator of AmtB activity by binding to the membrane 
(probably through direct association with AmtB) when nitrogen supplies are plentiful. 
Under low nitrogen conditions GlnK is uridylylated and is not strongly membrane 
associated. The glnk-amtB operon is also repressed by transcriptional regulation 
through the NtrB/NtrC two component regulatory system when nitrogen is plentiful. It 
is suggested that GlnK regulation can fine-tune the activity of AmtB in response to 
minor or transient fluctuations in ammonium availability. A second protein 
homologous to GlnK (GlnB) is also present in E. coli. Thus, this system could provide 
a viable model for Pit regulation. However, E. coli does not encode a 'Pit accessory 
protein', either in an operon with pitA or pitB, or elsewhere on the genome (by Blast 
sequence similarity analyses using several 'Pit accessory protein' amino acid 
sequences). 
It is also possible that pitB expression or activity is moderated by environmental 
conditions such as pH or sodium ion concentration. The PiT family of transporters 
contains several members that are induced by Pi limitation but also require specific 
conditions, such as an alkaline pH, for activity. pho89, a Pit-like Na+-Pi transporter 
from Saccharomyces cerevisiae, is induced by Pi limitation but needs alkaline 
conditions and Na+ to function (168). Similarly, pho-4 from Neurospora crassa codes 
for a Na+ /H+ /Li+ -Pi transporter induced by low Pi concentrations that is dominant at 
pH8 and above (274). Thus the activity of PitB (in a strain where genomic pitB is 
expressed) under different pH and sodium ion concentrations could be investigated. 
However, experiments checking the initial rates of plasmid-borne PitA (6µM Pi) and 
PitB (30µM Pi) over the pH range of 6.8-7 .6 found little change in activity (results not 
shown). Activity over a wider pH range could be investigated. 
Genomic pitB may produce a much lower level of Pi uptake than either PitA or the Pst 
system. For example, the Pit-like pho89 from Saccharomy ces cerevisiae has low 
activity levels and it can only be studied when the unrelated H+ -Pi transporter pho84, 
which is also induced by Pi limitation, is mutated ( 168). 
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While pitA does not appear to be regulated by the phoBR operon, other forms of 
activity modulation cannot be ruled out. The plasmid-borne PitA Km app of around 2µM 
is significantly lower than the 11.9 - 38µM range recorded by researchers using 
genomic pit genes (211) (290) (268). Western blot analysis shows that placing pitA on 
a plasmid correlates with a significant increase in protein expression (Figure 4.5 - first 
two lanes). Further analysis of genomic and plasmid-borne PitA kinetic parameters 
should determine if this transporter also undergoes changes in substrate affinity. Thus, 
Pit regulation may be quite complex. As shown above, many organisms contain at least 
two Pit genes, and some of these genes are accompanied by Pit accessory proteins, 
whose function has yet to be defined ((8) and NCBI blast searches). 
7.3 Structure ana function studies on PitA and 
PitB 
PitA and PitB have 81 % identity in their deduced amino acid sequences. Similar 
topological models were produced for PitA and PitB using a combination of 
hydropathy profiles and topology prediction programs. These models have 10 
transmembrane a-helices, with most variation between PitA and PitB occurring in the 
hydrophilic loops (Figure 3 .15). Measurement of kinetic parameters initially showed 
that PitA had a Km app 14-fold lower than that of PitB. Therefore PitA and PitB formed 
a good comparative system where relationships between the kinetic parameters, amino 
acid sequences and the Pi translocation mechanism of a membrane transporter could be 
systematically explored. 
It was noted that His-225, Asp-229 and Lys-232, a triad of amino acids shared by PitA 
and PitB, were similar to Lys-319, His-322 and Glu-325 found in helix 10 of lactose 
permease. These amino acids play a role in the functioning of lactose permease, with 
the mutant H322R carrying out facilitated diffusion without proton translocation (117), 
and neutral substitutions of Glu-325 and Lys-319 exhibiting no active transport or 
efflux while undergoing wild type levels of exchange and counter flow (29, 30, 209). 
Subsequent mutagenesis studies showed that the neutral combination of K319C/D240C 
had activity and normal protein assembly, suggesting this pair may form a salt bridge 
(222). Kaback's latest model incorporates this data, with His-322 and Glu-325 forming 
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part of the proton translocation pathway and Lys-319 playing a structural role as part of 
a salt bridge with Asp-240 (223). (This model is discussed in more detail in Section 
1.9.2 and Figure 1.5.) 
Polar substitutions of the equivalent amino acids in PitA (H225Q, D229N and K232Q) 
resulted in decreased initial rates of Pi uptake to less than 3% of wild type PitA, while 
allowing growth on 500µM Pi media (Table 6.2, Figure 6.3). Thus, these amino acids 
play an important role in Pit structure or function. The subsequent sequencing of 
putative Pit genes from many different species reveals that this sequence is highly 
conserved in the PiT family, although more distantly related organisms such as 
eukaryotes contain HxxxDxxN rather than HxxxDxxK. The PitA K232Q substitution 
had lower levels of protein assembly than H225Q, D229N or wild type PitA (Figure 
6.4), indicating that this mutation may have some effect on protein assembly. Perhaps 
Lys-232 forms a salt bridge, as Lys-319 is proposed to in lactose permease. In some 
PiT proteins this lysine residue is replaced by an asparagine residue, which may form a 
hydrogen bond rather than a salt bridge (20, 36, 308). 
The PitA H225Q, D229N and K232Q single mutants could be further characterised 
through measuring the Pi uptake, facilitated diffusion, efflux and exchange of 
proteoliposomes from cells carrying the above mutants or wild type PitA (268). These 
results may provide information on what aspect of the mechanism has been affected, 
such as substrate binding, substrate and/or proton translocation. PitB could also be 
characterised in this way. 
The initial mutagenesis experiments on His-225, Asp-229 and Lys-232 indicate that 
these amino acids play important roles in Pit structure or function. In the proposed 
PitA topology model, these residues were moved into a transmembrane helix because 
of the analogy with lactose permease (Figure 6.2). This topology is not predicted by 
any sequence analysis program. These topology prediction programs often under-
represent the presence of charged or polar amino acids within the membrane, as they 
cannot predict the interactions that make these insertions more favourable. 
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However, the predicted model is still a viable option. It is possible that His-225, Asp-
229 and Lys-232 may be structurally or functionally important, but located within the 
periplasm. The PiT family contains an internally repeated domain, PD 1131, and these 
three amino acids form part of the first highly conserved sequence in the N-terminal 
PD 1131 domain. The proposed topology for several PiT family members places this 
N-terminal conserved sequence just inside the periplasm, and the equivalent C-terminal 
conserved sequence just inside the cytoplasm. In all Pit topology models this C-
terminal conserved sequence is also located in the cytoplasm (Figures 3.15, 6.2). 
However, most of these topologies have yet to be supported by experimental data, and 
analysis of mammalian PiT-2 showed the last half of the protein's topology differed 
from that suggested by predictive programs (229). 
Therefore defining the environment of His-225, Asp-229 and Lys-232 is crucial for 
progress in elucidating the mechanism of PitA, and this should be carried out before 
any further mutagenesis studies are undertaken. This area of PitA is obviously 
important for the mechanism. As well as containing the above triad of amino acids, this 
putative transmembrane helix plus the putative loop 5 region contains amino acids 
determining the difference in Km app between PitA and PitB, as shown by chimera 
analysis (Section 6.4, Table 6.4, Figure 6.10). Nearby single mutations G220D and 
A213D cause complete loss of Pi uptake and minimal insertion of protein in the 
membrane (Figures 6.5, 6.6). 
Bacterial alkaline phosphatase sandwich fusions could be used to define the topology of 
PitA. This has been successfully used in other systems, such as the aromatic amino 
acid permease, AroP (39), and the phenylalanine-specific permease, PheP (198). The 
alkaline phosphatase reporter gene would be inserted within pitA near the end of 
putative periplasmic and cytoplasmic loops. The alkaline phosphatase protein is only 
active in the periplasm, and the sandwich fusion approach has the advantage of 
including the entire pitA sequence, leading to less ambiguous results (55). Analysis of 
the last half of PitA should easily determine if the protein has 9 or 10 transmembrane 
regions. Carefully targeted sandwich fusions within the putative transmembrane helix 
6 and the following loop should then be able to locate His-225, Asp-229 and Lys-232 
within either the membrane or the periplasm, as experimental evidence suggests that 
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approximately half of a transmembrane domain is needed to translocate the alkaline 
phosphatase protein through the membrane to the periplasm (118). Alternative 
approaches that could be trialed if the results of this experiment are ambiguous include 
the use of site-directed mutagenesis with biophysical labels to determine the 
environment of these amino acids, and the deletion of single amino acids at the putative 
helix/loop boundaries of helix 6, as described for lactose permease in Section 1.9.2. 
The proximity of other a-helices may also be determined through double labeling 
experiments, as for lactose permease (Sections 1.8.2, 1.9.2). 
Defining the PitA topology will allow more appropriate targeting and analysis of amino 
acids important for function and/or structure. If His-225, Asp-229 and Lys-232 are 
located in the membrane, different substitutions for each amino acid, such as H225R or 
H225F, may help determine if a certain charge or the presence of a dissociable proton is 
required for function. These amino acids may interact with each other and with other 
charged amino acids, which may also be located within the membrane. Interacting 
amino acids are often identified by second site suppressor mutagenesis. These 
experiments start with a detrimental mutant of an important residue ( such as a neutral 
substitution of a charged residue) and identify spontaneous mutations within the protein 
that confer activity. However, this powerful system may be difficult to use on PitA. 
Firstly, conditions would need to be established where a PitA mutant such as K232A 
produced negligible growth ( e.g. media with a very low Pi concentration) or could 
otherwise be distinguished from suppressor mutants. Then an effective screening assay 
for the identification of pitA suppressor mutants would need to be established. This 
may prove difficult, as mutations elsewhere in the E. coli genome (such as deleting the 
phoBR operon) are also able to confer Pi transport on Pi auxotrophic strains. Hoffer et 
al (99, 100) tried to create suppressor mutations in Pi auxotrophic ps tS strains, and 
identified pitA and pitB pseudo-revertants instead. With lactose permease Lee et al 
( 143) could only use this method when they assayed for melobiose fermentation as 
frequent mutations in the lac repressor created too many background cells with lactose 
transport, preventing the identification of genuine suppressor mutants. An alternative 
but more labour intensive approach is identify charged amino acids that may have the 
potential to interact with His-225, Asp-229 or Lys-232 and replace them with neutral 
substitutions via site-directed mutagenesis. Possible residues to mutate include Glu-27, 
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which is within TM 1 of all models and is conserved as a negatively charged residue 
(Glu or Asp) in the putative Pit sequences of many Gram negative bacteria. Model B 
(Figure 6.2B) also places Glu-259 within TM 7, so this should be tested. Other 
residues to check include Glu-3 80 and Asp-3 7 4, if the C-terminal end of the large 
variable loop is moved into the membrane. Any detrimental single mutants could then 
be analysed further. If the formation of a salt bridge is suspected a double neutral 
mutant could be constructed, to see if Pi uptake activity and/or protein assembly is 
increased. 
Russ et al (216) have identified GxxxG as a strong helix packing motif, which can be 
surrounded by a large variety of amino acids. This motif is strongly conserved in the 
N-PDl 131 domain of PiT proteins from distantly related organisms and is predicted to 
be within a membrane helix (putative TM 4 of PitA - Figure 6.12). The equivalent 
region in the C-PD 1131 domain contains alanine and serine substitutions in some 
proteins and is predicted to be in an aqueous environment in our models (SxxxG in 
putative loop 8 of PitA - Figure 6.12). Proteins closely related to PitA and PitB also 
have this GxxxG motif within the His-225, Asp-229 and Lys-232 sequence that has 
been shown to be important for Pit function (HGxNDGxQK) (near mauve boxes in 
Figure 6.13), which may support a membrane location for this sequence. However this 
particular GxxxG motif is not conserved in all PiT proteins. 
If His-225, Asp-229 or Lys-232 are found to be located in the periplasm mutagenesis 
studies may be used to analyse the role of these residues (such as in substrate binding or 
structure) and to identify other residues that may be involved in the MeHPOiH+ 
tmaslocation pathway. This model (Figure 3 .15) places Arg-211 in TM 6, so this 
residue should be changed to a neutral or polar residue. However, the amino acids 
involved in the translocation pathway need not be charged. 
Another useful strategy is to examine the other highly conserved regions in the PiT 
family. Conserved region 1, which contains the His, Asp and Lys triad in the C-
terminal PD 1131 domain of PitA and PitB, is more highly conserved in the N-terminal 
PDl 131 domain of the PiT family (region 1 in the first cytoplasmic loop - Figure 6.12) 
and targeted mutagenesis may be useful in defining its role. Disruption of these 
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conserved regions has already been shown to strongly affect Pit activity. For example, 
the PitA mutations I413D/G414L, which occur at the end of the third highly conserved 
region in the N-terminal PDl 131 domain, completely disrupted Pi uptake while 
allowing protein assembly (Figures 6.5, 6.6, 6.12). Further analysis of this area, 
through more conservative substitutions and mutagenesis of other conserved amino 
acids in this domain, may determine whether this region has a structural or functional 
role. Information can also be gained from analysis of the multiple sequence 
alignments, which may be useful for designing future experiments or models. An 
initial analysis shows that the putative TM 2 and TM 4 contain conserved glycines 
and/or alanines which is consistent with close packing between one face of each helix. 
It is interesting to note that the first cytoplasmic loop of the Major Facilitator 
Superfamily also contains a highly conserved region that is repeated later in the protein. 
This is thought to play a structural role as these proteins have many diverse substrates 
and often use different ions for energy coupling. Detrimental mutations (D68T or 
D68S) in this region of lactose permease led to many second site repressor mutations 
that appear to alter the helical topologies in the second half of the protein to facilitate a 
better interaction with the first half of the protein (Figure 7 .1 ). Therefore this region 
may be involved in global conformation changes in the protein (106). The conserved 
motif is GXXX(D/E)(RJK)XG[X](RJK)(RJK) (See Figure 1.6 for its location) (81), 
with mutations in GXXXD/E significantly inhibiting activity. The PiT family has a 
GXNDX motif in this location ( conserved region 1 ). Thus bulky substitutions at G and 
a conservative D to E substitution could be tried. 
Hoffer et al ( 100) have isolated an interesting pseudo-revertant for the PitA (G220D) 
mutation. The additional point mutation T4 l I was able to overcome the original 
G220D mutation to restore Pi transport, actually causing a greater degree of alkaline 
phosphatase repression when grown in high Pi media in comparison with the wild type 
PitA protein ( 100). This mutation may alleviate the protein assembly problems caused 
by G220D through either a direct interaction, such as removing an inappropriate charge 
interaction between the polar threonine and the negatively charged aspartic acid, or 
through some form of physical hindrance caused by the larger isoleucine side chain. 
While Thr-41, located several residues after the first highly conserved region within the 
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Figure 7.1 
Second site suppressor mutations in lactose permease produced in 
response to threonine or serine substitutions at Asp-68. 
This diagram is from Jessen-Marshall et al (106). 
Crosses mark the locations of the suppressor mutations which restored the ability of 
lactose permease with threonine or serine substitutions at Asp-68 to ferment 
melibiose. The suppressor mutation changes are Thr45Arg, Cys234Trp, Cys234Phe, 
Gln241Leu, Phe247Val, Gly257 Asp, Ser366Phe, Val367Glu and Ala369Pro. 
NH2 
' 
-POSITION 68, changed from 
ASPARTATE to THREONINE 
or SERINE 
Cytoplasm 
X-SECOND SITE MUTANTS 
first cytoplasmic loop (Figure 6.12), is conserved in most PiT family transporters, PitB 
has an alanine in this position (green box in Figure 6.1 lA). The Pi uptake and protein 
expression of this pseudo-revertant could be characterised. Perhaps PitB could be 
mutated to G220D, to see if this point mutation can also prevent Pit protein assembly 
and function with a nonpolar group at residue 41. 
The initial work on protein purification of PitA and PitB, plus the development of 
polyclonal antibodies for each protein, allows for the future optimisation of these 
methods. However, at this stage pure Pit protein is not required for the most relevant 
experiments for elucidating Pit regulation, structure or function. Pure protein could be 
used to form 3D crystals for X-ray crystallographic analysis, or for the formation of 2D 
crystalline arrays, tubes or single particles for cryo-EM analysis. However, the initial 
experiments in Section 3 .4 suggest obtaining enough pure Pit protein may be difficult. 
Providing pure protein or good quality 2D arrays is also just the first step towards 
solving the crystal structure of a membrane protein, as has been shown for lactose 
permease and the nicotinic acetylcholine receptor (94). It has taken almost 20 years to 
obtain an acetylcholine receptor structure with 4.6A resolution (175) and despite 
intense effort, the crystal structure of lactose permease has yet to be elucidated. 
Initial characterisation of PitA and PitB indicate that these proteins provide a good 
model system for examining the function and structure of the PiT family of 
transporters. This study also highlights the potential for pitA and pitB to form a good 
comparative system for examining repression mediated by the E. coli phoBR two 
component regulatory system - a form of regulation that has yet to be systematically 
explored. 
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